Download PNdex - กองควบคุมวัตถุเสพติด

PNdex ��.indd 5 24/3/2553 18:13:05 4th Edition ª×èÍË¹Ñ§Ê×Í ÀÒÉÒä·Â ÃÙ»áººàÀÊÑªÀÑ³±ÇÑµ¶ØÍÍ¡Ä·¸ÔìáÅÐÂÒàÊ¾µÔ´ãËŒâ·É »ÃÐà·Èä·Â 2553 ÀÒÉÒÍÑ§¡ÄÉ PNDEX THAILAND 2010 (Psychotropics & Narcotics Index 2010) ISBN 974-244-092-1 ¨Ñ´·íÒáÅÐ ÃÇºÃÇÁâ´Â ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ ÊíÒ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ ¡ÃÐ·ÃÇ§ÊÒ¸ÒÃ³ÊØ¢ â·Ã/â·ÃÊÒÃ 0 2590 7346 ÍÕàÁÅ : [email protected] àÃÕÂºàÃÕÂ§ ºÃÔÉÑ· ·ÔÁÊ (»ÃÐà·Èä·Â) ¨íÒ¡Ñ´ áÅÐ¨Ñ´¾ÔÁ¾â´Â 58-60 ÊØ¢ØÁÇÔ· 62 ºÒ§¨Ò¡ ¾ÃÐâ¢¹§ ¡ÃØ§à·¾Ï 10260 â·Ã 0 2741 5354 â·ÃÊÒÃ 0 2741 5360 All rights reserved. Ê§Ç¹ÅÔ¢ÊÔ·¸ÔìµÒÁ¾ÃÐÃÒªºÑÞÞÑµÔ AW_PNdex front 20100402.indd 1 2/4/2553 13:57:04 OBJECTIVES ÇÑµ¶Ø»ÃÐÊ§¤ 1. ÊíÒËÃÑºãªŒà»š¹¤Ù‹Á×Í¢Í§à¨ŒÒË¹ŒÒ·ÕèÊÒ¸ÒÃ³ÊØ¢ã¹¡ÒÃ¾ÔÊÙ¨¹àÍ¡ÅÑ¡É³ áÅÐÃÙ»¾ÃÃ³ (Identiﬁcation) ¢Í§ÇÑµ¶ØÍÍ¡Ä·¸Ôì áÅÐÂÒàÊ¾µÔ´ãËŒâ·É ¡Ã³Õ·Õèà¡Ô´ÍÒ¡ÒÃ äÁ‹¾Ö§»ÃÐÊ§¤¨Ò¡¡ÒÃãªŒÂÒ ËÃ×Í¡ÒÃãªŒÂÒà¡Ô¹¢¹Ò´ 2. ÊíÒËÃÑºãªŒà»š¹¤ÙÁ‹ Í× ¢Í§à¨ŒÒË¹ŒÒ·Õ»è Í‡ §¡Ñ¹áÅÐ»ÃÒº»ÃÒÁ´ŒÒ¹ÇÑµ¶ØàÊ¾µÔ´ã¹¡ÒÃ¾ÔÊ¨Ù ¹ àÍ¡ÅÑ¡É³ áÅÐÃÙ»¾ÃÃ³ (Identiﬁcation) ¢Í§ÇÑµ¶ØÍÍ¡Ä·¸Ôì áÅÐÂÒàÊ¾µÔ´ãËŒâ·É ¡Ã³Õ·ÕèÁÕ¡ÒÃ¡ÃÐ·íÒ½†Ò½„¹¡®ËÁÒÂ 3. ãªŒà»š¹¤Ù‹Á×ÍÍŒÒ§ÍÔ§ËÃ×ÍãªŒ»ÃÐâÂª¹Í×è¹æ ã¹·Ò§¡ÒÃá¾·Â ¤³Ð¼ÙŒ¨Ñ´·íÒ ·Õè»ÃÖ¡ÉÒ ¹¾.¾Ô¾Ñ²¹ ÂÔè§àÊÃÕ ¹¾.¾§È¾Ñ¹¸ Ç§ÈÁ³Õ ÀÞ.¹ÔµÂÒ áÂŒÁ¾ÂÑ¤¦ À¡.ÇÔâÃ¨¹ ÊØ‹ÁãËÞ‹ ¤³Ð·íÒ§Ò¹ àÅ¢Ò¸Ô¡ÒÃ¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ ÃÍ§àÅ¢Ò¸Ô¡ÒÃ¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ àÀÊÑª¡ÃàªÕèÂÇªÒÞ´ŒÒ¹ÃÐºÒ´ÇÔ·ÂÒ¢Í§ÇÑµ¶ØàÊ¾µÔ´ ¼ÙŒª‹ÇÂàÅ¢Ò¸Ô¡ÒÃ¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ ¹Ò§¨Ñ¹·¹Ò »Ò¹»ÃÕªÒ ¹ÒÂ¨ÔÃÇÑ²¹ ÈÃÕÁ§¤Å¡ØÅ ¹Ò§¨Ñ¹·¹Ò ¸ÃÃÁÇÕÃÐ¾§É ¹Ò§ÊØÀÒÇ´Õ ÇÑ¨¹Ð¾ÃÊÔ·¸Ôì ¹ÒÂ¸ÕÃÐ ªÑÂ¾ÔÃÔÂÐÈÑ¡´Ôì ¹Ò§¹ÑÂ¹Ò ¾ÑªÃä¾ÈÒÅ ¹ÒÂÊØ¹·Ã ¾Ø·¸ÈÃÕ¨ÒÃØ ¹Ò§¢¹ÔÉ°Ò µÑ¹µÔÈÔÃÔ¹·Ã ¹Ò§ÊÒÇ¸ÕÃ¸Ã Áâ¹¸ÃÃÁ ¹Ò§ÊÒÇ°»¹ÕÂ à¨ÃÔÞÊÔ¹ ¹Ò§ÊÒÇ¡ÁÅª¹¡ ÊØÃÔÂ¡ØÅ ³ ÍÂØ¸ÂÒ AW_PNdex front 20100402.indd 2 ¼ÙŒÍíÒ¹ÇÂ¡ÒÃ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ àÀÊÑª¡Ã ªíÒ¹ÒÞ¡ÒÃ¾ÔàÈÉ àÀÊÑª¡Ã ªíÒ¹ÒÞ¡ÒÃ¾ÔàÈÉ àÀÊÑª¡Ã ªíÒ¹ÒÞ¡ÒÃ¾ÔàÈÉ àÀÊÑª¡Ã ªíÒ¹ÒÞ¡ÒÃ¾ÔàÈÉ àÀÊÑª¡Ã ªíÒ¹ÒÞ¡ÒÃ¾ÔàÈÉ àÀÊÑª¡Ã ªíÒ¹ÒÞ¡ÒÃ àÀÊÑª¡Ã ªíÒ¹ÒÞ¡ÒÃ àÀÊÑª¡Ã ªíÒ¹ÒÞ¡ÒÃ àÀÊÑª¡Ã »¯ÔºÑµÔ¡ÒÃ àÀÊÑª¡Ã »¯ÔºÑµÔ¡ÒÃ 2/4/2553 13:57:04 CONTENTS ÊÒÃºÑÞ OBJECTIVES:วัตถุประสงค์ 2 HOWTOUSE:วิธีการใช้หนังสือ 5 PRODUCT IDENTIFICATION SEQUENCE ลำาดับการจัดภาพยาเม็ดด้วยสีรูปร่างและขนาด 9 PRODUCT IDENTIFICATION CHART หมวดรูปภาพเภสัชภัณฑ์ สีขาว สีเหลือง สีส้ม สีแดง สีชมพู สีมวง สีฟา/น้ําเงิน สีเขียว สีน้ําตาล สีเทา/ดํา หลายสี 10 14 15 16 16 19 19 21 23 23 23 PINK PAGES หมวดหน้าสีชมพู 10-39 40-61 CLASSIFICATION OF PSYCHOTROPICS AND NARCOTICS การจัดประเภทของวัตถุออกฤทธิ์และยาเสพติดให้โทษที่ขึ้นทะเบียน ในประเทศไทย 40 NATIONAL LIST OF ESSENTIAL MEDICINE (FOR PSYCHOTROPICS AND NARCOTICS) วัตถุออกฤทธิ์และยาเสพติดให้โทษในบัญชียาหลักแห่งชาติ 42 IMPORTANT DRUG NOTES ข้อมูลที่สำาคัญของตัวยาที่ขึ้นหรือเคยขึ้นทะเบียนในประเทศไทย 48 P2วัตถุออกฤทธิ์ในประเภท2 48 P3วัตถุออกฤทธิ์ในประเภท3 53 P4วัตถุออกฤทธิ์ในประเภท4 54 N2ยาเสพติดให้โทษประเภท2 58 N3ยาเสพติดให้โทษประเภท3 60 AW_PNdex front 20100402.indd 3 2/4/2553 13:57:04 4 INDEX หมวดดัชนีต่างๆ CONTROLLED SUBSTANCE CLASS ดัชนีเภสัชภัณฑ์เรียงตามประเภทกลุ่มยา และชื่อตัวยาจาก A-Z P2 วัตถุออกฤทธิ์ในประเภท 2 P3 วัตถุออกฤทธิ์ในประเภท 3 P4 วัตถุออกฤทธิ์ในประเภท 4 N2 ยาเสพติดให้โทษในประเภท 2 N3 ยาเสพติดให้โทษในประเภท 3 62-86 62 62 63 64 65 62-65 MANUFACTURER’S INDEX ดัชนีเภสัชภัณฑ์เรียงตามชื่อผู้ผลิต 66-70 GENERIC AND BRAND NAME INDEX ดัชนีรวมชือ่ สามัญและชื่อการค้า จัดเรียงตาม A-Z 71-86 แบบสำ�รวจ 87-88 AW_PNdex front 20100402.indd 4 5/4/2553 17:45:15 HOW TO USE5 1 ÇÔ¸Õ¡ÒÃãªŒË¹Ñ§Ê×Í ·ÃÒºµÑÇÍÂ‹Ò§ ÃÙ»¾ÃÃ³ àÍ¡ÅÑ¡É³ ËÃ×Í ÅÑ¡É³Ð¢Í§ÂÒàÁç´ PRODUCT IDENTIFICATION SEQUENCE การจัดลำาดับยาเม็ดด้วยสีรูปร่างขนาด...หน้า9 PRODUCT IDENTIFICATION CHART ค้นหารูปภาพเภสัชภัณฑ์...หน้า10-39 ชื่อผู้ผลิต(Manufacturer’sname) ชื่อการค้า(Tradename) ชื่อสามัญ(Genericname) ประเภทวัตถุออกฤทธิ์หรือยาเสพติดให้โทษ น้ําหนักของเม็ด ภาพเม็ดยาจะมีขนาดเทาของจริง ภาพผลิตภัณฑที่ไมใชเม็ดยาจะเปนขนาดยอ หมายเลขของภาพ AW_PNdex front 20100402.indd 5 2/4/2553 13:57:05 6 2 ·ÃÒºª×èÍ¡ÒÃ¤ŒÒËÃ×Íª×èÍÊÒÁÑÞ¢Í§ÇÑµ¶ØÍÍ¡Ä·¸ÔìËÃ×ÍÂÒàÊ¾µÔ´ãËŒâ·É GENERIC AND BRAND NAME INDEX ดัชนีรวมชื่อสามัญและชื่อการค้า...หน้า71-86 PRODUCT IDENTIFICATION CHART รูปภาพเภสัชภัณฑ์...หน้า10-39 ค้นตามหมายเลขภาพมุมลางซ้าย 3 ·ÃÒºª×èÍÊÒÁÑÞ¢Í§ÇÑµ¶ØÍÍ¡Ä·¸ÔìËÃ×ÍÂÒàÊ¾µÔ´ãËŒâ·É NATIONAL LIST OF ESSENTIAL MEDICINE ข้อกำาหนดบัญชียาหลักแห่งชาติ...หน้า42-47 (เฉพาะวัตถุออกฤทธิ์และยาเสพติดให้โทษ) ค้นตามชื่อสามัญเรียงลําดับชื่อA-Z AW_PNdex front 20100402.indd 6 2/4/2553 13:57:06 4 7 ·ÃÒº»ÃÐàÀ·¢Í§·ÐàºÕÂ¹ÇÑµ¶ØÍÍ¡Ä·¸ÔìËÃ×ÍÂÒàÊ¾µÔ´ãËŒâ·É CONTENTS สารบัญ...หน้า3-4 CLASSIFICATION OF PSYCHOTROPICS & NARCOTICS การจัดกลุ่มประเภทและสาระตามกฏหมาย...หน้า40-41 สาระสําคัญในการควบคุมตามกฎหมาย รายชื่อตัวยา (ชื่อสามัญ) ของวัตถุออกฤทธิ์และยาเสพติดให้โทษจัดตาม กลุม/ประเภทตามกฎหมาย CONTROLLED SUBSTANCE CLASS INDEX ดัชนีกลุ่ม/ประเภทของทะเบียน...หน้า62-65 ค้นตามชื่อสามัญเรียงลําดับชื่อA-Zในแตละกลุม AW_PNdex front 20100402.indd 7 IMPORTANT DRUG NOTES ข้อมูลสำาคัญของตัวยา...หน้า48-61 ค้นตามชื่อสามัญจากA-Zในแตละกลุม 2/4/2553 13:57:07 8 5 ·ÃÒºª×èÍºÃÔÉÑ·¼ÙŒ¼ÅÔµ MANUFACTURE’S INDEX ดัชนีรวมชื่อสามัญและชื่อการคา... หนา 66-70 PRODUCT IDENTIFICATION CHART รูปภาพเภสัชภัณฑ ... หนา 10-39 คนตามหมายเลขภาพมุมลางซาย 6 ¡ÒÃ¾ÔÊÙ¨¹ÊÑÞÅÑ¡É³¨Ò¡ á¼‹¹«Õ´Õ PNdex (powered by MIMS.com) โปรแกรมรูปภาพเภสัชภัณฑ ใหกดเลือกหรือพิมพคุณลักษณะที่สําคัญ ควรเลือกคุณสมบัติที่เดนที่สุดเทานั้น ไมควรเลือกทั้งหมด สีที่ 1 สีที่ 2 (เลือกกรณีมีมากกวาหนึ่งสี) รูปราง มีรอยบากกลาง มีอักษรหรือเลข (ใหพิมพตัวเลขหรืออักษร) มีโลโก ชื่อการคา (ใหพิมพชื่อ) ชื่อตัวยา (ใหพิมพชื่อสามัญ) ประเภทของทะเบียนผลิตภัณฑ ชื่อผูผลิต (ใหพิมพชื่อ) กลุมการออกฤทธิ์หรือการรักษา กดปุมคนหา หรือ ปุมลบเพื่อเลือกใหม AW_PNdex front 20100402.indd 8 ENTER กดปุมเขาสูโปรแกรม 7/4/2553 9:45:42 9 PRODUCT IDENTIFICATION SEQUENCE ÅíÒ´Ñº¡ÒÃ¨Ñ´ÀÒ¾ÂÒàÁç´ หมายเหตุ: สีที่ปรากฏในหนังสืออาจคลาดเคลื่อนกับสีจริงของเม็ดยาแนะนําให้ตรวจด้วยคุณลักษณะอื่นรวมด้วยเชนขนาดสัญลักษณ AW_PNdex front 20100402.indd 9 2/4/2553 13:57:09 10 PN DEX 2010 PRODUCT IDENTIFICATION CHART WHITE Tablet DILOMIL†  Diphenoxylate HCl 2.5 mg XN3 PHENOBARBITAL ATLANTIC  ⌫ Lorazepam 1 mg Phenobarbital Na 32.5 mg P4 [86 mg] P4 [100 mg] 022 011 PHENOBARBITAL ATLANTIC  LIZAVAN  Lorazepam 1 mg Phenobarbital Na 65 mg XP4 [100.4 mg] P4 [95 mg] 023 P2 [50 mg] 012 KEMORA  002 LORAZENE  001 BUPRINE  Buprenorphine HCl 0.2 mg LORAZEP ⌫ Lorazepam 1 mg 013 003 ZEDA LORAMED  Lorazepam 1 mg ☯  ⌫ XP4 Lorazepam 0.5 mg Codeine Phosphate (Analgesic) 15 mg P4 [90 mg] N2 [73 mg] 014 025 DIANO LORAPAM   Lorazepam 1 mg XP4 Diazepam 2 mg 004 PHENOBARBITONE NEW LIFE PHARMA  Phenobarbital Na 30 mg XP4 P4 [80 mg] 026 015 LORA-P ⌫ ⌫ ⌫ Lorazepam 1 mg 005 XP4 [113.37 mg] LOMOTIL†  016 Diphenoxylate HCl 2.5 mg N3 [63 mg] DIAZEPAM T P DRUG ⌫ ⌫  006 017 P2 [59.98 mg] Codeine Phosphate (Analgesic) 30 mg CODEINE GPO  N2 [113 mg] 007 018 XN3 Lorazepam 1 mg LONZA ⌫ P4 [85 mg] Diphenoxylate HCl 2.5 mg N3 [79.97 mg]   Lorazepam 1 mg P4 [100 mg] 020 009 DIAPINE ANTA  Diazepam 2 mg XP4 PHENOBARBITAL ACDHON Phenobarbital Na 60 mg MEILAX XP4 ORA  Lorazepam 1 mg P4 [100 mg] VALAX ⌫    Diazepam 2 mg XP4 031  Ethyl Loflazepate 1 mg RAZEPAM  Lorazepam 1 mg P4 [100 mg] XP4 XP4 010 021 032 Indicates brands that contain more than 1 ingredient  030 019 ⌫ Lorazepam 1 mg 029 DITROPINE† ⌫ SPASIL† ATIVAN  028 TEMGESIC  ⌫ 008  Lorazepam 1 mg P4 [100 mg] XP4 Diphenoxylate HCl 2.5 mg LORAVAN 027 Diazepam 2 mg Buprenorphine HCl 0.2 mg P4 [100 mg] 024 P4 [65 mg] CODEINE GPO  Lorazepam 1 mg XP4 Lorazepam 1 mg † ANXIRA  PN DEX 2010 PRODUCT IDENTIFICATION CHART 11 LORAZEPAM ACDHON  LORAZIN  PRENARPIL  XP4 P4 [103.02 mg] P4 [148.76 mg] Lorazepam 1 mg 033 Lorazepam 1 mg Clonazepam 2 mg 044 TRANAVAN  Lorazepam 1 mg P4 [100 mg] 054 PSEUDOEPHEDRINE MILANO  RIVOTRIL P2 [130 mg] P4 [170 mg] 034 LORAPINE ⌫ Lorazepam 1 mg XP4 055 045 PHENOBARB SIPAM ⌫ ⌫ ⌫ LORA   Diazepam 2 mg Phenobarbital Na 60 mg 035 P4 [164 mg] XP4 [130 mg] Lorazepam 1 mg 056 046 P4 [130 mg] PSEUDOEPHEDRINE ASIAN PHARM ⌫ 036 FRISIUM ⌫ Clobazam 10 mg  Clonazepam 2 mg Pseudoephedrine HCl 60 mg Pseudoephedrine HCl 60 mg ALPRAX  Alprazolam 1 mg XP4 [190 mg] P2 [155 mg] XP4 057 TAZCINE 047 037 RUBIFEN   Methylphenidate HCl 10 mg P2 [190 mg] ZOPAM  Diazepam 2 mg  XP3 [149 mg] P4 [160 mg] 058 048 038 MED-ZEPAM  Diazepam 2 mg XP4 DIVOPAN  VOMED ⌫     Diazepam 2 mg XP4 Diazepam 2 mg P4 [180 mg] 059 049 039 DIPAM  Diazepam 2 mg ☯ ⌫ Pentazocine HCl 25 mg DONNATAL†  DIAZEPAM BJ BENJAOSOTH Phenobarbital Na 16.2 mg ☯⌫  XP4 Diazepam 2 mg XP4 P4 [158.25 mg] 040 050 RITALIN ⌫ GRANDAXIN P2 [140 mg] P4 [180 mg] XP4 [180 mg] 051 061 DIAZEPAM GPO  NITRADOS  P4 [182 mg] P2 042 052 062 FRISIUM ⌫⌫ MED-ZEPOXIDE Chlordiazepoxide HCl 10 mg Diazepam 2 mg P4 [120 mg] XP4 [198.8 mg] XP4 043 053 Methylphenidate HCl 10 mg 041 ALPRALAN  Alprazolam 0.25 mg P4 [154.7 mg] Clobazam 5 mg 060 DIAZ  ⌫⌫ Diazepam 2 mg Tofisopam 50 mg Nitrazepam 5 mg Diazepam 2 mg  WINOPAM   063 † Indicates brands that contain more than 1 ingredient 12 PN DEX 2010 PRODUCT IDENTIFICATION CHART ⌫   VORAPAM PARADEINE†  Diazepam 2 mg Codeine Phosphate (Analgesic) 15 mg P4 [180 mg] N3 [470 mg] REINBAMATE  Meprobamate 400 mg XP3 [525 mg] 064 VALENIUM  Diazepam 2 mg 074 XP4 TYLENOL WITH CODEINE† 082  Codeine Phosphate (Analgesic) 15 mg N3 [432.5 mg] 065 DIAZEPAM LERD SINGH Diazepam 2 mg  Codeine Phosphate (Analgesic) 8 mg XN3  P4 [180 mg] 075 TYLENOL WITH CODEINE† 066 POVANIL PARADYL  Codeine Phosphate (Analgesic) 30 mg   Clonazepam 2 mg 083 DIETIL RETARD  Diethylpropion HCl 75 mg N3 [478.72 mg] P2 [755 mg] P4 [150 mg] 067 076 DIMED  PARCOD† Diazepam 2 mg Codeine Phosphate (Analgesic) 15 mg XP4 XN3 [600 mg] ⌫   084 ANAX  Alprazolam 0.25 mg P4 [130 mg] 068 XANAX XR 085  Alprazolam 1 mg 077 P4 [347.19 mg] ALODORM  ANZION  Alprazolam 0.25 mg XP4 [132.25 mg] Nitrazepam 5 mg P2 [556 mg] 069 LEXOTAN 086  ALNAX ⌫ Bromazepam 1.5 mg Alprazolam 0.25 mg P4 [200 mg] XP4 [130 mg] 078 PARCONO†  Codeine Phosphate (Analgesic) 8 mg 070 N3 [600 mg] COCET†  ANPRESS P4 [131.2 mg] XN3 088 079 † NASA WITH CODEINE  Codeine Phosphate (Analgesic) 15 mg CEMOL - CODEINE†   Codeine Phosphate (Analgesic) 15 mg ☯   Alprazolam 0.25 mg Codeine Phosphate (Analgesic) 15 mg 071 087 N3 [600 mg] DIZOLAM  Alprazolam 0.25 mg P4 [130 mg] 089 XN3 MARZOLAM  Alprazolam 0.25 mg 080 072 COTENOL† ⌫ ⌫  Codeine Phosphate (Analgesic) 15 mg MOGADON  Nitrazepam 5 mg P2 XN3 P4 [129.75 mg] 090 XANACINE ⌫ Alprazolam 0.25 mg P4 [110 mg] 073 † 081 Indicates brands that contain more than 1 ingredient 091  PN DEX 2010 PRODUCT IDENTIFICATION CHART 13 FARZOLAM  ALLAM Alprazolam 0.25 mg Alprazolam 0.25 mg Codeine Phosphate (Analgesic) 15 mg XP4 P4 [130 mg] XN3 [478.77 mg] 092 103 ZOLAM  INZOLAM  Alprazolam 0.25 mg 113 P4 [131.55 mg] P4 [132 mg] CONCERTA   093 104 Alprazolam 0.25 mg    PARAGEN CO†  Methylphenidate HCl 36 mg MOXINAX  Alprazolam 0.25 mg P4 [130 mg] P2 [515 mg] ALPRAMED  Alprazolam 0.5 mg P4 [130 mg] 094 XALAM  Alprazolam 0.25 mg XP4 114 REGENON RETARD  105 Diethylpropion HCl 75 mg P2 [755 mg] MITRANAX  Alprazolam 0.25 mg P4 [130 mg] 095 XANAX 106   Alprazolam 0.25 mg SUNAX P4 [128.25 mg] Alprazolam 0.25 mg 115 XP4 [130.03 mg] PARDEX ⌫ Dextropropoxyphene Napsylate 32.5 mg 096 XN3 ALCELAM   Alprazolam 0.25 mg P4 [130 mg] 107 XIEMED ⌫ Alprazolam 0.25 mg P4 [130.01 mg] 097  116 METHYLPHENIDATE HEXAL 108   P4 [125 mg] ALPRAZOLAM FRX  P2 [174.98 mg] 098 XP4 [130 mg] SIAMPRAXOL Alprazolam 0.25 mg MANEX Methylphenidate HCl 10 mg Alprazolam 0.25 mg ⌫   117 Alprazolam 0.25 mg 109 P4 [130 mg] STILNOX ⌫ Capsule ZEPOXIN Zolpidem Tartrate 10 mg Chlordiazepoxide HCl 10 mg P2 [126 mg] 099 XP4 [100 mg] ALPAZAM  Alprazolam 0.25 mg XP4 118 110 POPAM KAPANOL    Morphine Sulfate 20 mg Diazepam 2 mg 100 N2 [142.8 mg] XP4 PHARNAX  ⌫   Alprazolam 0.25 mg P4 [131.65 mg] 111 101 Codeine Phosphate (Analgesic) 15 mg LORAMET   119 CODIGESIC†  N3 [550 mg] KAPANOL  Morphine Sulfate 50 mg N2 [323.3 mg] Lormetazepam 1 mg P2 102 112  120 † Indicates brands that contain more than 1 ingredient 14 PN DEX 2010 PRODUCT IDENTIFICATION CHART KAPANOL  RAZEPAM  DIAZEPAM SAMAKEEPHAESAJ N2 [620.5 mg] XP4 Diazepam 5 mg Morphine Sulfate 100 mg Lorazepam 2 mg ⌫ XP4 131 VALAX ⌫ 142 Diazepam 5 mg PSEUDOEPHEDRINE ASIAN PHARM ⌫ XP4 121 Pseudoephedrine HCl 30 mg 132 YELLOW Phenobarbital Na 30 mg XP4  XP4 [153 mg] 143 133 Amobarbital 50 mg AMA†  DIAZEPAM VESCO  P3 [208.7 mg] P4 [109 mg] 144 134 ZOPAM  Diazepam 5 mg 122 LORA-P ⌫ ⌫ ⌫ Lorazepam 2 mg XP4 [113.43 mg] PSEUDOEPHEDRINE BJ BENJAOSOTH ☯⌫  123 BELLOID† ⌫⌫  Butobarbital 30 mg Diazepam 5 mg P4 [160 mg] P2 [158.22 mg] 145 DIVOPAN 124   Lorazepam 2 mg P4 [100 mg] 125 METHADONE GPO  Methadone HCl 5 mg Diazepam 5 mg PSEUDOEPHEDRINE MILANO P4 [209 mg]  Pseudoephedrine HCl 30 mg P2 [110 mg] 146 136 Diazepam 5 mg VOMED DIPAM  XP4 XP4 147 126 COZEP LORAZENE  Chlordiazepoxide HCl 10 mg   P4 [179.55 mg] DIAZEPAM GENERAL DRUGS HOUSE  Diazepam 5 mg P4 [160 mg] 148 138 ⌫ 127 PORA LORAPAM  Lorazepam 1 mg Lorazepam 2 mg ⌫  Diazepam 5 mg 137 XP4     135 N2 [110 mg] Lorazepam 2 mg  Pseudoephedrine HCl 60 mg XP4 ANTA P2 [145 mg] Clorazepate Dipotassium 5 mg Tablet PHENOBARBITAL ACDHON  ⌫  ⌫ DOPAM XP4 DIAZEPAM GPO  Diazepam 5 mg P4 [182 mg] XP4 139 149  128 DIANO ATIVAN  Diazepam 5 mg Lorazepam 2 mg P4 [110.2 mg] VALENIUM  Diazepam 5 mg XP4 XP4 140 129 TRANOLAN  Diazepam 2 mg P4 [150.62 mg] 130 † PHENYLPROPANOLAMINE PHARMASANT   150 DIZEPAM  Phenylpropanolamine HCl 25 mg Diazepam 5 mg XP2 P4 [170 mg] 141 151 Indicates brands that contain more than 1 ingredient  PN DEX 2010 VALIUM PRODUCT IDENTIFICATION CHART 15  DIAZEPAM POND’S CHEMICAL ⌫ Diazepam 5 mg XP4 Capsule  Diazepam 5 mg POSENE XP4 Clorazepate Dipotassium 5 mg XP4 [140 mg] 152 DIAZA  162 Diazepam 5 mg DIAZEPAM T MAN XP4 [172 mg] Diazepam 5 mg ⌫   172 XP4 TRANCAP ⌫ ⌫  Clorazepate Dipotassium 10 mg 153 XP4 SIPAM 163  DIMED  Diazepam 5 mg Diazepam 5 mg P4 [164 mg] 173 XP4 PREFAMONE  Diethylpropion HCl 75 mg 154 DIAZEPAM T P DRUG Diazepam 5 mg ⌫ ⌫  P2 164 CO-COF†  Codeine Phosphate (Antitussive) 10 mg XP4 N3 [294.9 mg] 155 ALPRAX 174 165  Alprazolam 0.25 mg DIAPINE P4 [189.74 mg] POZAPAM    Prazepam 10 mg Diazepam 5 mg P4 [336.5 mg] P4 [280 mg] 156 DIAZ  166 Diazepam 5 mg MILA-TERCON†  XP4 [180 mg] Codeine Phosphate (Antitussive) 8 mg 175 N3 [410.05 mg] ORANGE 157 ROPAM  ⌫  ⌫ Tablet Diazepam 5 mg 167 XP4 [170 mg] TRIALAM  MEILAX  Ethyl Loflazepate 2 mg XP4 Triazolam 0.25 mg P2 [100 mg] 158 VORAPAM ⌫   176 Diazepam 5 mg 168 P4 [183 mg] CONCERTA   TRANOLAN  Diazepam 5 mg Methylphenidate HCl 18 mg P4 [150.85 mg] P2 [268 mg] 159 DIAZEPAM H K PHARM 177    169 Diazepam 5 mg POPAM P4 [160 mg] Diazepam 5 mg DILIUM    Diazepam 2 mg XP4 XP4 160 DIAZEPAM LERD SINGH Diazepam 5 mg  178 170 DIZEP ZORA   P4 [175 mg] Diazepam 2 mg 161 171 Lorazepam 2 mg P4 [130 mg] P4 [115.05 mg]  179 † Indicates brands that contain more than 1 ingredient 16 PN DEX 2010 PRODUCT IDENTIFICATION CHART PHENOBARBITONE NEW LIFE PHARMA  Phenobarbital Na 60 mg XP4 DIZEP  Capsule Diazepam 5 mg P4 [115.05 mg] CORYNIL†  Codeine Phosphate (Antitussive) 10 mg XN3 [430 mg] 190 180 COZEP   Chlordiazepoxide HCl 25 mg P4 [206.23 mg] Capsule DIAZEPION  Diazepam 10 mg 191 Ethyl Loflazepate 2 mg 201 XP4 RED Tablet MST CONTINUS  Morphine Sulfate 60 mg N2 [154 mg] PONDNEBIUM ⌫ XP4 [74.82 mg] EPOXIDE XP4 [205.49 mg] P2 [144.7 mg] 193 BENPINE Codeine Phosphate (Antitussive) 10 mg ⌫ ⌫ ⌫ Phenobarbital Na 60 mg XP4 [120 mg] ROTUSS†  P4 [165.2 mg] 194 CHLORDIXIDE  185 Chlordiazepoxide HCl 10 mg POVANIL P4 [237 mg]   N3 [456.5 mg] 204 ZEPOXIN  Chlordiazepoxide HCl 5 mg 195 CLINOPECT†  205 Codeine Phosphate (Antitussive) 10 mg 186 EPOXIDE   ⌫ Codeine Phosphate (Antitussive) 10 mg XP4 [100 mg] Clonazepam 0.5 mg P4 [150 mg] N3 [430 mg] 203 Chlordiazepoxide HCl 25 mg  N3 [430 mg] ROLAR†   Chlordiazepoxide HCl 25 mg Pseudoephedrine HCl 60 mg MENOBARB   Codeine Phosphate (Antitussive) 10 mg 202 192 184 CODEPECT† Chlordiazepoxide HCl 10 mg 183 PSEUDOEPHEDRINE MEDICINE PRODUCTS ⌫   ⌫ N3 [558.5 mg] 181 182 ROPECT† Codeine Phosphate (Antitussive) 10 mg XP4 [100 mg] VICTAN ⌫ 200 ⌫ ⌫ ⌫ Chlordiazepoxide HCl 10 mg XP4 [284.17 mg] PINK XN3 [217 mg] Tablet 196 PAM-5 ZORITUSS    Diazepam 5 mg Codeine Phosphate (Antitussive) 10 mg ⌫ ⌫  XP4 XN3 187 NEOCOF†  206 Codeine Phosphate (Antitussive) 10 mg 197 XN3 NEO-COPHEN ⌫ Codeine Phosphate (Antitussive) 10 mg BELLERGAL† ⌫ Phenobarbital Na 20 mg XP4 XN3 188 198 XN3 [580 mg] Codeine Phosphate (Antitussive) 10 mg Codeine Phosphate (Analgesic) 8 mg 189 † 207 PACOGESIC†  NEOPECT†  PHENOBARBITAL ATLANTIC  Phenobarbital Na 16.25 mg N3 [399.73 mg] XP4 [84.99 mg] 199 208 Indicates brands that contain more than 1 ingredient  PN DEX 2010 PHENOBARB ⌫ ⌫ ⌫ PRODUCT IDENTIFICATION CHART 17 S.CO ZEPAM Phenobarbital Na 30 mg Diazepam 5 mg XP4 [90 mg] XP4    ANAX P4 [130 mg] 209 LORAMED  Lorazepam 2 mg P4 [100 mg] 230 220 BELLADONNA ALKALOIDS WITH PHENOBARBITAL† ⌫ Phenobarbital Na 16.2 mg XP4 [160 mg] 210  Alprazolam 0.5 mg ANZION  Alprazolam 0.5 mg XP4 [132.5 mg] 231 DIAZEPAM T MAN Diazepam 5 mg ⌫   ALNAX 221 DIAZEPAM BJ BENJAOSOTH 211 Diazepam 10 mg ORA XP4 [130 mg] ☯⌫   ⌫ Alprazolam 0.5 mg P4 [62.46 mg] 232 P4 [233 mg] DIZOLAM  Lorazepam 2 mg Alprazolam 0.5 mg XP4 222 212 P4 [130 mg]  KENSPA† Chlordiazepoxide HCl 5 mg VISPAM ⌫ Diazepam 5 mg 233 P4 [246 mg] PRAZOL  Alprazolam 0.5 mg XP4 [70.02 mg] P4 [216.36 mg] 223 DIZEPAM  213 ALPRALAN  Alprazolam 0.5 mg Diazepam 2 mg 234 P4 [170 mg] MARZOLAM  P4 [157.28 mg] Alprazolam 0.5 mg P4 [130 mg] 224 214 PORA ⌫ Lorazepam 2 mg XP4 CENTRODINE CD†   Codeine Phosphate (Antitussive) 10 mg 235 N3 [205.2 mg] XANACINE P4 [110 mg] 225 215 DIAZEPAM POND’S CHEMICAL ⌫ Diazepam 5 mg TAZCINE ☯ ⌫ 236 Pentazocine HCl 50 mg ZOLAM  XP3 Alprazolam 0.5 mg P4 [145.6 mg] P4 [133.8 mg] 226 216 LORA  Lorazepam 2 mg P4 [200 mg] ⌫  Alprazolam 0.5 mg LORAZIN  237 Lorazepam 2 mg MOXINAX P4 [200 mg]  Alprazolam 0.5 mg P4 [130 mg] 227 217 DIAZEPAM H K PHARM    Diazepam 2 mg LEXOTAN  238 Bromazepam 3 mg XALAM  P4 [200 mg] Alprazolam 0.5 mg XP4 P4 [130 mg] 228 218 AZEPAM  Diazepam 2 mg PHENOCON 239  Phenobarbital Na 60 mg XANAX XP4 219  Alprazolam 0.5 mg XP4 [100 mg] P4 [128.56 mg] 229  240 † Indicates brands that contain more than 1 ingredient 18 PN DEX 2010 PRODUCT IDENTIFICATION CHART ALPRAMED  ANXENE Alprazolam 0.25 mg Clorazepate Dipotassium 10 mg P4 [130 mg] P4 [130 mg] XP4 241 252 FARZOLAM ⌫ MITRANAX  XP4 P4 [130 mg] ALCELAM   Alprazolam 0.5 mg Alprazolam 0.5 mg 242 ⌫  262 MANOTRAN  Alprazolam 0.5 mg Clorazepate Dipotassium 10 mg XP4 [150 mg] 253 SIAMPRAXOL  SUNAX  Alprazolam 0.5 mg Alprazolam 0.5 mg 263 P4 [125.75 mg] XP4 [129.95 mg] CLORAMED  243 254 Clorazepate Dipotassium 10 mg XP4 ⌫   MANEX CODICET PINK† ⌫   Alprazolam 0.5 mg Codeine Phosphate (Analgesic) 15 mg P4 [130 mg] XN3 264 DEDA    Clorazepate Dipotassium 10 mg 244 P4 [130 mg] 255 ALPAZAM  Alprazolam 0.5 mg XP4 245 ALPAZAM  Alprazolam 1 mg XP4 ALPRAZOLAM FRX  Alprazolam 0.5 mg P4 [130 mg] 265 256 CLORAZE  TRANSPON FORTE  XP4 [120 mg] Clorazepate Dipotassium 10 mg Clorazepate Dipotassium 10 mg XP4 [190 mg] 246 266 257 PHARNAX ⌫   P4 [131.9 mg] UPTRAN Capsule Alprazolam 0.5 mg  Clorazepate Dipotassium 10 mg SANOR  XP4 Clorazepate Dipotassium 10 mg XP4 247 ANPRESS ⌫ 267 POLIZEP  Alprazolam 0.5 mg 258 P4 [130 mg] SERENE MASA LAB Clorazepate Dipotassium  10 mg XP4 [234 mg] XP4 [173.5 mg] 248 XIEMED ☯   Alprazolam 0.5 mg P4 [130.25 mg] 268 259 DIPOSEF 249 ALLAM Clorazepate Dipotassium 10 mg ⌫ Clorazepate Dipotassium 10 mg    Alprazolam 0.5 mg XP4 [140 mg] TENMED  Clorazepate Dipotassium 10 mg P4 [234 mg] P4 [130 mg] 250 INZOLAM  Alprazolam 0.5 mg P4 [132.81 mg] 251 † 260 269 TRANMED  POLYDINE CD† Clorazepate Dipotassium 10 mg XP4 [163.13 mg] 261 Indicates brands that contain more than 1 ingredient   Codeine Phosphate (Antitussive) 10 mg XN3 270  PN DEX 2010 PRODUCT IDENTIFICATION CHART 19 TRANXENE ⌫ ANZION  MANEX Alprazolam 1 mg Alprazolam 1 mg XP4 XP4 [133.12 mg] P4 [130 mg] 280 291 Clorazepate Dipotassium 10 mg 271 TRANCLOR  Clorazepate Dipotassium 10 mg XP4 ALNAX ⌫ PHARNAX ⌫   Alprazolam 1 mg Alprazolam 1 mg XP4 [100 mg] P4 [132.41 mg] 281 272 ⌫   292 ANPRESS ☯   ALLAM    Alprazolam 1 mg Alprazolam 1 mg P4 [131.2 mg] P4 [130 mg] 282 293 273 MARZOLAM  INZOLAM  FLULIUM   P4 [130 mg] P4 [134.39 mg] CEXENE ⌫    Clorazepate Dipotassium 10 mg XP4 Alprazolam 1 mg Clorazepate Dipotassium 10 mg Alprazolam 1 mg XP4 283 294 XANACINE ⌫ MITRANAX  Alprazolam 1 mg 274 † DAVOL ☯⌫  Dextropropoxyphene HCl 32.5 mg XN3 [377.5 mg] Alprazolam 1 mg P4 [110 mg] P4 [130 mg] 284 295 ZOLAM  XIEMED Alprazolam 1 mg Alprazolam 1 mg P4 [136.67 mg] P4 [130 mg] 285 296 XALAM  275 DIZOLAM  Alprazolam 1 mg PURPLE Tablet CALMIPAM  Diazepam 5 mg XP4 ⌫ Alprazolam 1 mg XP4 P4 [130 mg] 286 XANAX 297   Alprazolam 1 mg BRONPECT† P4 [129.12 mg] Codeine Phosphate (Antitussive) 10 mg N3 [573.5 mg] 276 287 PHENOBARBITAL ATLANTIC  ALCELAM   P4 [128.97 mg] P4 [130.2 mg] 277 288 MST CONTINUS  FARZOLAM ⌫ N2 [154 mg] XP4 278 289 ZEPOXIDE SIAMPRAXOL  ANXIRA Alprazolam 1 mg Lorazepam 0.5 mg P4 [91.2 mg] XP4 P4 [50 mg] 279 290 Phenobarbital Na 100 mg 298 Alprazolam 1 mg AZEPAM  Diazepam 5 mg XP4 Morphine Sulfate 30 mg 299 Alprazolam 1 mg BLUE ⌫ ⌫  Chlordiazepoxide HCl 10 mg  Tablet ⌫ 300 † Indicates brands that contain more than 1 ingredient 20 PN DEX 2010 PRODUCT IDENTIFICATION CHART LORAZENE  Lorazepam 0.5 mg PHENOBARBITAL CHEW BROTHERS XP4 Phenobarbital Na 30 mg  XP4 [70 mg] VISPAM ⌫ Diazepam 10 mg P4 [102.26 mg] 323 301 LORAVAN  Lorazepam 0.5 mg 312 LONZA ⌫ P4 [50 mg] Lorazepam 0.5 mg 302 313 LOZEPAM  LORAPINE P4 [50 mg] LORAZIN  Lorazepam 0.5 mg P4 [103.03 mg] 324 Lorazepam 0.5 mg XP4 ⌫    Lorazepam 0.5 mg XP4 ANTA   Lorazepam 0.5 mg RAZEPAM  Lorazepam 0.5 mg XP4 P4 [49.6 mg] LIZAVAN  Lorazepam 0.5 mg XP4 [50.22 mg] 305 LORAMED  Lorazepam 0.5 mg XP4 306 TRANAVAN  ⌫ VEMED Lorazepam 0.5 mg Lorazepam 0.5 mg P4 [50 mg] ⌫   ZORA  Lorazepam 0.5 mg Lorazepam 0.5 mg XP4 [50 mg] P4 [130 mg] 317 328 DIAZEPAM GENERAL DRUGS HOUSE  DIAPAM   Diazepam 5 mg P4 [152 mg] 329 LORA-P ⌫ ⌫ ⌫ Lorazepam 0.5 mg XP4 [105.2 mg] DIPAM  Diazepam 10 mg XP4 330 319 LORAZEP ⌫ Diazepam 10 mg 327 318 308 DIAZEPAM T MAN LORAZEPAM ACDHON  P4 [50 mg] XP4 XP4 316 P4 [139.83 mg] Lorazepam 0.5 mg Diazepam 5 mg XP4 Diazepam 2 mg ATIVAN  DILIUM  XP4 Lorazepam 0.5 mg 307 P4 [110 mg] 326 315 304 Diazepam 2 mg 325 314 303 DIAZEPAM VESCO  DIAZEPAM SOMMAI BHAESAJ ZOPAM  Diazepam 5 mg P4 [180 mg]  Diazepam 10 mg  XP4 331 309 ORA BLUCON† 320  Lorazepam 0.5 mg P4 [50.02 mg] HAWKCOPAX  ⌫  ⌫ Lorazepam 0.5 mg P4 [100 mg] ⌫   Codeine Phosphate (Antitussive) 10 mg XN3 [175.2 mg] 332 † 310 321 LORAPAM  VALAX Lorazepam 0.5 mg Diazepam 10 mg XP4 [43.67 mg] XP4 XP4 311 322 333 Indicates brands that contain more than 1 ingredient ⌫    DIAZEPAM CHAROEN BHAESAJ  Diazepam 2 mg  PN DEX 2010 DIAZEPAM GPO Diazepam 10 mg  PRODUCT IDENTIFICATION CHART 21 XANAX XR  Capsule Alprazolam 0.5 mg ZEPAM  P4 [182 mg] P4 [346.11 mg] 334 344 MANODIAZO  NEOCOD† Diazepam 5 mg XP4 Diazepam 10 mg P4 [160 mg] 354      Codeine Phosphate (Antitussive) 10 mg BLUCO† XN3 [497.3 mg] Codeine Phosphate (Antitussive) 10 mg N3 [249.7 mg] 335 345 MED-ZEPAM  NEO-CODEIN† ⌫ Diazepam 5 mg Codeine Phosphate (Antitussive) 10 mg XP4 355 XN3 [503 mg] GREEN Tablet 336 PRENARPIL  346 PHENOBARBITAL ACDHON Phenobarbital Na 15 mg P4 [147.79 mg] PARA-CO  Codeine Phosphate (Analgesic) 15 mg Clonazepam 1 mg N3 [390.09 mg] XP4 356 337 LORAZEP ⌫ DIAZA  Lorazepam 2 mg Diazepam 2 mg P4 [65 mg] 347 XP4 [172 mg] TRYCAM  Triazolam 0.25 mg 357 P2 CHLORDIXIDE  338 SIPAM  Chlordiazepoxide HCl 5 mg  P4 [232 mg] 348 Diazepam 10 mg DIADON P4 [160 mg]  Diazepam 5 mg 358 XP4 CHLORZEP ⌫ 339 Chlordiazepoxide HCl 5 mg DIAZEPAM T P DRUG Diazepam 10 mg ⌫ ⌫  XP4 349 XP4 HALCION ⌫ Triazolam 0.25 mg 359 P2 [97.408 mg] ZEDA ☯  ⌫ Lorazepam 1 mg 340 350 DIAZ  DORMICUM  Midazolam 15 mg 360 XP4 [180 mg] P2 [208 mg] CALMIPAM  341 351 Diazepam 10 mg P4 [90 mg] Diazepam 2 mg XP4 CLONARIL ⌫  CODICET BLUE P4 [150 mg] Clonazepam 1 mg †     361 Codeine Phosphate (Analgesic) 15 mg COMOBEN N3 [365 mg] Chlordiazepoxide HCl 5 mg     P4 [125.82 mg] 342 DIAZEPAM H K PHARM 362 352     XANAX XR Diazepam 10 mg Alprazolam 2 mg P4 [166.62 mg] P4 [345.69 mg] 343 353  DIAZEPAM SAMAKEEPHAESAJ ⌫ Diazepam 2 mg XP4 363 † Indicates brands that contain more than 1 ingredient 22 PN DEX 2010 PRODUCT IDENTIFICATION CHART DIAZEPAM T MAN Diazepam 2 mg ⌫   P4 [115 mg] WINOPAM  DIRAX†  XP4 P4 [200 mg] Diazepam 5 mg Chlordiazepoxide HCl 5 mg 364 HAWKCOPAX  ⌫  ⌫ 375 385   Lorazepam 1 mg POBRAX† XP4 Chlordiazepoxide HCl 5 mg XP4 Diazepam 2 mg 376 386 MODURAX† ⌫ XP4 [140 mg] Chlordiazepoxide HCl 5 mg P4 [250 mg] 366  Diazepam 10 mg P4 [320 mg] 365 VISPAM ⌫ DIAPINE ⌫   TERCO-C† Codeine Phosphate (Antitussive) 10 mg N3 [591.1 mg] DIAZEPAM POND’S CHEMICAL ⌫ 377 Diazepam 2 mg CLINOPRONT†  P4 [122 mg] Codeine Phosphate (Antitussive) 10 mg CODEE-C†  Codeine Phosphate (Antitussive) 10 mg N3 [283.31 mg] 367 387 N3 [345.02 mg] LORA  Lorazepam 0.5 mg 378 P4 [100 mg] LICON†   388 Chlordiazepoxide HCl 5 mg SECO† XP4 Codeine Phosphate (Antitussive) 10 mg 368 DIAPAM   Diazepam 2 mg P4 [142 mg] 379 CEBARAX† 369 PORA ⌫ N3 [331.56 mg]  Chlordiazepoxide HCl 5 mg ⌫ Lorazepam 0.5 mg P4 [250 mg] 389 TOCODYL† ⌫  ⌫ Codeine Phosphate (Antitussive) 10 mg XN3 [325.82 mg] XP4 380 370 PONDNEBIUM LIBRAX† ⌫ Chlordiazepoxide HCl 5 mg P4 [200 mg]  Chlordiazepoxide HCl 5 mg P4 [299 mg] CODESIA† ⌫ Codeine Phosphate (Antitussive) 10 mg N3 [350 mg] 371 381 LORAZEPAM MACROPHAR CHLORDIBRAX† ⌫ 391 XP4 RADIBRAX†  Lorazepam 1 mg Chlordiazepoxide HCl 5 mg XP4 372 382 CHLORDIAZEPOXIDE T MAN UTORAX† ⌫ ⌫   Chlordiazepoxide HCl 10 mg   Chlordiazepoxide HCl 5 mg XP4 [120 mg] Chlordiazepoxide HCl 5 mg XP4 392 ALPRAMED  Alprazolam 1 mg P4 [168.8 mg] P4 [259 mg] 373 383 ZEPOBRAX†  393 DIAZEPAM BJ BENJAOSOTH Chlordiazepoxide HCl 5 mg ROHYPNOL XP4 Flunitrazepam 1 mg ☯⌫  Diazepam 5 mg 374  P2 [175 mg] P4 [190.2 mg] † 390 384 Indicates brands that contain more than 1 ingredient 394  PN DEX 2010 PRODUCT IDENTIFICATION CHART 23 PARAMED-CO†  BENERA† Codeine Phosphate (Analgesic) 15 mg Phenobarbital Na 20 mg ⌫  ⌫ XN3 [601.1 mg] XP4 [135.5 mg] MIXED COLORS Tablet CODICET 404 ⌫   Codeine Phosphate (Analgesic) 15 mg LOZEPAM  N3 [565 mg] Lorazepam 1 mg 395 † XP4 VASON  Diazepam 2 mg 405 P4 [110 mg] 414 MST CONTINUS  Morphine Sulfate 10 mg 396 CELIUM ⌫ Capsule N2 [154 mg] FREXENE Clorazepate Dipotassium 5 mg Medazepam 5 mg XP4 406 P4 [110 mg]   PRENARPIL  397 Clonazepam 0.5 mg 415 P4 [147.22 mg] TRANPATE Capsule EUHYPNOS 20  ⌫  Temazepam 20 mg P2 [868.96 mg] ⌫   Clorazepate Dipotassium 5 mg P4 [146 mg] 407 RIVOTRIL  Clonazepam 0.5 mg 416 P4 [150 mg] DIZAN  Diazepam 5 mg XP4 [175 mg] 408 398 ZEPAM  Diazepam 2 mg ALPRAX  Alprazolam 0.5 mg XP4 XP4 [189.98 mg] 399 409 TUMAX† ⌫ MASAPARA WITH CODEINE†  P4 [180 mg] N3 [500 mg] 417 DITRAN Chlordiazepoxide HCl 5 mg   Diazepam 2 mg P4 [163 mg] Codeine Phosphate (Analgesic) 15 mg 418 FREXENE   Clorazepate Dipotassium 10 mg 400 XP4 STESOLID  410 Diazepam 2 mg 419 BLACK XP4 CONZEP Tablet 401 POSENE  Clorazepate Dipotassium 10 mg XP4 KEMORA  XP4 P4 [50 mg] 420 Lorazepam 0.5 mg CLOZENE 411 BENPINE 402 Tablet NEURAMIZONE† ⌫ XP4 [165 mg] P4 [136.82 mg] 421 412 ZEPOXIDE TRANCON ⌫ ⌫ ⌫  Phenobarbital Na 20 mg Chlordiazepoxide HCl 5 mg P4 [30.3 mg] XP4 403 413   Clorazepate Dipotassium 5 mg  Chlordiazepoxide HCl 5 mg BROWN  Clorazepate Dipotassium 10 mg Clorazepate Dipotassium 10 mg XP4 [140 mg] 422 † Indicates brands that contain more than 1 ingredient 24 PN DEX 2010 PRODUCT IDENTIFICATION CHART POMADOM   DIPOT ⌫ TRANPON  P4 [140 mg] P4 [145 mg] XP4 [173 mg] 423 432 441 PHENTERMINE TRENKER CLORAZE  CLOZEPATE  P4 [120 mg] XP4 Clorazepate Dipotassium 10 mg  Clorazepate Dipotassium 5 mg Clorazepate Dipotassium 5 mg Phentermine Resinate 30 mg P2 [180 mg] TRANZEP  Clorazepate Dipotassium 5 mg PANBESY Clorazepate Dipotassium 5 mg 442 433 424 Clorazepate Dipotassium 5 mg FLULIUM   Clorazepate Dipotassium 5 mg XP4 XP4 [160 mg] 434 443 MANOTRAN  POLIZEP  XP4 [150 mg] P4 [234 mg]  Phentermine HCl 15 mg P2 [310 mg] Clorazepate Dipotassium 5 mg 425 SANOR Clorazepate Dipotassium 5 mg  Clorazepate Dipotassium 5 mg XP4 [149.55 mg] 435 444 CLORAXENE 5 ⌫  ⌫ Clorazepate Dipotassium 5 mg P4 [121.8 mg] 426 DIPOSEF TAMYLAB-S ⌫ Clorazepate Dipotassium 5 mg XP4 [220 mg] ⌫ Clorazepate Dipotassium 5 mg XP4 [140 mg] 436 DEDA 445    Clorazepate Dipotassium 5 mg P4 [160 mg] 427 T-FIVE ⌫   Clorazepate Dipotassium 5 mg XP4 TRANMED  Clorazepate Dipotassium 5 mg P4 [163.1 mg] 437 TRANXENE 446  Clorazepate Dipotassium 5 mg P4 [145 mg] 428 CLORAMED  TRANADON-S  Clorazepate Dipotassium 5 mg XP4 [220 mg] Clorazepate Dipotassium 5 mg XP4 438 TRANCLOR  429 ANXENE Clorazepate Dipotassium 5 mg ⌫  XP4 447 GAXENE ⌫   Clorazepate Dipotassium 5 mg XP4 Clorazepate Dipotassium 5 mg XP4 430 SERENE V S PHARMA ⌫   Clorazepate Dipotassium 5 mg XP4 [163.1 mg] 431 † 439 448 TENMED  ZETRAN  P4 [234 mg] XP4 [166 mg] 440 449 Clorazepate Dipotassium 5 mg Indicates brands that contain more than 1 ingredient Clorazepate Dipotassium 5 mg  PN DEX 2010 CEXENE ⌫    PRODUCT IDENTIFICATION CHART 25 ANXIELAX  Clorazepate Dipotassium 5 mg Clorazepate Dipotassium 5 mg XP4 XP4 [248 mg] MED-ZEPOXIDE  Chlordiazepoxide HCl 5 mg XP4 468 450 MANODIAZO  PHENTERMINE OSMOPHARM 460 Phentermine HCl 15 mg PANBESY P2 [130.01 mg] Phentermine HCl 30 mg  Diazepam 2 mg  P4 [165 mg] P2 [320 mg] 469 TRANCAP ⌫ ⌫  Clorazepate Dipotassium 5 mg 451 CLOZENE  P4 [160 mg] 461 Clorazepate Dipotassium 10 mg ZEPAXID XP4 [165 mg] P4 ☯ ⌫ Diazepam 5 mg 470 DZP2 452 A-ZERAX ⌫ Diazepam 2 mg P4 [145 mg]   Diazepam 2 mg 462 XP4 A-ZERAX ⌫ Diazepam 5 mg 471 P4 [145 mg] DIAZEPAM ACDHON Diazepam 2 mg 453  XP4 CONZEP  Clorazepate Dipotassium 5 mg XP4 463 DOMAR  472 Pinazepam 5 mg P4 [101 mg] 454 DIAPINE P4 [146 mg] POMADOM   Clorazepate Dipotassium 5 mg XP4 464 V DAY ZEPAM Diazepam 5 mg 455 TRANCON ⌫ ⌫ ⌫ ⌫ 473 DIAZEPION  P4 [200 mg] Diazepam 5 mg Clorazepate Dipotassium 5 mg P4 [140 mg]  Diazepam 2 mg XP4 [100 mg] 465 474 PHENTERMINE TRENKER V DAY ZEPAM  456 DIZAN  Diazepam 2 mg XP4 [175 mg] Diazepam 2 mg Phentermine Resinate 15 mg ⌫ ⌫ ⌫ P4 [200 mg] P2 [160 mg] 475 457 DITRAN PRASEPINE  Prazepam 5 mg XP4 CHLORDIAZEPOXIDE MARCH PHARMA  Chlordiazepoxide HCl 25 mg 458 POZAPAM   P4 [165 mg] 476 P4 [346 mg] MINOXIDE ☯⌫  Chlordiazepoxide HCl 10 mg Prazepam 5 mg P4 [149.5 mg] P4 [170 mg] 459   Diazepam 5 mg 466 477 467  † Indicates brands that contain more than 1 ingredient 26 PN DEX 2010 PRODUCT IDENTIFICATION CHART DALMADORM  DUROMINE Flurazepam 15 mg Phentermine Resinate 30 mg Chlordiazepoxide HCl 10 mg P2 P2 [291 mg]    P4 [130 mg] BENPINE  478 STESOLID  488 Diazepam 10 mg EXAN XP4 Clorazepate Dipotassium 5 mg 498 ⌫ XP4 489  Diazepam 2 mg UPZENE XP4 [100 mg] Clorazepate Dipotassium 5 mg XP4 ☯ ⌫ 499 CHLORDIAZEPOXIDE CHAROEN BHAESAJ  480 METAXIDE    Phentermine Resinate 15 mg P2 [291.03 mg] 479 DIAZEPION  DUROMINE 490 Chlordiazepoxide HCl 10 mg     Chlordiazepoxide HCl 10 mg COMOBEN P4 [120 mg] Chlordiazepoxide HCl 10 mg P4 [211.36 mg] XP4 500 CHLORDIAZEPOXIDE ACDHON 481 DIAMED   491 Chlordiazepoxide HCl 10 mg ⌫ Diazepam 5 mg EXAN P4 [168.5 mg] Clorazepate Dipotassium 10 mg XP4 XP4 501 492 482 MEDAZINE  Medazepam 10 mg P4 [165 mg]  ⌫  Codeine Resinate 30 mg XN3 [234 mg]  Diazepam 5 mg P4 [147 mg] 484 STESOLID  Diazepam 5 mg XP4 MANODIAZO  Diazepam 5 mg P4 [165 mg] 502 493 483 DIAPINE CODIPRONT† CODIPRONT†  Codeine Resinate 30 mg N3 [298.6 mg] DIAMED  Diazepam 2 mg P4 [165.53 mg] 503 494 CLINEPECT†  Codeine Phosphate (Antitussive) 10 mg XN3 [270 mg] MIRAPRONT N  D-norpseudoephedrine HCl 20 mg P2 504 485 REGENON RETARD  495 Diethylpropion HCl 75 mg MONOZIDE P2 [480 mg] Diazepam 2 mg  ⌫ ⌫ ⌫ XP4 D-NORPSEUDOEPHEDRINE SR OSMOPHARM  D-norpseudoephedrine Resinate 20 mg P2 [173.28 mg] 496 486 MEDAZINE  Medazepam 5 mg ATRACTIL  Diethylpropion Resinate 75 mg 505 P2 [402.64 mg] ZEPAXID 487 † ☯ ⌫ Diazepam 2 mg P4 [165 mg] P4 497 Indicates brands that contain more than 1 ingredient 506  PN DEX 2010 *COMODINE COUGH †     PRODUCT IDENTIFICATION CHART 27 *PHENOBARBITAL ELIXIR ACDHON  Codeine Phosphate (Antitussive) 60 mL Phenobarbital Na 20 mg/5 mL x 240 mL XN3 XP4 *BROMTUSSIA DC† ⌫ Codeine Phosphate (Antitussive) 60 mL XN3 507 511 515 *PHENOBARBITAL ELIXIR ACDHON  *PHENOBARBITAL ELIXIR ACDHON  *CODESIA† Phenobarbital Na 20 mg/5 mL x 30 mL XP4 ⌫ Phenobarbital Na 20 mg/5 mL x 450 mL Codeine Phosphate (Antitussive) 10 mg/5 mL x 60 mL XP4 N3 508 512 516 *PHENOBARBITAL ELIXIR ACDHON  *PHENOBARBITAL ELIXIR ACDHON  *PHENOTAL ELIXIR ⌫ Phenobarbital Na 20 mg/5 mL x 60 mL Phenobarbital Na 20 mg/5 mL x 500 mL XP4 Phenobarbital Na 20 mg/5 mL x 60 mL P4 XP4 509 513 517 *PHENOBARBITAL ELIXIR ACDHON  *PHENOBARBITAL ELIXIR ACDHON  *PSEUDOEPHEDRINE SYRUP ASIAN PHARM ⌫ Phenobarbital Na 20 mg/5 mL x 120 mL Phenobarbital Na 20 mg/5 mL x 1000 mL XP4 510 XP4 514  Pseudoephedrine HCl 30 mg/5 mL x 60 mL P2 518 *Shown smaller than actual size 28 PN DEX 2010 PRODUCT IDENTIFICATION CHART *TENADRIN-C† ⌫   Codeine Phosphate (Antitussive) 60 mL XN3 *PSEUDOEPHEDRINE SYRUP BJ BENJAOSOTH ⌫  Pseudoephedrine HCl 30 mg/5 mL x 60 mL P2 *BROWN MIXTURE GPO†  Camphorated Opium Tinct 0.6 mL/5 mL x 180 mL N3 519 *TERADENE† 527 523 ⌫   *PHENSODI†  Codeine Phosphate (Antitussive) 60 mL Codeine Phosphate (Antitussive) 60 mL XN3 XN3 *BROWN MIXTURE GPO†  Camphorated Opium Tinct 0.6 mL/5 mL x 450 mL N3 520 *COFCODYL COUGH 528 524 †  Codeine Phosphate (Antitussive) 60 mL † *PHENSODI  Codeine Phosphate (Antitussive) 120 mL XN3 Opium Tinct 5 mL/100 mL x 1000 mL XN3 N3 521 525 *COFCODYL COUGH† *PHENSODI†  Codeine Phosphate (Antitussive) 100 mL *CAMPHORATED OPIUM TINCTURE BP 1980†  529  Codeine Phosphate (Antitussive) 1000 mL XN3 XN3 *COUGH SYRUP GPO†  Camphorated Opium Tinct 0.6 mL/5 mL x 60 mL XN3 522 † 526 Indicates brands that contain more than 1 ingredient 530  PN DEX 2010 PRODUCT IDENTIFICATION CHART 29 † *MIST. SCILL AMMON. GPO  *MASADYL COUGH Camphorated Opium Tinct 0.6 mL/5 mL x 180 mL †  *NEO COUGH†  Codeine Phosphate (Antitussive) 100 mL Codeine Phosphate (Antitussive) 240 mL XN3 XN3 N3 531 535 *TERADYL SYRUP †     539 *MASADYL COUGH †  Codeine Phosphate (Antitussive) 240 mL XN3 Codeine Phosphate (Antitussive) 60 mL *CODYL COUGH†  Codeine Phosphate (Antitussive) 9 mg/5 mL x 60 mL N3 XN3 540 532 536 *TERADYL SYRUP† *NEO COUGH†      Codeine Phosphate (Antitussive) 60 mL XN3 Codeine Phosphate (Antitussive) 1000 mL *CODYL COUGH†  Codeine Phosphate (Antitussive) 9 mg/5 mL x 100 mL N3 XN3 537 533 *MASADYL COUGH †  541 † *NEO COUGH  Codeine Phosphate (Antitussive) 60 mL Codeine Phosphate (Antitussive) 100 mL XN3 XN3 *CODYL COUGH†  Codeine Phosphate (Antitussive) 9 mg/5 mL x 1000 mL XN3 534 538  542 *Shown smaller than actual size 30 PN DEX 2010 PRODUCT IDENTIFICATION CHART *CODYL COUGH†  Codeine Phosphate (Antitussive) 9 mg/5 mL x 4500 mL XN3 Pseudoephedrine HCl 30 mg/5 mL x 60 mL *BENADRYL CD†  Codeine Phosphate (Antitussive) 1000 mL XN3 P2 543 *MENOBARB ELIXIR *PSEUDOEPHEDRINE SYRUP MILANO  551 547  Phenobarbital Na 15 mg/5 mL x 60 mL XP4 *POLY-COF SYRUP†  Codeine Phosphate (Antitussive) 9 mg/5 mL x 60 mL *BENYLIN CD†  Codeine Phosphate (Antitussive) 60 mL XN3 N3 544 *MENOBARB-20 ELIXIR 552 548  Phenobarbital Na 20 mg/5 mL x 60 mL XP4 *POLY-COF SYRUP †  *PHENSEDYL†  Codeine Phosphate (Antitussive) 9 mg/5 mL x 100 mL Codeine Phosphate (Antitussive) 9 mg/5 mL x 100 mL N3 N3 545 549 *MILA-CONO†  *BENADRYL CD† 553  Codeine Phosphate (Antitussive) 60 mL Codeine Phosphate (Antitussive) 60 mL XN3 XN3 *BROWN MIXTURE OSOTH INTERLAB†  Camphorated Opium Tinct 0.6 mL/5 mL x 180 mL N3 546 † 550 Indicates brands that contain more than 1 ingredient 554  PN DEX 2010 † *HISEDYL  PRODUCT IDENTIFICATION CHART 31 † *P-CODYL Codeine Phosphate (Antitussive) 60 mL XN3 555 † *HISEDYL   XN3 N3 563 *PHENOBARB ELIXIR *PONDNADYL† ⌫ ⌫ ⌫ XN3 ⌫ Phenobarbital Na 20 mg/5 mL x 60 mL Codeine Phosphate (Antitussive) 9 mg/5 mL x 100 mL XP4 N3 556 560 *MIXTURE SCILLAE AMMON† *BONADINE CD† 564   Codeine Phosphate (Antitussive) 60 mL XN3 Camphorated Opium Tinct 2 mL/15 mL x 180 mL ⌫ Codeine Phosphate (Antitussive) 9 mg/5 mL x 60 mL 559 Codeine Phosphate (Antitussive) 120 mL  *PONDNADYL† Codeine Phosphate (Antitussive) 9 mg/5 mL x 120 mL *PONDNADYL† ⌫ Codeine Phosphate (Antitussive) 9 mg/5 mL x 1000 mL XN3 XN3 557 561 *P-CODYL †  *PERCIDYL COUGH† Codeine Phosphate (Antitussive) 9 mg/5 mL x 60 mL Codeine Phosphate (Antitussive) 100 mL XN3 XN3 558 565 ⌫ *NORDYL LINCTUS†   Codeine Phosphate (Antitussive) 9 mg/5 mL x 100 mL N3 562  566 *Shown smaller than actual size 32 PN DEX 2010 PRODUCT IDENTIFICATION CHART *NORDYL LINCTUS†   Codeine Phosphate (Antitussive) 9 mg/5 mL x 500 mL *PHENOSIL ELIXIR ⌫ Phenobarbital Na 20 mg/5 mL x 450 mL XP4 XN3  Camphorated Opium Tinct 0.45 mL/5 mL x 60 mL N3 571 567 *NORTUSS LINCTUS†   Codeine Phosphate (Antitussive) 100 mL XN3 568 *NORTUSS LINCTUS *MIXTURE TUSSIS† †   *DECOS† 575 ⌫ *MIXTURE TUSSIS†  Codeine Phosphate (Antitussive) 9 mg/5 mL x 100 mL Camphorated Opium Tinct 0.45 mL/5 mL x 120 mL N3 N3 572 576 *ELIXIR PHENOBARB Codeine Phosphate (Antitussive) 500 mL Phenobarbital Na 60 mL XN3 XP4  *MIXTURE TUSSIS†  Camphorated Opium Tinct 0.45 mL/5 mL x 240 mL N3 569 573 *PHENOSIL ELIXIR ⌫ *MIXTURE TUSSIS† Phenobarbital Na 20 mg/5 mL x 60 mL XP4 570 † 577  *MIXTURE TUSSIS†  Camphorated Opium Tinct 0.45 mL/5 mL x 30 mL Camphorated Opium Tinct 0.45 mL/5 mL x 450 mL N3 N3 574 578 Indicates brands that contain more than 1 ingredient  PN DEX 2010 *MIXTURE TUSSIS † PRODUCT IDENTIFICATION CHART 33  † *CONADYL Camphorated Opium Tinct 0.45 mL/5 mL x 1800 mL ⌫  ⌫ Codeine Phosphate (Antitussive) 60 mL XN3 XN3 *PHENCODIN† ⌫   Codeine Phosphate (Antitussive) 9 mg/5 mL x 500 mL XN3 579 583 *MIXTURE TUSSIS†  587 *PHENOCO ELIXIR Camphorated Opium Tinct 0.45 mL/5 mL x 3600 mL ⌫  ⌫ Phenobarbital Na 20 mg/5 mL x 450 mL P4 XN3 *PHENCODIN† ⌫   Codeine Phosphate (Antitussive) 9 mg/5 mL x 1000 mL XN3 580 584 *MANTADYL COUGH† ⌫   588 *PHENOCO ELIXIR ⌫  ⌫ Codeine Phosphate (Antitussive) 60 mL Phenobarbital Na 20 mg/5 mL x 3800 mL XN3 XP4 *TUSSIDYL† ⌫   Codeine Phosphate (Antitussive) 9 mg/5 mL x 60 mL N3 581 585 *COSEDYL COUGH LINCTUS† *PHENCODIN† ⌫ ⌫  589 ⌫   *MIST TUSSIS†  Codeine Phosphate (Antitussive) 60 mL Codeine Phosphate (Antitussive) 9 mg/5 mL x 60 mL Camphorated Opium Tinct 0.6 mL/5 mL x 450 mL XN3 N3 N3 586 590 582  *Shown smaller than actual size 34 PN DEX 2010 PRODUCT IDENTIFICATION CHART *SQUILL AND AMMONIA MIXTURE† *ORAMORPH    Morphine Sulfate 20 mg/mL x 30 mL *FENTANYL ANTIGEN  Fentanyl Citrate 0.05 mg/mL x 10 mL N2 N2 591 595 599 *DIMETANE EXPECTORANT DC† *METHADONE GPO *DIAPINE Camphorated Opium Tinct 1.3 mL/10 mL x 450 mL N3  Codeine Phosphate (Antitussive) 2.5 L XN3  Methadone HCl 10 mg/mL x 1000 mL  Diazepam 5 mg/mL x 1 mL P4 N2 592 † *CODIPRONT   Codeine Resinate 60 mL XN3 596 600 *PENTAZOCINE ALL PLANTS *DIAPINE  Pentazocine 30 mg/mL x 1 mL  Diazepam 10 mg/2 mL x 2 mL P4 XP3 593 597 601 *ORAMORPH   *FENTANYL ANTIGEN  *PETHIDINE BIOLAB  Morphine Sulfate 10 mg/5 mL x 250 mL † Fentanyl Citrate 0.05 mg/mL x 2 mL Pethidine HCl 100 mg/2 mL x 2 mL N2 N2 N2 594 598 602 Indicates brands that contain more than 1 ingredient  PN DEX 2010 *DIAZEPAM GPO  PRODUCT IDENTIFICATION CHART 35 *PANGON  ⌫  ⌫ Diazepam 10 mg/2 mL x 2 mL Pentazocine 30 mg/mL x 1 mL P4 P3 *PETHIDINE M & H MANUFACTURING     Pethidine HCl 50 mg/mL x 1 mL N2 603 607 *EPHEDRINE GPO  *ROPAM 611  ⌫  ⌫ Ephedrine HCl 30 mg/mL x 1 mL Diazepam 10 mg/2 mL x 2 mL P2 P4 *PETHIDINE M & H MANUFACTURING     Pethidine HCl 100 mg/2 mL x 2 mL N2 604 608 612 *FENTANYL JANSSEN-CILAG *MORPHINE SULFATE INJ BLUE *MANOLIUM  ⌫     Diazepam 10 mg/2 mL x 2 mL P4 Fentanyl Citrate 0.05 mg/mL x 2 mL Morphine Sulfate 10 mg/mL x 1 mL N2 N2 605 609 613 *FENTANYL JANSSEN-CILAG *MORPHINE SULFATE INJ PURPLE *ZEPAM ⌫     Fentanyl Citrate 0.05 mg/mL x 10 mL Morphine Sulfate 10 mg/mL x 1 mL N2 N2 606 610   Diazepam 10 mg/2 mL x 2 mL XP4 614 *Shown smaller than actual size 36 PN DEX 2010 PRODUCT IDENTIFICATION CHART *TRANOLAN  Diazepam 10 mg/2 mL x 2 mL P4 *TEMGESIC  ⌫ Buprenorphine HCl 0.3 mg/mL x 1 mL P2 *FENTANYL SANDOZ   Fentanyl Citrate 0.05 mg/mL x 2 mL N2 615 *V DAY ZEPAM 619 ⌫ ⌫ ⌫ 623  Diazepam 10 mg/2 mL x 2 mL Diazepam 10 mg/2 mL x 2 mL P4 XP4 616 *V DAY ZEPAM NL ⌫ ⌫ ⌫ Diazepam 10 mg/2 mL x 2 mL *SOSEGON ⌫ Pentazocine 30 mg/mL x 1 mL P3 620 624 *DORMICUM  *DIAZA  Midazolam 5 mg/mL x 1 mL Diazepam 10 mg/2 mL x 2 mL P4 P2 617 621 625 *FORTWIN ⌫ *DORMICUM  *SIPAM Pentazocine 30 mg/mL x 1 mL XP3 618 † *VALIUM XP4  Midazolam 15 mg/3 mL x 3 mL Diazepam 10 mg/2 mL x 2 mL P2 P4 622 626 Indicates brands that contain more than 1 ingredient  PN DEX 2010 *DIAZEPAM T P DRUG PRODUCT IDENTIFICATION CHART 37 ⌫ ⌫  *PETHIDINE T.P. DRUG ⌫ ⌫  Diazepam 10 mg/2 mL x 2 mL Pethidine HCl 50 mg/mL x 1 mL P4 N2 627 631 *MORPHINE T.P. DRUG ⌫ ⌫  635 *MONOZIDE-10  ⌫ ⌫ ⌫ Morphine Sulfate 10 mg/mL x 1 mL Diazepam 10 mg/2 mL x 2 mL P4 ⌫ ⌫  *TAZCINE *VESCOPAM  Diazepam 10 mg/2 mL x 2 mL P4 632 *MORPHINE T.P. DRUG Diazepam 10 mg/2 mL x 2 mL XP4 N2 628 *LAYLIUM-10  636 ☯ ⌫ *RIVOTRIL  Morphine Sulfate 10 mg/mL x 1 mL Pentazocine 30 mg/mL x 1 mL Clonazepam 1 mg/mL x 1 mL N2 XP3 XP4 629 633 *MORPHINE T.P. DRUG ⌫ ⌫  *ZEPAXID 637 ☯ ⌫ *GARDENAL ⌫⌫ Morphine Sulfate 10 mg/mL x 1 mL Diazepam 10 mg/2 mL x 2 mL N2 P4 P4 634 638 630  Phenobarbital Na 200 mg/4 mL *Shown smaller than actual size 38 PN DEX 2010 PRODUCT IDENTIFICATION CHART *NEMBUTAL ⌫   Pentobarbital Na 50 mg/mL x 20 mL P3 *KETALAR  Ketamine HCl 50 mg/mL x 10 mL P2 *FENTANYL SANDOZ   Fentanyl Citrate 0.05 mg/mL x 10 mL N2 639 *AMYTAL 643 ⌫ ⌫ Amobarbital Na 0.5 g XP3 645 ⌫⌫  Ketamine HCl 50 mg/mL x 10 mL *FENTANYL GPO  ⌫⌫ Fentanyl 25 mcg/hr P2 N2 641 646 *KETA-HAMELN  *FENTANYL GPO  ⌫⌫ Ketamine HCl 50 mg/mL x 10 mL † Fentanyl 12 mcg/hr N2 640 *CALYPSOL 644 *FENTANYL GPO  ⌫⌫ Fentanyl 50 mcg/hr P2 N2 642 647 Indicates brands that contain more than 1 ingredient  PN DEX 2010 *FENTANYL HEXAL  ⌫ Fentanyl 12 mcg/hr PRODUCT IDENTIFICATION CHART 39 *DUROGESIC ⌫ Fentanyl 50 mcg/hr x 5 mg N2 N2 648 652 *FENTANYL HEXAL  ⌫ *DUROGESIC ⌫ Fentanyl 25 mcg/hr Fentanyl 100 mcg/hr x 10 mg N2 N2 649 653 *FENTANYL HEXAL  ⌫ Fentanyl 50 mcg/hr N2 650 *DUROGESIC ⌫ Fentanyl 25 mcg/hr x 2.5 mg N2 651  *Shown smaller than actual size CLASSIFICATION OF PSYCHOTROPICS & NARCOTICS  ⌫ ⌫ ⌫           ⌦    ⌦  ⌫ ⌫ ⌫  ⌫ ⌦⌫⌫                    ⌦       ⌫ ⌫ ⌫⌫  ⌦⌫⌫                      ⌫  ⌫ ⌫       ⌫⌦    ⌫ ⌫ ⌦    ⌦  ⌫      ⌫  ⌦  ⌫  ⌫⌫ ⌦          1. AMFEPRAMONE (DIETHYLPROPION) 2. AMINEPTINE 3. AMINOREX 4. BROTIZOLAM 5. BUPRENORPHINE 6. BUTORPHANOL 7. CATHINE (D-NORPSEUDOEPHEDRINE) 8. EPHEDRINE 9. ESTAZOLAM 10. FENCAMFAMIN 11. FENETHYLLINE 12. FLUNITRAZEPAM 13. FLURAZEPAM 14. HALOXAZOLAM 15. KETAMINE 16. LOPRAZOLAM 17. LORMETAZEPAM 18. MAZINDOL 19. MESOCARB 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. METHYLPHENIDATE MIDAZOLAM N-ETHYLAMPHETAMINE NIMETAZEPAM NITRAZEPAM PEMOLINE PHENCYCLIDINE PHENDIMETRAZINE PHENMETRAZINE PHENTERMINE PHENYLPROPANOLAMINE PIPRADROL PSEUDOEPHEDRINE QUAZEPAM SECOBARBITAL TEMAZEPAM TRIAZOLAM ZALEPLON ZIPEPROL ZOLPIDEM ZOPICLONE     1. 2. 3. 4. AMOBARBITAL BUTALBITAL CYCLOBARBITAL GLUTETHIMIDE Pink Pages_2010_Tip.pmd 5. MEPROBAMATE 6. PENTAZOCINE 7. PENTOBARBITAL 40 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. ALLOBARBITAL ALPRAZOLAM BARBITAL BENZPHETAMINE BROMAZEPAM BUTOBARBITAL CAMAZEPAM CHLORAL HYDRATE AND ITS ADDUCTS CHLORDIAZEPOXIDE CHLORPHENTERMINE CLOBAZAM CLONAZEPAM CLORAZEPATE CLORTERMINE CLOTIAZEPAM CLOXAZOLAM DIAZEPAM DELORAZEPAM ETHCHLORVYNOL ETHINAMATE ETHYL LOFLAZEPATE FENPROPORAX FLUDIAZEPAM HALAZEPAM INORGANIC BROMIDES KETAZOLAM 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45. 7/4/2553, 09:28 LORAZEPAM MEDAZEPAM MEFENOREX METHYPHENOBARBITAL METHYPRYLON NORDAZEPAM OXAZEPAM OXAZOLAM PERLAPINE PHENOBARBITAL PINAZEPAM PRAZEPAM PROPYLHEXEDRINE PYROVALERONE SECBUTABARBITAL SPA TETRAZEPAM TOFISOPAM VINYLBITAL PN DEX 2010 41   ⌫  ⌦ ⌫  ⌫⌫ ⌦     1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45. 46. 47. 48. 49. 50. 51. 52. 53. 54. 55. 56. 57. 58. 59. 60. 61. 62. 63. 64. 65. 66. 67. 68. 69. 70. 71. 72. 73. 74. 75. 76. 77. 78. 79. 80. 81. 82. 83. 84. 85. 86. 87. 88. 89. 90. 91. 92. 93. 94. 95. 96. 97. 98. 99. 100. 101. ACETYLDIHYDROCODEINE ACETYLMETHADOL ALFENTANIL ALLYLPRODINE ALPHACETYLMETHADOL ALPHAMEPRODINE ALPHAMETHADOL ALPHAPRODINE ANILERIDINE BENZETHIDINE BENZYLMORPHINE BETACETYLMETHADOL BETAMEPRODINE BETAMETHADOL BETAPRODINE BEZITRAMIDE CLONITAZENE COCA BUSH COCAINE CODEINE CODOXIME CONCENTRATE OF POPPY STRAW DEXTROMORAMIDE DEXTROPROPOXYPHENE DIAMPROMIDE DIETHYLTHIAMBUTENE DIFENOXIN DIHYDROCODEINE DIHYDROMORPHINE DIMENOXADOL DIMEPHEPTANOL DIMETHYLTHIAMBUTENE DIOXAPHETYLBUTYRATE DIPHENOXYLATE DIPIPANONE DROTEBANOL ECGONINE ETHYLMETHYLTHIAMBUTENE ETHYLMORPHINE ETONITAZENE ETOXERIDINE FENTANYL FURETHIDINE HYDROCODONE HYDROMORPHINOL HYDROMORPHONE HYDROXYPETHIDINE ISOMETHADONE LEVOMETHORPHAN LEVOMORAMIDE LEVOPHENACYLMORPHAN Pink Pages_2010_Tip.pmd 41 LEVORPHANOL MEDICINAL OPIUM METAZOCINE METHADONE METHADONE INTERMEDIATE METHYLDESORPHINE METHYLDIHYDROMORPHINE METOPON MORAMIDE-INTERMEDIATE MORPHERIDINE MORPHINE MORPHINE METHOBROMIDE MORPHINE N-OXIDE MYROPHINE NICOCODINE NICODICODINE NICOMORPHINE NORACYMETHADOL NORCODEINE NORLEVORPHANOL NORMETHADONE NORMORPHINE NORPIPANONE OPIUM OXYCODONE OXYMORPHONE PETHIDINE PETHIDINE-INTERMEDIATE-A PETHIDINE-INTERMEDIATE-B PETHIDINE-INTERMEDIATE-C PHENADOXONE PHENAMPROMIDE PHENAZOCINE PHENOMORPHAN PHENOPERIDINE PHOLCODINE PIMINODINE PIRITRAMIDE PROHEPTAZINE PROPERIDINE PROPIRAM RACEMETHORPHAN RACEMORAMIDE RACEMORPHAN REMIFENTANIL SUFENTANIL THEBACON THEBAINE TILIDINE TRIMEPRIDINE    1. CODEINE 2. DIPHENOXYLATE 3. OPIUM TINCTURE/CAMPORATED OPIUM TINCTURE 7/4/2553, 09:28 NATIONAL LIST OF ESSENTIAL MEDICINES (NLEM) ⌫    ⌫         ⌧  ⌫ ⌫    ⌫     ⌫ ⌫  ⌫   ⌫ ⌫   ⌫   ⌫ ⌫           ⌫⌫ ⌦    ⌫       ⌫          ⌦⌦⌫          ⌫           ⌦⌦  ⌫ ⌦       ⌫  ⌫ ⌫ ⌦ ⌫ ⌫     ⌦   ⌫ ⌫   ⌦⌦⌫ ⌫     ⌫ ⌫ Pink Pages_2010_Tip.pmd 42 7/4/2553, 09:28 PN DEX 2010 43  ⌫   ⌫ ⌫  ⌫ ⌫ ⌫⌫ ⌫    ⌫ ⌫ ⌫⌫         ⌫⌫ ⌫⌫⌫          ⌫    ⌫  ⌦ ⌫        ⌫ ⌫  ⌦ ⌫ ⌫ ⌫⌫ ⌫⌫⌫  ⌫  ⌦ ⌫ ⌫ ⌫     ⌫   ⌫  ⌦ ⌫     ⌫     ⌫ ⌦ ⌫  ⌫  ⌦   ⌫ ⌫          ⌫ ⌫ ⌫  ⌫ ⌫  ⌫⌫  ⌫  ⌫  ⌫ ⌫  ⌦ ⌫ ⌫  ⌫ ⌫ ⌫ ⌫ ⌫   ⌫ ⌫  ⌦ ⌫ ⌫  ⌫     ⌫               ⌦  ⌫ ⌫        ⌫ ⌦     ⌫  Pink Pages_2010_Tip.pmd 43 7/4/2553, 09:28 PN DEX 2010 44 ⌫  ⌫   ⌫   ⌫ ⌫⌫⌫    ⌫     ⌫       ⌫⌫⌫ ⌫    ⌫ ⌫  ⌦ ⌫ ⌦    ⌦  ⌫          ⌫   ⌫ ⌫⌫ ⌫ ⌫  ⌫      ⌦    ⌫    ⌫⌫ ⌫ ⌫⌫   ⌫    ⌫  ⌫ ⌫       ⌦⌫      ⌫  ⌫    ⌫     ⌦   ⌫ ⌫    Pink Pages_2010_Tip.pmd 44 7/4/2553, 09:28 PN DEX 2010 45    ⌫       ⌫   ⌦  ⌫        ⌫ (Generic Name) Alprazolam P4 tab  4.1. Hypnotics and anxiolytics Buprenorphine hydrochloride P2 sublingual tab, sterile sol  4.7.1. Opioid analgesics Chloral hydrate P4 oral sol (hosp)  4.1. Hypnotics and anxiolytics Chlordiazepoxide P4 cap, tab  4.1. Hypnotics and anxiolytics Clonazepam tab  4.1. Hypnotics and anxiolytics P4      ⌫  4.8.1. Drugs used in the control of epilepsy 4.9. Drugs used in movement disorders Codeine phosphate N2 tab  3.6.1. Cough suppressants 4.7.1. Opioid analgesics Diazepam P4 cap, tab, sterile sol  4.1. Hypnotics and anxiolytics Dipotassium clorazepate P4 cap, tab  4.1. Hypnotics and anxiolytics Ephedrine hydrochloride P2 nasal drop (hosp) ( 0.5-3%)  12.2.2. Topical nasal decongestants sterile sol  2.7.2. Vasoconstrictor sympathomimetics    ⌫  ⌫      Pink Pages_2010_Tip.pmd 45 7/4/2553, 09:28 PN DEX 2010 46   ⌫ Fentanyl N2 transdermal therapeutic system (as base)  4.7.1. Opioid analgesics Fentanyl citrate N2 sterile sol  15.1.4. Sedative and analgesic peri-operative drugs Ketamine hydrochloride P2 sterile sol  15.1.1. Intravenous anaesthetics Lorazepam P4 tab  4.1. Hypnotics and anxiolytics Methadone N2 oral sol    (Generic Name) hydrochloride      ⌫ 4.10. Drugs used    ⌫ ⌫    ⌫   ⌫  ⌫    ⌫ in substance dependence tab, oral sol 4.7.1. Opioid analgesics Methylphenidate P2 tab (10 mg)  4.4. Central nervous system stimulants  AttentionDeficit Hyperactivity Disorder (ADHD) Midazolam hydrochloride P2 sterile sol  15.1.4. Sedative and analgesic peri-operative drugs         ⌦     ⌫⌫    ⌦ 4.8.2. Drugs used in epilepticus status  15.1.4. Sedative and analgesic peri-operative drugs ⌫    ⌦ Midazolam maleate P2 tab  refractory status epilepticus (premedication)     ⌦     ⌫  ⌫      Pink Pages_2010_Tip.pmd 46 7/4/2553, 09:28 PN DEX 2010   47   ⌫ (Generic Name) Morphine sulfate Nitrazepam N2 P2      ⌫ cap, tab, SR cap, SR tab, sterile sol  4.7.1. Opioid analgesics sterile sol  15.1.4. Sedative and analgesic peri-operative drugs tab  4.8.1. Drugs used in the control of epilepsy ⌫    infantile spasms Opium and Glycyrrhiza Mixture Compound (Mist. Tussis; Brown Mixture) N2 mixt (hosp)  3.6.1. Cough suppressants Pethidine hydrochloride N2 sterile sol  15.1.4. Sedative and analgesic peri-operative drugs 4.7.1. Opioid analgesics Phenobarbital P4 tab (as base or sodium)  4.8.1. Drugs used in the control of epilepsy Phenobarbital sodium P4 sterile pwdr  4.8.2. Drugs used in status epilepticus  16. Antidotes (Phenobarbitone sodium) Pseudoephedrine P2 hydrochloride tab, syr  3.7. Systemic nasal decongestants Squill and Ammonia Mixture mixt (hosp)  3.6.1. Cough suppressants N3      ⌫     ⌫  ⌫      Pink Pages_2010_Tip.pmd 47 7/4/2553, 09:28 IMPORTANT DRUG NOTES ⌫ ⌫ ⌫ Provides useful information on significant contraindications, precautions, adverse reactions and interactions of drugs, presented according to the Psychotropic & Narcotic Drugs List of Thailand. Note: I: Indications; CI: Contraindications; SP: Precautions; AR: Adverse Reactions; DI: Drug Interactions. P2 - Psychotropic Substance Schedule 2 AMFEPRAMONE (DIETHYLPROPION)      ⌫ ⌫  I: Obesity. CI: Advanced arteriosclerosis. Hyperthyroidism. Hypersensitivity. Glaucoma. Agitated states. History of drug abuse. Pulmonary HTN or severe hypertension. Heart murmur or valvular disorders. Emotional instability. History of psychiatric illness. Concomitant use w/ other anorectic agents. MAOI therapy or w/in 2 wk of discontinuation. Pregnancy & lactation. Child & elderly. SP: Increased risk of developing primary pulmonary HTN (PPH). HTN & severe CV disease. Prolonged use may induce dependence w/ withdrawal symptoms on cessation of therapy; do not use for more than 3 months. May increase convulsions in some epileptic patients. Toxic psychosis. Peptic ulceration. Prostatic hyperplasia. AR: CV & CNS disturbances; GI effects; allergic reactions; impotence; changes in libido, gynecomastia, menstrual upset; hematopoietic effects; dyspnea, hair loss, muscle pain, dysuria, increased sweating, polyuria. DI: Hypertensive risk w/ MAOIs. b-blockers, guanethidine, tricyclic antidepressants, urinary alkalinisers or acidifiers. Alters antidiabetic drug requirements. ⊗ BUPRENORPHINE ⌦ I: As a perioperative analgesic supplement. Moderate to severe pain. Premedication before anaesthesia. ⊗ CI: Acute alcoholism; convulsive disorders; head injuries; increased intracranial pressure; comatose patients; resp depression & obstructive airway disease; patients on established opioid agonists. SP: Hepatic or renal disease; pregnancy, lactation; hypothyroidism; adrenocortical insufficiency; asthma; prostatic hyperplasia; shock; hypotension; inflammatory or obstructive bowel disorders; myasthaenia gravis; infants/neonates. Reduce dose in elderly & debilitated patients. May precipitate withdrawal symptoms in narcotic addicts. AR: Sedation, nausea, dizziness, vertigo, hypotension, miosis, headache, hypoventilation, resp or CNS depression; tachycardia, bradycardia, urinary retention, coma, vomiting, drowsiness, sweating, confusion, dry mouth, diaphoresis, withdrawal syndrome. DI: Plasma-buprenorphine concentrations may be affected when co-administered w/ drugs that induce or inhibit cytochrome P450 isoenzyme CYP3A4. Enhanced depressant effects w/ other CNS depressants e.g. alcohol, anaesthetics, anxiolytics, hypnotics, TCAs & antipsychotics. Diazepam may produce resp & cardiac collapse. CATHINE (D-NORPSEUDOEPHEDRINE)  I: Obesity. CI: Patients treated w/ MAOI or stopped MAOI w/in the last 2 wk; moderate or severe hypertension; pulmonary hypertension; structural cardiac abnormalities or advanced arteriosclerosis; adrenal tumour; hyperthyroidism or hyperexcitability; coronary thrombosis; closed-angle glaucoma; pregnancy. SP: Heart disease, mild hypertension, CHF or angina of effort; prostate hyperplasia; patients w/ history of drug or alcohol abuse; DM; psychotic patients; renal disease. Growth retardation may occur in children. AR: Headache, tachycardia, precordial pain, Registration expired Pink Pages_2010_Tip.pmd 48 7/4/2553, 09:28 PN DEX 2010 IMPORTANT DRUG NOTES 49 giddiness, restlessness or insomnia; dry mouth & thrist, nausea, vomiting, sweating; difficulty in micturition; muscular weakness & tremors; tolerance & /or dependence may occur. DI: Reduced effect of guanethidine. Increased risk of arrhythmia in patients treated w/ digitalis due to its sympathomimetic effects. Increased risk of arrhythmia w/ chloroform, cyclopropane, halothane or other halogenated anesthetics. The effect of cathine may be reduced/enhanced by tricyclic antidepressants. Cathine should not be used in patients treated w/ a MAOI or w/in 14 days of stopping MAOI as hypertensive crisis may occur if used. EPHEDRINE   I: Relief of moderate to severe acute asthma, relief of broncoconstiction. CI: Hypersensitivity. Hypertension, thyrotoxicosis, BPH. Lactation. SP: Ischaemic heart disease, hyperthyroidism, diabetes mellitus, hypertension, angle-closure glaucoma, renal impairment; prostatic enlargement; pregnancy, elderly. AR: Anxiety, tachycardia, tremor, dry mouth, hypertension, cardiac arrhythmias, impaired circulation to the extremities, nervousness, insomnia, palpitations. Difficulty in micturition in patients w/ prostatic enlargement. Nasal drops: Local irritation, rebound nasal congestion & drug-induced rhinitis on prolonged use. Delusions, hallucinations. Seen w/ hypersensitivity & overdosage. Acute CNS & CVS stimulation presenting as vomiting, fever, hypertension, psychosis. Cardiac arrhythmias. DI: Reduces antihypertensive effect of bethanidine & guanethidine. May increase clearance of dexamethasone. Increased incidence of adverse effects when used w/ theophylline. Severe HTN when combined w/ MAOIs or within 2 wk of discontinuance of MAOI treatment. Increased risk of arrhythmias w/ cardiac glycosides, quinidine or tricyclic antidepressants. Increased vaso-constriction or pressor effects w/ ergot alkaloids or oxytocin. FLUNITRAZEPAM  I: Induction of anaesthesia. Premedication in surgery. Short-term management of insomnia. CI: Preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; chronic psychosis, phobic or obsessional states; may precipitate suicide or aggressive behavior; not to be used alone to treat depression or anxiety associated w/ depression; glaucoma. Pregnancy, lactation. Neonates. SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardio-respiratory function when used for deep sedation; personality disorders or organic brain changes; history of alcohol or drug addiction; resp depression & hypotension w/ parenteral admin; this route should only be used when facilities for reversing resp depression are available. AR: Drowsiness & lightheadedness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia. DI: Enhanced sedation or resp & CV depression w/ drugs w/ CNS depressant properties eg, antidepressants, antihistamines, antipsychotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Alcohol. Calciumchannel blockers; clonidine; diaxozide; disulfiram; clozapine; diuretics; moxonidine; nabitone; nitrates; cimetidine, esomeprazole & omeprazole; muscle relaxants; dopaminergics; lofexidine; hydralazine, minoxidil & nitroprusside; antifungals; angiotensin II receptor antagonist; antiepileptics; β-blockers; antibacterials. Drugs which alter the hepatic microsomal enzymes. ⊗ FLURAZEPAM  I: Short-term management of insomnia. CI: Hypersensitivity; porphyria. Pregnancy (3 rd trimester); neonates. SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardio-respiratory function when used for deep sedation; personality disorders or organic brain changes; history of alcohol or drug addiction. Respiratory depression & hypotension w/ parenteral admin. Dependence; lactation. Safety & efficacy are not proven in child <15 yr. ⊗ Pink Pages_2010_Tip.pmd 49 7/4/2553, 09:28 Registration expired 50 KETAMINE  ⌫      I: Induction of anaesthesia. CI: Hypertension, history of cerebrovascular accident. Eye injury, raised ocular & intracranial pressure. Psychotic disorders. SP: Minimise verbal & tactile stimulation during recovery period. Chronic alcoholic & alcoholintoxicated patients. Preanaesthetic elevated CSF pressure. Dependence & tolerance may develop. May impair ability to drive or operate machinery. Monitor cardiac function in patients w/ HTN or cardiac decompensation. Pregnancy & lactation. AR: Emergence reactions e.g. vivid dreams, hallucinations, confusion, irrational behaviour. Increased muscle tone sometimes resembling seizures. Temporary HTN & tachycardia. Hypotension, bradycardia, arrhythmias. Respiratory depression, apnoea, laryngospasm, diplopia, nystagmus, nausea, vomiting, lachrymation, hypersalivation, raised intraocular & CSF pressure, skin rash & pain at inj site. DI: May increase effects of nondepolarising muscle relaxants. May reduce hypnotic effect of thiopental. Prolonged recovery time w/ barbiturates/narcotics. Reduced cardiac output, BP & pulse rate w/ halothane. Increased risk of HTN & tachycardia w/ thyroid hormones. Seizures & tachycardia may occur when used w/ theophyllines. ⊗ PN DEX 2010 IMPORTANT DRUG NOTES AR: Drowsiness & lightheadedness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia. DI: Antidepressants, antihistamines, antipsychotics, general anesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Increased toxicity by amprenavir, cimetidine, ciprofloxacin, clarithromycin, clozapine, CNS depressants, diltiazem, disulfiram, digoxin, erythromycin, ethanol, levodopa, loxapine, metoprolol, metronidazole, miconazole, nefazodone, nelfinavir, omeprazole, phenytoin, rifabutin, rifampicin, ritonavir, troleandromycin, valproic acid & verapamil. Effect is decreased by carbamazepine, rifampicin & rifabutin. Alcohol. ⊗ LORMETAZEPAM   I: Short-term management of insomnia. CI: CNS depression; resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; chronic psychosis, phobic or obsessional states; not to be used alone to treat depression or associated anxiety; unstable myasthenia gravis; glaucoma. Pregnancy & lactation, children SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; personality disorders or organic brain changes; history of alcohol or drug addiction. AR: Drowsiness & lightheadedness, muscle weakness & ataxia, vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia. DI: Enhanced sedation or resp & CV depression w/ drugs w/ CNS depressant properties eg, antidepressants, antihistamines, antipsychotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics & alcohol. METHYLPHENIDATE      I: Hyperactivity disorders. Narcolepsy. CI: Marked anxiety, tension, agitation; glaucoma; Tourette’s syndrome or tics. Known severe structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac disorders that could increase the risk of sudden death. Extended-release form: Severe hypertension, heart failure, arrhythmia, hyperthyroidism, recent MI or angina. SP: Pregnancy & lactation. History of alcohol or drug abuse. Hypertension & other CV disorders that might be exacerbated by increases in BP or heart rate. Pre-existing psychosis or bipolar disorder; monitor for symptoms of aggression or hostility. History of seizure disorder. Children <6 yr (growth suppression); monitor growth during therapy. May impair ability to drive or operate machinery. Transdermal: Avoid exposure of application site to any direct external heat source. AR: Angina, arrhythmia, cerebral arteritis, cerebral Registration expired Pink Pages_2010_Tip.pmd 50 7/4/2553, 09:28 PN DEX 2010 IMPORTANT DRUG NOTES 51 occlusion, changes in BP, MI, necrotising vasculitis, palpitation, pulse changes, tachycardia; depression, dizziness, drowsiness, fever, headache, insomnia, nervousness, neuroleptic malignant syndrome (NMS), Tourette’s syndrome, toxic psychosis; erythema multiforme, exfoliative dermatitis, hair loss, rash, urticaria; growth retardation; abdominal pain, anorexia, diarrhoea, nausea, vomiting, wt loss; anaemia, leukopenia, thrombocytopenic purpura, thrombocytopenia; abnormal LFTs, hepatic coma, increased transaminases; arthralgia, dyskinesia; blurred vision, visual accommodation disturbance; cough, pharyngitis, sinusitis, upper resp tract infection; accidental injury, hypersensitivity. Transdermal: Insomnia, decreased appetite; nausea; tic, emotional instability; vomiting, anorexia; nasal congestion, nasopharyngitis; wt loss. DI: May reduce effects of antihypertensive agents. Reduced serum level w/ carbamazepine. Increased serum levels or effects w/ CYP2D6 inhibitors e.g. chlorpromazine, delavirdine, fluoxetine, miconazole, paroxetine, pergolide, quinidine, quinine, ritonavir, ropinirole. May increase serum levels of phenytoin, TCAs. Possible severe HTN & tachycardia w/ sibutramine. CNS depression w/ alcohol. Severe toxic reactions w/ clonidine. Increased risk of hypertensive crisis w/ MAOIs. respiration rate; apnoea; headache; hiccup; nausea, increased appetite, vomiting; cough; oversedation; seizure-like activity (paediatrics); paradoxical reactions; kernicterus; nystagmus; skin rash, pruritus; reduced alertness, confusion, euphoria, hallucinations, fatigue, dizziness, ataxia, post-op sedation, anterograde amnesia; jaundice; cardiac arrest, heart rate changes, thrombosis; anaphylaxis; laryngospasm, bronchospasm. Resp depression, resp arrest; hypotension. DI: Increased CNS depression w/ alcohol, opioids, barbiturates, other sedatives & anaesthetics. Increased resp depression w/ opiates, phenobarbital, other benzodiazepines. Plasma concentrations increased by CYP3A4 inhibitors e.g. cimetidine, erythromycin, clarithromycin, diltiazem, verapamil, ketoconazole & itraconazole, antiretroviral agents, quinupristin w/ dalfopristin. Midazolam conc decreased by phenytoin, carbamazepine, phenobarbital, rifampicin. Halothane, thiopental requirements may be reduced during concurrent use. NITRAZEPAM   MIDAZOLAM   I: Induction of anaesthesia. Premedication in surgery. Sedation for dental & minor surgical procedures. Sedation in critical care. Short-term management of insomnia. CI: Acute narrow-angle glaucoma; coma or patients in shock; acute alcohol intoxication; intrathecal & epidural admin. Acute pulmonary insufficiency or marked neuromuscular resp weakness including unstable myasthenia gravis; severe resp depression. SP: Paediatric patients w/ CV instability; chronic renal failure; open-angle glaucoma; cardiac disease; resp disease; myasthenia gravis; neonates; history of drug or alcohol abuse; elderly & debilitated (reduce dose); avoid prolonged use or abrupt withdrawal; hepatic impairment; severe fluid or electrolyte disturbances. May impair ability to drive or operate machinery; titrate dose carefully; monitor for early signs of hypoventilation, airway obstruction, or apnea. Pregnancy, lactation. AR: Physical & psychological dependence w/ withdrawal symptoms; decreased tidal vol & I: Infantile spasms. Short-term management of insomnia. CI: Myasthenia gravis, narrow-angle glaucoma, severe resp insufficiency, sleep apnoea syndrome, severe hepatic impairment, porphyria. SP: May induce anterograde amnesia; caution patients to have uninterrupted sleep of 7-8 hr after ingestion of dose. May impair ability to drive or operate machinery. Depression, esp if suicidal risk may be present. History of drug abuse or acute alcoholism. Hepatic & renal impairment. Respiratory disease. Debilitated patients. Patients who are at risk of falls. Children, elderly. Pregnancy & lactation. AR: Hypotension, palpitation; agitation, aggressiveness, amnesia, ataxia, confusion, delusions, disorientation, dizziness, fatigue, hallucination, hangover, headache, irritability, nightmares, psychoses, rage, restlessness, sedation; rash; changes in libido; constipation, diarrhoea, excessive salivation, heartburn, nausea, vomiting; granulocytopenia, leukopenia; falling, muscle weakness; blurred or double vision; tinnitus (associated w/ withdrawal); aspiration, increased bronchial secretion, dyspnoea. DI: CNS depressant effect increased w/ alcohol, barbiturates, TCAs, phenothiazines, morphine ⊗ Pink Pages_2010_Tip.pmd 51 7/4/2553, 09:28 Registration expired 52 PHENTERMINE  I: Anorectic in short-term treatment of moderate to severe obesity. CI: Pulmonary hypertension, advanced arteriosclerosis, moderate to severe hypertension, hyperthyroidism, CV disease, glaucoma, history of alcohol/drug abuse, agitated states, use during or w/in 14 days following MAOI therapy. Lactation. SP: Hypertension, DM, seizure disorder, Tourette’ s syndrome, patients who have used other anorexigens w/in the past year, children. May impair ability to drive & operate machinery. Potential for drug dependency. Discontinue if results are not satisfactory w/in 4 wk or tolerance develops. History of epilepsy. Renal or hepatic disease. Pregnancy. AR: Urticaria, GI upsets, palpitations, tachycardia, elevated blood pressure, overstimulation, restlessness, insomnia, tremor, headache, dry mouth, dizziness, dysphoria, euphoria, psychosis, changes in libido & impotence. Primary pulmonary HTN & valvular heart disease. DI: Decreased excretion by antacids, carbonic anhydrase inhibitors (e.g. acetazolamide, dichlorphenamide, methazolamide). Excretion is increased by urinary acidifiers. Increased risk of adverse effects w/ other sympathomimetic agents. There is a risk of arrhythmias when used w/ TCA. May reduce serum concentrations of phenytoin, phenobarbital and ethosuximide. Severe hypertensive episodes w/ MAOI. Primary pulmonary HTN or valvular heart disease may occur when phentermine is used concurrently w/ fenfluramine or dexfenfluramine. Avoid concurrent use w/ sibutramine. PSEUDOEPHEDRINE  I: Nasal congestion. CI: Severe hypertension, phaeochromocytoma. SP: Hyperthyroidism; ischaemic heart disease, arrhythmia or tachycardia; occlusive vascular ⊗ PN DEX 2010 IMPORTANT DRUG NOTES derivatives. Effects may be antagonised by theophylline. Increased levels/effects w/ probenecid. Reduced levels/effects w/ rifampicin. May reduce effects of levodopa. disorders e.g. arteriosclerosis, HTN or aneurysms; DM & closed-angle glaucoma; renal impairment, prostatic enlargement. Pregnancy; lactation. AR: Anginal pain; rebound congestion & rhinorrhoea; fear, anxiety, restlessness, tremor, insomnia, confusion, irritability & psychotic states; reduced appetite, nausea, vomiting; gangrene; cerebral haemorrhage & pulmonary oedema; reflex bradycardia, tachycardia & cardiac arrhythmias, palpitations & cardiac arrest, hypotension & dizziness, fainting & flushing. Tissue necrosis & sloughing; myocardial & arterial necrosis. DI: Increased risk of HTN & arrhythmias if given w/ cardiac glycosides, quinidine or TCAs. Increased risk of vasoconstrictor effects if given w/ ergot alkaloids or oxytocin. Co-admin w/ MAOIs may cause hypertensive crisis. Anaesthetics e.g. cyclopropane, halothane & other halogenated anaesthestics; antihypertensive agents. TEMAZEPAM  I: Short-term management of insomnia. CI: Severe hepatic impairment. Pregnancy. SP: Chronic pulmonary insufficiency, elderly or debilitated patients, impaired liver or kidney function, personality disorders or organic brain changes, history of alcohol or drug addiction, lactation. AR: Confusion, dizziness, drowsiness, fatigue, headache, lethargy, hangover, euphoria, difficulty w/ coordination, ataxia, anorexia, tremor, vomiting & backache. DI: Enhanced sedation, resp & CV depression w/ drugs w/ CNS depressant properties. TRIAZOLAM  I: Short-term management of insomnia. CI: Preexisting CNS depression or coma; resp depression; acute pulmonary insufficiency or sleep apnoea; myasthenia gravis; chronic psychosis, phobic or obsessional states; may precipitate suicide or aggressive behaviour so it should not to be used alone to treat depression or anxiety associated w/ depression. Porphyria. Pregnancy & lactation. Child. Registration expired Pink Pages_2010_Tip.pmd 52 7/4/2553, 09:28 PN DEX 2010 IMPORTANT DRUG NOTES 53 SP: Chronic pulmonary insufficiency; elderly or debilitated patients; sleep apnoea; muscle weakness; impaired liver or kidney function; drowsiness may affect skilled tasks; personality disorders or organic brain changes; history of alcohol or drug addiction. AR: Drowsiness, lightheadedness, dizziness, sedation, agitation, hallucinations, abnormal behaviour, muscle weakness, ataxia, confusion, slurred speech, changes in libido, urinary retention, anterograde amnesia. DI: Increased plasma triazolam concentrations w/ oral contraceptives, ergotamine, ciclosporin, isoniazid, ranitidine & CYP3A inhibitors e. g. some macrolide antibiotics, cimetidine, isoniazid, fluvoxamine, sertraline, paroxetine, diltiazem, verapamil, amiodarone. Additive CNS depression w/ other CNS depressants eg, antipsychotics, other hypnotics or sedatives, opioid analgesics & alcohol. Increased risk of prolonged sedation w/ potent CYP3A inhibitors e.g. azole antifungal agents, nefazodone, HIV protease inhibitors, nonnucleoside reverse transcriptase inhibitors. ZOLPIDEM  I: Short-term management of insomnia. CI: Severe hepatic insufficiency. SP: Obstructive sleep apnoea, myasthenia gravis, compromised resp function, hepatic impairment. Caution in patients exhibiting symptoms of depression. Patients should be warned from doing any work involving mental alertness or motor coordination after ingestion of the drug. Pregnancy & lactation. Re-evaulate if insomnia fail to remit after 7-10 days. Max duration of treatment: 4 wk including tapering. AR: Amnesia, drowsiness, dizziness, diarrhoea, nausea, vomiting, abnormal thinking & behaviour, drugged feelings, back pain, ataxia, hiccups, confusion, euphoria, insomnia, vertigo, diplopia, abnormal vision. Hepatitis, anaphylactic reactions, sleep-driving (driving while not fully awake after drug ingestion, w/ no recollection of the event). DI: Increased sedation & incoordination w/ TCA. Increased sedation w/ haloperidol & alcohol. Small increase in zolpidem conc w/ ketoconazole. Reduced effect of hypnotic effects w/ rifampicin. Increased risk of prolonged sedation & resp depression w/ ritonavir. P3 - Psychotropic substance Schedule 3 AMOBARBITAL            ⌫ ⌫       I: Severe intractable insomnia. CI: Depression; pulmonary insufficiency; sleep apnoea; preexisting CNS depression or coma; severe hepatic impairment. Porphyria. Pregnancy & lactation. Elderly & debilitated patients; young adults & child. SP: Renal insufficiency; given to patients in pain may provoke a paradoxical excitatory reaction, unless an analgesic is given concomitantly; may impair ability to drive or operate machinery. AR: Dependence; drowsiness, sedation, ataxia; resp depression; headache; GI disturbances; skin reactions; confusion & memory defects; paradoxical excitement, irritability; hypersensitivity reactions; haematologic disorders. DI: Sedation or resp depression may be enhanced by drugs w/ CNS depressants; MAOIs may prolong the CNS depressant effects & also reduce the convulsive threshold, thereby antagonise the anitconvulsant action of barbiturates. Others: Fenoprofen, methadone, pethidine & opioid analgesics; disopyramide, lidocaine & quinidine; chloramphenicol, doxycycline; warfarin & coumarin; antidepressants eg, bupropion, fluoxetine, lithium & mianserin; valproate & progabide; vigabatrin, oxcarbazepine, carbamazepine, clonazepam, ethosuximide, lamotrigine, tiagabine & zonisamide, griseofulvin; teniposide; metronidazole; chlorpromazine; HIV-protease inhibitors; βblockers; calcium-channel blockers eg, nifedipine & verapamil; digitoxin; ciclosporin; corticosteroids; furosemide; montelukast; oral contraceptives; theophylline; levothyroxine; flu vaccination & vitamins. Alcohol. St. John’s wort. PENTAZOCINE ⌦ I: Moderate to severe pain. CI: Head injury; narcotic dependence; resp depression; raised intracranial pressure; MI; heart failure; arterial or pulmonary hypertension; porphyria; pregnancy (prolonged use or high doses at term). ⊗ Pink Pages_2010_Tip.pmd 53 7/4/2553, 09:28 Registration expired 54 IMPORTANT DRUG NOTES SP: May precipitate withdrawal in narcotic addicts. Impaired respiratory, renal & hepatic function; morbidly obese patients; thyroid dysfunction; prostatic hyperplasia or urinary stricture; biliary tract impairment; adrenal insufficiency (including Addison’s disease); abdominal conditions. Elderly or debilitated patients; seizure-prone patients; child & infants (safety & efficacy not established in <1 yr); lactation. May impair ability to drive or operate machinery. Administer IM rather than SC (when frequent inj are needed) & inj sites should be varied. AR: Physical dependence; sedation, dizziness, euphoria, lightheadedness, alterations of mood; resp depression; visual hallucinations, disorientation, confusion; hypertension, tachycardia, circulatory depression; shock; hypotension; nausea, vomiting, constipation; seizures, diaphoresis; rash; blood dyscrasias; local tissue damages (SC), muscle fibrosis (IM). Respiratory depression, hypotension, circulatory failure, deepening coma, convulsions. DI: Depressant affects potentiated by alcohol, CNS depressants; concurrent use w/ fluoxetine may lead to diaphoresis, ataxia flushing & tremor associated w/ serotonin syndrome. P4 - Psychotropic Substance Schedule 4 ALPRAZOLAM   I: Panic attacks. Short-term management of anxiety. CI: Acute narrow-angle glaucoma, preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation. SP: Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal function; arteriosclerosis; obesity; depression particularly suicidal tendency; chronic pulmonary insufficiency. May impair ability to drive or operate machinery. Children <18 yr. AR: Psychological & physical dependence, withdrawal syndrome; drowsiness, sedation, vertigo, headache, visual disturbances, GI disturbances, jaundice; fatigue, muscle weakness, ataxia, dizziness, confusion & depression. Blood dyscrasias. ⊗ PN DEX 2010 DI: Potentiates action of alcohol & CNS depressants. Reduced conc w/ cigarette smoking by 50%. Cimetidine & fluoxetine reduce the clearance of alprazolam. Alprazolam enhances activity of imipramine & desipramine. BROMAZEPAM  I: Anxiety. CI: Preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnea; severe hepatic impairment; not indicated for chronic psychosis, phobic or obsessional states; may precipitate suicide or aggressive behavior, not used alone to treat depression or anxiety associated w/ depression; glaucoma. SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardio-respiratory function when used for deep sedation; patients w/ personality disorders or organic brain changes; pregnancy & lactation; history of alcohol or drug addiction due to risk of dependence; resp depression & hypotension w/ parenteral administration, therefore this route should only be used when facilities for reversing resp depression are available. AR: Drowsiness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia; rarely, jaundice, blood disorders & hypersensitivity reactions; pain & thrombophlebitis; raised liver enzyme values; paradoxical excitation. DI: Enhanced sedation or resp & CV depression w/ drugs w/ CNS depressant properties eg, antidepressants, antihistamines, antipsychotics, general anesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Alcohol. Drugs which alter the hepatic microsomal enzymes. CHLORDIAZEPOXIDE  I: Acute anxiety. Acute symptoms of alcohol withdrawal. Anxiety. Insomnia. Muscle spasms. Premedication before anaesthesia. Severe Registration expired Pink Pages_2010_Tip.pmd 54 7/4/2553, 09:28 PN DEX 2010 IMPORTANT DRUG NOTES 55 symptoms of alcohol withdrawal. CI: Acute pulmonary insufficiency, resp depression, patients w/ marked neuromuscular resp weakness; hypersensitivity to benzodiazepines; chronic psychosis; porphyria; pregnancy & lactation. SP: Alcohol; sedation, dependence. Elderly & debilitated patients. Liver or kidney dysfunction. Avoid prolonged usage. AR: Physical & psychological dependence; withdrawal syndrome; impairs psychomotor performance, aggression (in predisposed individuals esp in combination w/ alcohol); sedation; blood dyscrasias, jaundice, hepatic dysfunction. May rarely cause hypoplastic or haemolytic anaemia. DI: Cimetidine increases serum conc of chlordiazepoxide. Potentiates action of major neuroleptics. Alcohol potentiates CNS-depressant effect of chlordiazepoxide. CLOBAZAM   I: Adjunct in epilepsy. Short-term management of anxiety. CI: Hypersensitivity; history of drug dependence; myasthaenia gravis; pregnancy (1 st trimester), lactation; serious liver damage; sleep apnoea syndrome; impaired resp function. SP: May impair ability to perform skilled tasks & hazardous activities; elderly; renal or hepatic impairment; alcoholics; obesity; withdrawal should be gradual. AR: Constipation, anorexia, nausea; dizziness, fine tremors; worsening of resp symptoms in predisposed individuals; ataxia, drowsiness, headache, confusion; loss of libido, motor dysfunction; dependence; visual disturbances & wt gain. Respiratory depression. DI: Increased hepatic clearance of clobazam when administered w/ phenytoin, phenobarbital or carbamazepine. Cimetidine may increase levels of clobazam. Concurrent alcohol, hypnotics & sedative antidepressants can potentiate CNS side effects of clobazam. CLONAZEPAM   I: Emergency management of status epilepticus. Epilepsy. Panic disorder. CI: Hypersensitivity to benzodiazepines, acute pulmonary insufficiency, acute narrow angle glaucoma. SP: Neonates, chronic pulmonary insufficiency, hepatic/renal dysfunction, porphyria, elderly; pregnancy & lactation. AR: Drowsiness, fatigue, muscular hypotonia, coordination disturbances, dizziness, vertigo, anorexia, visual disturbances, libido changes. Salivary or bronchial hypersecretion leading to resp problems (children). May produce diminished reflexes or coma. Rarely, blood dyscrasias. DI: Carbamazepine, phenobarbitone or phenytoin may accelerate clonazepam metabolism. Increased sedative effect w/ alcohol, general anaesthetics & TCAs. CLORAZEPATE  I: Alcohol withdrawal syndrome. Anxiety. Epilepsy. CI: Hypersensitivity (cross-sensitivity w/ other benzodiazepines may occur); narrow-angle glaucoma. Patients w/ depressive or psychotic disorders. child <9 yr. Pregnancy; lactation. SP: Elderly, debilitated patients; hepatic disease, alcoholics; renal impairment; resp disease; impaired gag reflex; patients experiencing apnoea during sleep; operating machines or driving; patients on CNS depressant or psychoactive drug therapy; depression, esp those w/ suicidal tendencies; history of drug-dependence. AR: Jaundice, hepatic necrosis; extrapyramidal disorders; acute attacks of porphyria in porphyric patients, hypotension; drowsiness, fatigue, ataxia, lightheadedness, memory impairment, insomnia, anxiety, headache, depression, slurred speech, confusion, nervousness, dizziness, irritability; rash; decreased libido; xerostomia, constipation, diarrhoea, decreased salivation, nausea, vomiting, increased or decreased appetite; dysarthria, tremor; blurred vision, diplopia. DI: Potentiates CNS effects of narcotic analgesics, barbiturates, phenothiazines, ethanol, antihistamines, MAO Inhibitors, sedativehypnotics, cyclic antidepressants. CYP3A4 inhibitors eg, amprenavir, cimetidine, ciprofloxacin, clarithromycin may increase serum conc & toxicity of clorazepate. Carbamazepine, rifampin & rifabutin may decrease clorazepate therapeutic effects by enhancement of clorazepate metabolism. ⊗ Pink Pages_2010_Tip.pmd 55 7/4/2553, 09:28 Registration expired 56 PN DEX 2010 IMPORTANT DRUG NOTES ⊗ DIAZEPAM ETHYL LOFLAZEPATE    I: Adjunct in the management of seizures. Alcohol withdrawal syndrome. Insomnia associated w/ anxiety. Muscle spasms. Premedication before anaesthesia. Sedation in minor surgical & medical procedures. Severe anxiety. CI: Hypersensitivity; myasthenia gravis, preexisting CNS depression or coma, resp depression; acute pulmonary insufficiency or sleep apnoea syndrome; severe hepatic impairment; acute narrow angle glaucoma; child <6 mth (oral); pregnancy & lactation. I: Short-term management of anxiety. SP: Impaired renal & hepatic function, resp disease, organic cerebral changes, elderly, psychotic patients, epileptics, history of alcohol or drug addiction, impaired gag reflex, obese patients. May cause CNS depression. Discontinue treatment if patient develops psychiatric & paradoxical reactions. Caution when used in patients w/ depression or anxiety associated w/ depression, esp if patient has suicidal risk. May increase risk of falls. Safety & efficacy of the inj have not been established in child <1 mth of age. Safety & efficacy of oral use have not been established in child <6 mth of age. Safety & efficacy of rectal gel have not been established in child <2 yr of age. Abrupt withdrawal or large dose reduction may cause rebound or withdrawal symptoms. AR: Psychological & physical dependence w/ withdrawal syndrome, fatigue, drowsiness, sedation, ataxia, vertigo, confusion, depression, GI disturbances, changes in salivation, amnesia, jaundice, paradoxical excitation, elevated liver enzyme values; muscle weakness, visual disturbances, headache, slurring of speech & dysarthria, mental changes, incontinence, constipation, hypotension, tachycardia, changes in libido, pain & thrombophlebitis at inj site (IV). Respiratory & CNS depression, coma. DI: Increased clearance of diazepam when used w/ phenytoin, carbamazepine & phenobarbital. Reversible deterioration of parkinsonism may occur when given together w/ levodopa. Combination w/ lithium may produce hypothermia. May need to reduce dose of narcotics when used concurrently. Phenothiazines, barbiturates, MAOIs potentiate action of diazepam. Additive CNS depressant effects w/ alcohol & CNS depressants or psychoactive medications. Mutual potentiation of action w/ analgesics, anaesthetics & some anticonvulsants. ⊗ CI: Preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; not indicated for chronic psychosis, phobic or obsessional states; may precipitate suicide or aggressive behaviour, not used alone to treat depression or anxiety associated w/ depression; glaucoma. SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardio-respiratory function when used for deep sedation; patients w/ personality disorders or organic brain changes; pregnancy, lactation; history of alcohol or drug addiction due to risk of dependence. Resp depression & hypotension may occur w/ parenteral admin. AR: Drowsiness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia; rarely, jaundice, blood disorders & hypersensitivity reactions; pain & thrombophlebitis; raised liver enzyme values; paradoxical excitation. DI: Enhanced sedation or resp & CV depression w/ drugs that have CNS depressant properties e.g. antidepressants, antihistamines, antipsychotics, general anesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Drugs which alter the hepatic microsomal enzymes. LORAZEPAM  I: Acute anxiety. Anxiety. Insomnia associated w/ anxiety. Premedication in surgery. Prophylaxis of nausea & vomiting associated w/ cytotoxic therapy. Sedation in critical care. Status epilepticus. CI: Severe hepatic impairment; resp depression; acute narrow-angle glaucoma; pregnancy & lactation. SP: Hepatic & renal dysfunction; pulmonary insufficiency; myasthenia gravis; may impair ability to drive or operate machinery; elderly or debilitated patients. Registration expired Pink Pages_2010_Tip.pmd 56 7/4/2553, 09:28 PN DEX 2010 IMPORTANT DRUG NOTES 57 AR: Drowsiness, headache, dizziness, confusion; blurred vision; nausea; weakness; unsteadiness. Resp depression. DI: Potentiation of CNS depression produced by alcohol; general anaesthetics; narcotic analgesics; TCAs; MAOIs; phenothiazines; antipsychotics; barbiturates; scopolamine. MEDAZEPAM  I: Short-term management of anxiety. CI: Glaucoma. SP: Severe hepatic impairment. Elderly or debilitated patients; muscle weakness or myasthenia gravis; impaired liver or kidney function; predisposition to seizures; depression; severe resp dysfunction; sleep apnoea; movement disorders; drowsiness may affect skilled tasks; history of alcohol or drug addiction. Treatment withdrawal should be gradual. Avoid long-term use. Pregnancy & lactation. AR: Fatigue, drowsiness, dizziness, prolonged reaction time, headache, coordination disorders (ataxia), confusion, anterograde amnesia. Rarely, GI symptoms, laryngeal spasm, chest pain, hypotension, bradycardia, depression, decreased libido, increased appetite, dry mouth, muscle weakness, resp failure. DI: Additive CNS depression or sedative effects w/ drugs that have CNS depressant properties e.g. alcohol, antidepressants, sedating antihistamines, antipsychotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics, cisapride. Increased risk of toxicity w/ hepatic microsomal enzyme inhibitors. function. Patients w/ acute pain & depressive disorders. May impair ability to drive or operate machinery. Lactation. AR: Bradycardia, hypotension, syncope; drowsiness, lethargy, CNS excitation or depression, impaired judgment, hangover effect, confusion, somnolence, agitation, hyperkinesia, ataxia, nervousness, headache, insomnia, nightmares, hallucinations, anxiety, dizziness; rash, exfoliative dermatitis; nausea, vomiting, constipation; agranulocytosis, thrombocytopenia, megaloblastic anaemia; pain at inj site, thrombophlebitis (IV); oliguria: laryngospasm, resp depression, apnoea (especially w/ rapid IV admin), hypoventilation. Stevens-Johnson syndrome. DI: May enhance the hepatotoxic potential of paracetemaol overdoses. May decrease levels/ effects of various CYP isoenzyme substrates e.g. teniposide, methotrexate, antipsychotics, b-blockers, calcium-channel blockers, other anticonvulsants, chloramphenicol, cimetidine, corticosteroids, ciclosporin, doxycycline, oestrogens, felbamate, griseofulvin, tacrolimus, furosemide, methadone, oral contraceptives, theophylline, TCAs, warfarin. May reduce effects of guanfacine. Reduced metabolism & or increased toxicity w/ chloramphenicol, felbamate, MAOIs, valproic acid. May enhance the nephrotoxic effects of methoxyflurane. Additive sedation and/or resp depression w/ ethanol, sedatives, antidepressants, opioid analgesics, benzodiazepines & other CNS depressants. May decrease levels/effects of antiarrhythmic drugs e.g. disopyramide, propafenone, quinidine. PINAZEPAM   PHENOBARBITAL       I: Emergency management of acute seizures. Generalised tonic-clonic seizures. Hypnotic. Partial seizures. Preoperative sedation. Sedation. Status epilepticus. CI: Severe renal & hepatic disorders. Severe resp depression, dyspnoea or airway obstruction; porphyria. Pregnancy. SP: Elderly or debilitated patients, children. Withdraw gradually. Impaired renal, hepatic & resp I: Insomnia associated w/ anxiety. Short-term management of anxiety. CI: Preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency, myasthenia gravis, sleep apnoea, severe hepatic impairment; not indicated for chronic psychosis, phobic or obsessional states; glaucoma. SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardio-respiratory function when used for deep sedation; patients w/ personality disorders or organic brain changes; pregnancy, lactation; history of alcohol or drug addiction, hypotension & apnoea w/ IV admin, therefore this route should only be used when ⊗ Pink Pages_2010_Tip.pmd 57 7/4/2553, 09:28 Registration expired 58 IMPORTANT DRUG NOTES facilities for reversing resp depression are available. Monitor for signs of suicidal tendency or aggressive behavior; not to be used alone to treat depression or anxiety associated w/ depression. AR: Drowsiness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia; rarely, jaundice, blood disorders & hypersensitivity reactions; pain & thrombophloebitis; raised liver enzyme values; paradoxical excitation. DI: Enhanced sedation or resp & CV depression w/ drugs w/ CNS depressant properties e.g. alcohol, antidepressants, antihistamines, antipsychotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. PN DEX 2010 general anaesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Decreased serum levels when used w/ phenytoin. May increase the plasma levels of bupivacaine. Serum levels may be increased by valproate & modafinil. TOFISOPAM  I: Alcohol withdrawal syndrome. Short-term management of anxiety. CI: Aggressive-impulsive psychopathy. Pregnancy. SP: Discontinue if sleep disturbances occur. Avoid sleep disturbances by taking last dose earlier (e.g. before 5 pm). AR: Nausea, rash, epigastric pain, itching, extreme liveliness, hyperactivity, aggressiveness. PRAZEPAM  N2 - Narcotic Drug Schedule 2 I: Short-term management of anxiety. CI: Preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; chronic psychosis, phobic or obsessional states; glaucoma; porphyria. Myasthenia gravis. SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardio-respiratory function when used for deep sedation; patients w/ personality disorders or organic brain changes; pregnancy & lactation; history of alcohol or drug addiction due to risk of depression. resp depression & hypotension w/ parenteral admin, therefore this route should only be used when facilities for reversing resp depression are available. May precipitate suicide or aggressive behavior, not used alone to treat depression or anxiety associated w/ depression. AR: Drowsiness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia; rarely, jaundice, blood disorders & hypersensitivity reactions; pain & thrombophloebitis; raised liver enzyme values; paradoxical excitation. DI: Enhanced sedation or resp & CV depression w/ alcohol, drugs w/ CNS depressant properties eg, antidepressants, antihistamines, antipsychotics, ⊗ CODEINE (ANALGESIC) ⌦ I: Mild to moderate pain. CI: Resp depression, obstructive airway disease, asthma. Acute alcoholism, convulsive disorders, head injuries, comatose patients, raised intracranial pressure. Pregnancy (prolonged use or high doses at term). SP: Hypothyroidism, adrenocortical insufficiency; asthma, impaired hepatic or renal function, prostatic hyperplasia, hypotension, shock, inflammatory or obstructive bowel disorders, myasthenia gravis. Infants, neonates; Reduce dose in elderly or debilitated patients. May impair ability to drive or operate machinery. Lactation. AR: Dependence, withdrawal symptoms; nausea, vomiting, constipation; drowsiness, confusion; difficulty in micturition, ureteric or biliary spasms, urinary retention; dry mouth, dizziness, sweating, facial flushing, headache, vertigo, bradycardia, tachycardia, palpitations, orthostatic hypotension, hypothermia, restlessness, mood changes, decreased libido or potency, hallucination, miosis; raised intracranial pressure, muscle rigidity. Resp depression & hypotension, w/ circulatory failure & deepening coma (larger doses). Convulsions (especially in child & infants). Rhabdomyolysis. Registration expired Pink Pages_2010_Tip.pmd 58 7/4/2553, 09:28 PN DEX 2010 IMPORTANT DRUG NOTES 59 DI: Enhanced depressant effects w/ alcohol, anaesthetics, anxiolytics, hypnotics, TCAs, antipsychotics. Possible CNS depression or excitation w/ MAOIs. May alter effects of other compounds e.g. cyclizine, mexiletine, cisapride, metoclopramide & domperidone. METHADONE ⌫  ⌫ ⌫   I: Analgesia. Intractable cough associated w/ lung cancer. Neonatal abstinence syndrome. Opioid dependence. FENTANYL ⌫    I: Adjunct to general anaesthesia. Breakthrough cancer pain. Intractable chronic pain. Premedication before anaesthesia. CI: Hypersensitivity. SP: Myasthaenia gravis. Head injury; increased intracranial pressure; intracranial lesions; renal or hepatic impairment; neonates; opioid-nontolerant patients. Increased risk of resp depression in elderly, debilitated patients, patient w/ hypoxia or hypercapnia. Hypothyroidism, prostatic hyperplasia, inflammatory bowel disorders, bradycardia or bradyarrhythmias. Rapid IV infusion may cause skeletal muscle & chest wall rigidity, impaired ventilation or resp distress/arrest. Prolonged use may cause tolerance, psychological & physical dependence. Abrupt withdrawal after prolonged admin may lead to withdrawal symptoms. Lactation. Pregnancy (avoid high doses or prolonged usage). AR: Nausea, vomiting; bradycardia, oedema, CNS depression, confusion, dizziness,drowsiness, headache, sedation, transient hypotension, peripheral vasodilation; increased intracranial pressure. High IV dose may cause chest wall rigidity. Transdermal: Rash, erythema & itching. Respiratory depression, trunk rigidity, laryngospasm, bronchoconstriction. DI: Depressant effects may be enhanced by other CNS depressants e.g. alcohol, anaesthetics, anxiolytics, hypnotics, TCAs & antipsychotics. Ammonium Cl may increase excretion of fentanyl. Phenothiazines may increase hypotensive effect of opioid analgesics. Serum levels may be increased by CYP3A4 inhibitors (e.g. azole antifungals, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, telithromycin & verapamil). May reduce the efficacy of pegvisomant. Serum levels may be reduced by rifamycin derivatives. May increase serotonergic effect of SSRIs & sibutramine. CI: Acute resp depression; acute bronchial asthma; acute alcoholism; risk of paralytic ileus; raised intracranial pressure or head injury. SP: Dose should be individualised. Prolonged QT interval; CV disease; hepatic impairment; electrolyte abnormalities; concommitant use of QT prolonging drug; resp disease; elderly. May impair ability to drive or operate machinery. AR: Nausea; vomiting; constipation; anorexia; abdominal pain; drowsiness; resp depression; hypotension; bradycardia; euphoria; headache; dysphoria; urinary retention; miosis; visual disturbances; impotence; dizziness; sweating; pruritis; asthenia; arrythmias; QT prolongation. Cardiac arrest; resp arrest; shock. DI: Withdrawal symptoms may be experienced w/ naloxone, naltrexone, pentazocine, nalbuphine, butorphanol, & buprenorphine. Increased clearance & possible reduced efficacy w/ some antiretrovirals (abacavir, amprenavir, efavirenz, nelfinavir, nevirapine, ritonavir, lopinavir); rifampin; phenytoin; phenobarbital; carbamazepine. Decreased clearance & possibly increased toxicity w/ CYP3A4 inhibitors (e.g. ketoconazole, voriconazole, sertraline, fluvoxamine). Increased chance of cardiac toxicity w/ other QT prolonging drugs. Increased CNS depression w/ alcohol, other opioids or CNS depressants. Methadone may increase plasma levels of desipramine, zidovudine. MORPHINE ⌦ I: Acute pain. Acute pulmonary oedema. Analgesia during labour. Chronic pain. Intractable cough associated w/ lung cancer. Moderate to severe pain. Pain associated w/ myocardial infarction. Pain relief. Premedication in surgery. Unstable angina not responsive to anti-ischaemic therapy. CI: Respiratory depression, acute or severe asthma; paralytic ileus; obstructive airway disease; acute liver disease; comatose patients; increased intracranial pressure; acute alcoholism. Pulmonary ⊗ Pink Pages_2010_Tip.pmd 59 7/4/2553, 09:28 Registration expired 60 IMPORTANT DRUG NOTES PN DEX 2010 oedema resulting from a chemical resp irritant. SP: Elderly; hypothyroidism; renal & liver disease; head injury, intracranial lesions; hypotension, circulatory shock; adrenocortical insufficiency; asthma; prostatic hyperplasia; inflammatory or obstructive bowel disease; myasthaenia gravis; infants <3 mth; pregnancy, lactation; hypovolaemia, biliary tract disorders. AR: Convulsions; nausea, vomiting, dry mouth, constipation; urinary retention; headache, vertigo; palpitations; hypothermia; pruritus, urticaria; tachycardia, bradycardia; blurred vision; miosis; dependency; drowsiness; lightheadedness; dizziness; sweating; dysphoria; euphoria. Respiratory depression; circulatory failure; hypotension; deepening coma; anaphylactic reactions. DI: May potentiate effects of TCAs; increased risk of serotonin syndrome w/ serotonergic drugs; risk of cardiac arrythmias w/ QT prolonging drugs; sedative effects may be increased by metoclopramide; antagonises efficacy of diuretics; morphine levels decreased by rifampicin. Increased CNS depression w/ other CNS depressants (e.g. other opioids, general anaesthetics, benzodiazepines, barbiturates), alcohol. Risk of severe hypotension w/ MAOIs. nausea, vomiting, constipation, anorexia, stomach cramps, xerostomia, biliary spasm, paralytic ileus, sphincter of Oddi spasm; ureteral spasms, decreased urination; pain at inj site; weakness; dyspnoea; histamine release, physical & psychological dependence. DI: Increased pethidine metabolite levels w/ aciclovir, cimetidine, ritonavir. Reduced analgesic effects w/ phenytoin, barbiturates. Additive sedative and/or resp depressive effects w/ alcohol, barbiturates, benzodiazepines, phenothiazines, TCAs, other CNS depressants. Increased risk of serotonin syndrome w/ MAOIs (not be given concurrently or w/in 14 days of their discontinuation), serotonin agonists, serotonin reuptake inhibitors, sibutramine, TCAs. PETHIDINE I: Cough suppressant. Mild to moderate pain. CI: Resp depression, obstructive airway disease, asthma. Acute alcoholism, convulsive disorders, head injuries, comatose patients, raised intracranial pressure. Pregnancy (prolonged use or high doses at term). SP: Hypothyroidism, adrenocortical insufficiency; asthma, impaired hepatic or renal function, prostatic hyperplasia, hypotension, shock, inflammatory or obstructive bowel disorders, myasthenia gravis. Infants, neonates; Reduce dose in elderly or debilitated patients. May impair ability to drive or operate machinery. Lactation. AR: Dependence, withdrawal symptoms; nausea, vomiting, constipation; drowsiness, confusion; difficulty in micturition, ureteric or biliary spasms, urinary retention; dry mouth, dizziness, sweating, facial flushing, headache, vertigo, bradycardia, tachycardia, palpitations, orthostatic hypotension, hypothermia, restlessness, mood changes, decreased libido or potency, hallucination, miosis; raised intracranial pressure, muscle rigidity. Resp depression & hypotension, w/ circulatory failure & deepening coma (larger doses). Convulsions (especially in child & infants). Rhabdomyolysis. DI: Enhanced depressant effects w/ alcohol, anaesthetics, anxiolytics, hypnotics, TCAs, ⌦  I: Adjunct to anaesthesia. Moderate to severe acute pain. Obstetric analgesia. Postoperative pain. Preoperative medication. SP: May impair ability to drive or operate machinery. Hypovolaemia, CV disease; adrenal insufficiency; biliary tract disorder; CNS depression or coma; history of drug abuse or acute alcoholism; head injury, intracranial lesions, elevated intracranial pressure; hepatic or renal impairment; morbidly obese; prostatic hyperplasia; toxic psychoses; pre-existing resp compromise (hypoxia and/or hypercapnia), COPD or other obstructive airway disease; sickle-cell disease; supraventricular tachycardia; thyroid dysfunction. Elderly & debilitated patients. Withdraw gradually. Pregnancy (avoid prolonged use or high doses at term) & lactation. AR: Hypotension; fatigue, drowsiness, dizziness, nervousness, headache, restlessness, malaise, confusion, depression, hallucinations, tremors, muscle twitches, increased intracranial pressure, seizure, serotonin syndrome; rash, urticaria; ⊗ N3 - Narcotic Drug Schedule 3 CODEINE (ANTITUSSIVE/ANALGESIC)  ⌦ Registration expired Pink Pages_2010_Tip.pmd 60 7/4/2553, 09:28 PN DEX 2010 IMPORTANT DRUG NOTES 61 antipsychotics. Possible CNS depression or excitation w/ MAOIs. May alter effects of other compounds e.g. cyclizine, mexiletine, cisapride, metoclopramide & domperidone. ⊗ DEXTROPROPOXYPHENE ⌦ I: Mild to moderate pain. CI: Hypersensitivity, chronic resp diseases, porphyria, pregnancy. Patients on MAOI treatment or w/in 2 wk of stopping treatment. SP: Suicidal patients, hepatic or renal disease; lactation, elderly. AR: Dizziness, sedation, weakness; nausea, vomiting, constipation; rash, urticaria; visual disturbances; physiological dependence. Convulsions in long-term therapy. Cardiac conduction abnormalities & arrhythmias; liver impairment. DI: Inhibits hepatic metabolism of benzodiazepines, b-blockers, carbamazepine, phenytoin & warfarin. Increased risk of toxicity when coadministered w/ ritonavir. Potentiation of depressant effects when used w/ alcohol or CNS depressants. Accidental or intentional overdosage fatal (especially if combined w/ alcohol, & analgesics e.g. paracetamol & aspirin). OPIUM TINCTURE / CAMPORATED OPIUM TINCTURE  I: Cough suppressant. CI: Severe hepatic & renal diseases; raised intracranial pressure; acute resp depression or obstructive airways disease; comatose patients; prolonged use or high dosages near term. SP: Hepatic or renal diseases; head injury, CNS depression, history of opioid agonist dependence; biliary tract or acute abdominal disorders; Addison’ s disease; obesity; urinary difficulties; resp disease; thyroid disease; infants<3 mths, debilitated patients & elderly; pregnancy. AR: CNS depression, hypotension, drowsiness & palpitation, bradycardia; sweating, flushing, pruritis; malaise; urinary tract spasm & reduction in urination; constipation; miosis. Severe resp depression; increased intracranial pressure. DI: Increased CNS depression w/ alcohol, other opiate agonists, general anesthetics, tranquillizers, sedatives & hypnotics. However, some tranquillizers e.g. phenothiazines may antagonize the effect of opiate analgesia; opium prep may increase the effect of TCA & MAOIs. Reduced effectiveness of diuretics in patients w/ CHF. Should not be given to patients bitten by Centruroides sculpturatus, Ewing & C. gertschi Stahnke scorpions as opiate agonist may potentiate the effect of the venoms. May cause serotonin syndrome if used w/ MAOIs. DIPHENOXYLATE ⌫⌫  ⌫ I: Acute diarrhoea. Chronic diarrhoea. CI: Infants & child <4 yr. Jaundice, intestinal obstruction. Diarrhoea associated w/ pseudomembranous colitis or enterotoxinproducing bacteria. SP: Hepatic dysfunction, inflammatory bowel disease. Pregnancy, lactation; young children. AR: GI effects; headache, drowsiness, dizziness, restlessness, euphoria, depression, numbness of the extremities; hypersensitivity reactions, swelling of the gums. DI: Potentiates effects of other CNS depressants (alcohol, barbiturates) & some anxiolytics. Theoretical hypertensive crisis w/ MAOIs. ⊗ Pink Pages_2010_Tip.pmd 61 7/4/2553, 13:01 Registration expired Color profile: Disabled Composite 150 lpi at 45 degrees CONTROLLED SUBSTANCE CLASS ´Ñª¹ÕàÀÊÑªÀÑ³±ì¨Ñ´àÃÕÂ§µÒÁ¡ÅØèÁ/»ÃÐàÀ·¢Í§·ÐàºÕÂ¹ Ketamine HCl P2 Calypsol 50 mg/mL x 10 mL Keta-Hameln 50 mg/mL x 10 mL Ketalar 50 mg/mL x 10 mL Buprenorphine HCl 002 007 Buprine 0.2 mg Temgesic 0.2 mg Temgesic 0.3 mg/mL x 1 mL 619 D-Norpseudoephedrine HCl Lormetazepam Loramet 1 mg Methylphenidate HCl Concerta 18 mg 504 Concerta 36 mg Methylphenidate Hexal 10 mg Ritalin 10 mg D-Norpseudoephedrine Rubifen 10 mg Mirapront N 20 mg Resinate D-Norpseudoephedrine SR Osmopharm 20 mg Diethylpropion HCl Dietil Retard 75 mg Prefamone 75 mg Regenon Retard 75 mg Regenon Retard 75 mg 505 Atractil 75 mg Dormicum 5 mg/mL x 1 mL Dormicum 15 mg 084 Dormicum 15 mg/3 mL x 3 mL 174 115 486 Alodorm 5 mg Resinate Mogadon 5 mg 497 Nitrados 5 mg Ephedrine GPO 30 mg/mL x 1 mL Panbesy 15 mg 604 Panbesy 30 mg Phentermine Osmopharm 15 mg Flunitrazepam Rohypnol 1 mg Flurazepam Dalmadorm 15 mg † 621 Temazepam 351 Euhypnos 20 20 mg 394 047 135 184 136 045 518 523 547 398 622 Triazolam Halcion 0.25 mg 078 Trialam 0.25 mg 081 Trycam 0.25 mg 062 350 168 348 Zolpidem Tartrate Phentermine HCl Ephedrine HCl 143 Midazolam Nitrazepam Diethylpropion Pseudoephedrine HCl 641 Pseudoephedrine Asian Pharm 30 mg 642 Pseudoephedrine Asian Pharm 60 mg 643 Pseudoephedrine BJ Benjaosoth 60 mg Pseudoephedrine Medicine Products 60 mg 102 Pseudoephedrine Milano 30 mg Pseudoephedrine Milano 60 mg Pseudoephedrine Syrup 169 Asian Pharm 114 30 mg/5 mL x 60 mL Pseudoephedrine Syrup 117 BJ Benjaosoth 041 30 mg/5 mL x 60 mL 038 Pseudoephedrine Syrup Milano 30 mg/5 mL x 60 mL 425 461 110 Stilnox 10 mg 451 P3 Phentermine Resinate Duromine 15 mg Duromine 30 mg Phentermine Trenker 15 mg 478 Phentermine Trenker 30 mg Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp Monday, April 05, 2010 1:45:06 PM 499 488 466 Amobarbital 424 Ama† 50 mg ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ 144 Color profile: Disabled Composite 150 lpi at 45 degrees PN DEX 2010 Pangon 30 mg/mL x 1 mL Sosegon 30 mg/mL x 1 mL Pentobarbital Na Nembutal 50 mg/mL x 20 mL P4 Prazol 0.5 mg Siampraxol 0.25 mg 607 Siampraxol 0.5 mg Xanacine 0.25 mg 624 Xanacine 0.5 mg Xanacine 1 mg Xanax 0.25 mg Xanax 0.5 mg Xanax 1 mg Xanax XR 0.5 mg 639 Xanax XR 1 mg Xanax XR 2 mg Xiemed 0.25 mg Xiemed 0.5 mg Xiemed 1 mg Zolam 0.25 mg Zolam 0.5 mg Zolam 1 mg Alprazolam Alcelam 0.25 mg Alcelam 0.5 mg Alcelam 1 mg Allam 0.25 mg Allam 0.5 mg Allam 1 mg Alpralan 0.25 mg Alpralan 0.5 mg Alpramed 0.25 mg Alpramed 0.5 mg Alpramed 1 mg Alprax 0.25 mg Alprazolam Frx 0.5 mg Anax 0.25 mg Anax 0.5 mg Anpress 0.25 mg Anpress 0.5 mg Anpress 1 mg Dizolam 0.25 mg Dizolam 0.5 mg Dizolam 1 mg Inzolam 0.25 mg Inzolam 0.5 mg Inzolam 1 mg Manex 0.25 mg Manex 0.5 mg Manex 1 mg Marzolam 0.25 mg Marzolam 0.5 mg Marzolam 1 mg Mitranax 0.25 mg Mitranax 0.5 mg Mitranax 1 mg Moxinax 0.25 mg Moxinax 0.5 mg Pharnax 0.25 mg Pharnax 0.5 mg Pharnax 1 mg 097 241 288 103 250 293 042 214 252 105 393 156 256 085 230 088 248 282 089 233 297 104 251 294 099 244 291 090 235 283 106 253 295 094 238 101 247 292 Bromazepam Lexotan 1.5 mg Lexotan 3 mg Chlordiazepoxide HCl Benpine 5 mg Benpine 10 mg Benpine 25 mg Cebarax† 5 mg Chlordiazepoxide March Pharma 25 mg Chlordiazepoxide T Man 10 mg Chlordixide 5 mg Chlordixide 10 mg Comoben 5 mg Comoben 10 mg Cozep 10 mg Cozep 25 mg Dirax† 5 mg Kenspa† 5 mg † Librax 5 mg Metaxide 10 mg Minoxide 10 mg Modurax† 5 mg Pondnebium 5 mg Tumax† 5 mg Zepoxide 10 mg 234 098 243 091 236 284 096 240 287 344 069 353 108 249 296 093 237 285 Frisium 5 mg C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp Monday, April 05, 2010 1:45:06 PM Clonaril 1 mg Povanil 0.5 mg Povanil 2 mg Prenarpil 0.5 mg Prenarpil 1 mg Prenarpil 2 mg Rivotril 0.5 mg Rivotril 2 mg 412 498 194 380 467 373 358 195 362 491 138 181 385 223 381 481 477 377 371 400 279 043 342 186 067 407 337 054 408 055 Clorazepate Dipotassium Cloraxene 5 5 mg Cloraze 5 mg Deda 5 mg Deda 10 mg Dipot 5 mg Polizep 5 mg Pomadom 10 mg Tenmed 5 mg 070 Tenmed 10 mg 228 Trancap 5 mg Trancon 5 mg Tranmed 5 mg Tranpate 5 mg Tranxene 5 mg Clobazam ÊÓ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Clonazepam 436 433 437 265 432 444 423 440 269 470 456 428 416 438 Diazepam A-Zerax 2 mg A-Zerax 5 mg Diamed 2 mg Diamed 5 mg Diano 2 mg Diano 5 mg Diapam 2 mg Diapam 5 mg Diapine 2 mg Diapine 2 mg Diapine 5 mg Diapine 5 mg Diapine 5 mg/mL x 1 mL Diapine 10 mg Diapine 10 mg/2 mL x 2 mL Diazepam BJ Benjaosoth 2 mg Diazepam BJ Benjaosoth 5 mg Diazepam BJ Benjaosoth 10 mg Diazepam General Drugs House 2 mg 453 463 503 482 015 140 369 329 010 473 166 484 600 386 601 050 374 222 318 Frame Numbers in Bold Italics CONTROLLED SUBSTANCE CLASS Pentazocine CONTROLLED SUBSTANCE CLASS 63 Color profile: Disabled Composite 150 lpi at 45 degrees CONTROLLED SUBSTANCE CLASS 64 Diazepam General Drugs House 5 mg Diazepam GPO 2 mg Diazepam GPO 5 mg Diazepam GPO 10 mg Diazepam GPO 10 mg/2 mL x 2 mL Diazepam H K Pharm 2 mg Diazepam H K Pharm 5 mg Diazepam H K Pharm 10 mg Diazepam Lerd Singh 2 mg Diazepam Lerd Singh 5 mg Diazepam Pond’s Chemical 2 mg Diazepam Pond’s Chemical 5 mg Diazepam T Man 2 mg Diazepam T Man 5 mg Diazepam T P Drug 10 mg/2 mL x 2 mL Diazepam Vesco 2 mg Diazepam Vesco 5 mg Ditran 2 mg Ditran 5 mg Divopan 2 mg Divopan 5 mg Dizep 2 mg Dizep 5 mg Dizepam 2 mg Dizepam 5 mg Manodiazo 2 mg Manodiazo 5 mg Manodiazo 10 mg Manolium 10 mg/2 mL x 2 mL Monozide-10 10 mg/2 mL x 2 mL Ropam 10 mg/2 mL x 2 mL Sipam 2 mg Sipam 5 mg Sipam 10 mg Sipam 10 mg/2 mL x 2 mL Tranolan 2 mg Tranolan 5 mg Tranolan 10 mg/2 mL x 2 mL V Day Zepam 2 mg V Day Zepam 5 mg V Day Zepam 10 mg/2 mL x 2 mL † PN DEX 2010 CONTROLLED SUBSTANCE CLASS V Day Zepam NL 148 10 mg/2 mL x 2 mL 052 Vason 2 mg 149 Vescopam 334 10 mg/2 mL x 2 mL Vispam 10 mg 603 Vorapam 2 mg Vorapam 5 mg 218 Zepaxid 2 mg Zepaxid 5 mg 160 Zepaxid 10 mg/2 mL x 2 mL 343 Zopam 2 mg Zopam 5 mg 066 Zopam 10 mg Phenobarbital Na 617 Gardenal 396 200 mg/4 mL † Neuramizone 20 mg 636 323 Phenobarbital Atlantic 32.5 mg 064 159 Phenobarbital Atlantic 65 mg 506 462 Phenobarbital Atlantic 100 mg 634 Phenoco Elixir 20 mg/5 mL x 450 mL 048 Phenotal Elixir 145 20 mg/5 mL x 60 mL 331 638 403 011 012 277 584 517 161 367 Pinazepam 216 Anta 0.5 mg 364 Anta 1 mg 211 Anta 2 mg Anxira 0.5 mg 627 Anxira 1 mg 325 Hawkcopax 0.5 mg 134 Kemora 0.5 mg 418 Kemora 1 mg 476 Lonza 0.5 mg 049 Lonza 1 mg 146 Lora 0.5 mg 171 Lora 1 mg Lora 2 mg 190 Loramed 2 mg 224 Loravan 0.5 mg 151 Loravan 1 mg 469 Lorazep 0.5 mg 502 Lorazep 1 mg 335 Lorazep 2 mg Lorazin 0.5 mg 613 Lorazin 1 mg Lorazin 2 mg 632 Ora 0.5 mg Ora 1 mg 608 Tranavan 0.5 mg 056 Tranavan 1 mg 154 Zeda 0.5 mg 339 Zeda 1 mg Zora 0.5 mg 626 Zora 2 mg 130 177 615 475 Medazepam 465 Celium 5 mg Medazine 5 mg 616 Medazine 10 mg Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp Monday, April 05, 2010 1:45:06 PM 464 Domar 5 mg Lorazepam 304 020 125 300 022 321 411 024 313 019 368 036 217 210 302 027 309 003 357 324 044 227 310 030 307 034 014 360 328 179 Prazepam Pozapam 5 mg Pozapam 10 mg 459 175 Tofisopam Grandaxin 50 mg 051 N2 Codeine Phosphate (Analgesic) Codeine GPO 15 mg Codeine GPO 30 mg 004 018 Fentanyl Durogesic 25 mcg/hr x 2.5 mg Durogesic 50 mcg/hr x 5 mg Durogesic 100 mcg/hr x 10 mg Fentanyl GPO 12 mcg/hr Fentanyl GPO 397 25 mcg/hr 487 Fentanyl GPO 50 mcg/hr 483 ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ 651 652 653 645 646 647 Color profile: Disabled Composite 150 lpi at 45 degrees PN DEX 2010 Pethidine M & H Manufacturing 50 mg/mL x 1 mL Pethidine M & H Manufacturing 649 100 mg/2 mL x 2 mL Pethidine T.P. Drug 650 50 mg/mL x 1 mL 648 611 † 612 631 Fentanyl Citrate Fentanyl Antigen 0.05 mg/mL x 2 mL Fentanyl Antigen 0.05 mg/mL x 10 mL Fentanyl Janssen-Cilag 0.05 mg/mL x 2 mL Fentanyl Janssen-Cilag 0.05 mg/mL x 10 mL Fentanyl Sandoz 0.05 mg/mL x 2 mL Fentanyl Sandoz 0.05 mg/mL x 10 mL Methadone HCl Methadone GPO 5 mg Methadone GPO 10 mg/mL x 1000 mL Morphine Sulfate Kapanol 20 mg Kapanol 50 mg Kapanol 100 mg Morphine Sulfate Inj Blue 10 mg/mL x 1 mL Morphine Sulfate Inj Purple 10 mg/mL x 1 mL Morphine T.P. Drug 10 mg/mL x 1 mL Morphine T.P. Drug 10 mg/mL x 1 mL Morphine T.P. Drug 10 mg/mL x 1 mL MST Continus 10 mg MST Continus 30 mg MST Continus 60 mg Oramorph 10 mg/5 mL x 250 mL Oramorph 20 mg/mL x 30 mL Pethidine HCl Pethidine Biolab 100 mg/2 mL x 2 mL N3 598 599 605 Camphorated Opium Tinct 606 Brown Mixture GPO† 0.6 mL/5 mL x 180 mL 623 Brown Mixture GPO† 0.6 mL/5 mL x 450 mL 644 Brown Mixture Osoth Interlab† 0.6 mL/5 mL x 180 mL † Mist Tussis 0.6 mL/5 mL x 450 mL † Mist. Scill Ammon. GPO 126 0.6 mL/5 mL x 180 mL † Mixture Tussis 596 0.45 mL/5 mL x 30 mL Mixture Tussis† 0.45 mL/5 mL x 60 mL Mixture Tussis† 0.45 mL/5 mL x 120 mL 119 Mixture Tussis† 120 0.45 mL/5 mL x 240 mL 121 Mixture Tussis† 0.45 mL/5 mL x 450 mL 609 Squill and Ammonia Mixture† 1.3 mL/10 mL x 450 mL 610 527 528 554 590 531 574 575 576 577 578 591 628 629 Codeine Phosphate (Analgesic) 630 406 278 183 † Codicet 15 mg Codicet Blue† 15 mg † Codigesic 15 mg † Masapara With Codeine 15 mg † 594 Nasa With Codeine 15 mg 595 Para-Co 15 mg Paradeine† 15 mg Parcono† 8 mg Tylenol With Codeine† 15 mg Tylenol With Codeine† 30 mg 602 ÊÓ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp Monday, April 05, 2010 1:45:06 PM Codeine Phosphate (Antitussive) Bluco 10 mg † Bronpect 10 mg † Centrodine CD 10 mg Clinopront† 10 mg Co-Cof† 10 mg † Codee-C 10 mg † Codepect 10 mg † Codesia 10 mg † Codesia 10 mg/5 mL x 60 mL Codyl Cough † 9 mg/5 mL x 60 mL † Codyl Cough 9 mg/5 mL x 100 mL Decos† 9 mg/5 mL x 100 mL † Mila-Tercon 8 mg Neopect† 10 mg † Nordyl Linctus 9 mg/5 mL x 100 mL † Phencodin 9 mg/5 mL x 60 mL Phensedyl† 9 mg/5 mL x 100 mL Poly-Cof Syrup† 9 mg/5 mL x 60 mL Poly-Cof Syrup† 9 mg/5 mL x 100 mL Pondnadyl† 9 mg/5 mL x 60 mL Pondnadyl† 9 mg/5 mL x 100 mL † Rolar 10 mg Ropect† 10 mg Rotuss† 10 mg † Seco 10 mg † Terco-C 10 mg Tussidyl† 9 mg/5 mL x 60 mL 355 298 225 378 165 388 202 391 516 540 541 572 167 199 566 586 553 548 549 563 564 203 201 204 389 387 589 Codeine Resinate 414 Codipront† 30 mg 352 112 410 494 Diphenoxylate HCl Lomotil† 2.5 mg 080 Spasil† 2.5 mg 347 074 079 006 009 Opium Tinct 075 Camphorated Opium Tincture † BP 1980 5 mL/100 mL x 1000 mL 076 529 Frame Numbers in Bold Italics CONTROLLED SUBSTANCE CLASS Fentanyl Hexal 12 mcg/hr Fentanyl Hexal 25 mcg/hr Fentanyl Hexal 50 mcg/hr CONTROLLED SUBSTANCE CLASS 65 Color profile: Disabled Composite 150 lpi at 45 degrees MANUFACTURER'S INDEX ´Ñª¹ÕàÀÊÑªÀÑ³±ì¨Ñ´àÃÕÂ§µÒÁª×èÍ¼Ùé¼ÅÔµ 2M (MED-MAKER) 2 àÍçÁ (àÁ´-àÁà¡ÍÃì) Anpress 0.25 mg Anpress 1 mg Xiemed 0.5 mg Dipot 5 mg Lorazep 0.5 mg Lorazep 1 mg 088 Lorazep 2 mg 282 Phenotal Elixir 249 20 mg/5 mL x 60 mL 3 àÍçÁ ¿ÒÃìÁÒ/ÍÂ. A N H PRODUCTS àÍ àÍç¹ àÍª â»Ã´Ñ¤Êì Comoben 5 mg Comoben 10 mg Divopan 2 mg Divopan 5 mg ºÒ§¡Í¡áÅç»áÍ¹´ì¤ÍÊàÁµÔ¤ 517 BARD/FDA 3M PHARMA/FDA Duromine 15 mg Duromine 30 mg 432 BANGKOK LAB & COSMETIC 309 003 † Clinopront 10 mg 378 357 † Codigesic 15 mg 112 ºÒÃì´/ÍÂ. ASIAN PHARM/FDA àÍàªÕèÂ¹¿ÒÃìÁÒ«ÙµÔ¤ÑÅ/ÍÂ. 499 488 Pseudoephedrine Asian Pharm 30 mg Pseudoephedrine Asian Pharm 60 mg Pseudoephedrine Syrup Asian Pharm 30 mg/5 mL x 60 mL 362 491 049 146 MST Continus 10 mg MST Continus 30 mg 143 MST Continus 60 mg 406 278 183 047 BIOLAB/FDA 518 äºâÍáÅ»/ÍÂ. Pethidine Biolab 100 mg/2 mL x 2 mL 602 ATLANTIC LAB áÍµáÅ¹µÔ¤ ALPHAPHARM/FDA ÍÑÅ¿Ò¿ÒÃìÁ/ÍÂ. Alodorm 5 mg Trialam 0.25 mg 078 168 ALZA CORP/FDA ÍÑÅ«Ò ¤ÍÃìà»ÍàÃªÑè¹/ÍÂ. Concerta 18 mg Concerta 36 mg 169 114 ANTIGEN/FDA áÍ¹µÔà¨¹/ÍÂ. Fentanyl Antigen 0.05 mg/mL x 2 mL Fentanyl Antigen 0.05 mg/mL x 10 mL ASIAN PHARM 598 599 Ama† 50 mg Benpine 5 mg Benpine 10 mg Benpine 25 mg Diapine 2 mg Diapine 2 mg Diapine 5 mg Diapine 5 mg Diapine 5 mg/mL x 1 mL Diapine 10 mg Diapine 10 mg/2 mL x 2 mL Dizolam 0.25 mg Dizolam 0.5 mg Dizolam 1 mg Lora 0.5 mg Lora 1 mg Lora 2 mg Phenobarbital Atlantic 32.5 mg Phenobarbital Atlantic 65 mg Phenobarbital Atlantic 100 mg àÍàªÕèÂ¹¿ÒÃìÁÒ«ÙµÔ¤ÑÅ A-Zerax 2 mg A-Zerax 5 mg Codesia† 10 mg Codesia† 10 mg/5 mL x 60 mL † 453 B L HUA 463 391 Codicet† 15 mg 516 Terco-C† 10 mg ºÕ àÍçÅ ÎÑéÇ Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp Wednesday, March 31, 2010 10:04:03 AM 144 412 498 194 010 473 166 484 600 386 601 089 233 297 368 036 217 BJ BENJAOSOTH ºÕà¨ (àº¨âÍÊ¶) Diazepam BJ Benjaosoth 2 mg Diazepam BJ Benjaosoth 5 mg Diazepam BJ Benjaosoth 10 mg Minoxide 10 mg 374 222 477 BJ BENJAOSOTH/FDA ºÕà¨ (àº¨âÍÊ¶)/ÍÂ. Pseudoephedrine BJ Benjaosoth 60 mg Pseudoephedrine Syrup BJ Benjaosoth 011 30 mg/5 mL x 60 mL 012 277 050 135 523 BOEHRINGER INGELHEIM/FDA àºÍÃÔ§à¡ÍÃì ÍÔ¹à¡ÅäÎÁì/ÍÂ. Oramorph 10 mg/5 mL x 250 mL 414 Oramorph 20 mg/mL x 30 mL 387 ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ 594 595 Color profile: Disabled Composite 150 lpi at 45 degrees PN DEX 2010 MANUFACTURER'S INDEX BRITISH DISPENSARY GLAXOSMITHKLINE/FDA ÍÑ§¡ÄÉµÃÒ§Ù (áÍÅ ¾Õ) ÎÒàÁÅ¹/ÍÂ. á¡Åç¡â«ÊÁÔ·ä¤Åì¹/ÍÂ. 014 Kapanol 20 mg 360 Kapanol 50 mg Kapanol 100 mg 119 Keta-Hameln 50 mg/mL x 10 mL 120 121 CARDINAL HEALTH AUSTRALIA HEXAL AG/FDA ¤ÒÃì´Ô¹ÑÅ àÎÅ·ì ÍÍÊàµÃàÅÕÂ Ropect† 10 mg † Rotuss 10 mg CEVA ANIMAL HEALTH «ÕÇÒ áÍ¹ÔÁÍÅ àÎÅì· Nembutal 50 mg/mL x 20 mL CHAROEN BHAESAJ à¨ÃÔàÀÊÑª Paradeine † 15 mg Í§¤ì¡ÒÃàÀÊÑª¡ÃÃÁ 201 204 Brown Mixture GPO† 0.6 mL/5 mL x 180 mL † Brown Mixture GPO 0.6 mL/5 mL x 450 mL Camphorated Opium Tincture † BP 1980 5 mL/100 mL x 1000 mL 639 Diazepam GPO 2 mg Diazepam GPO 5 mg Diazepam GPO 10 mg Diazepam GPO 10 mg/2 mL x 2 mL Mist. Scill Ammon. GPO† 074 0.6 mL/5 mL x 180 mL à´¤â«/ÍÂ. DOUGLAS/FDA ´Ñ¡ÅÒÊ/ÍÂ. Nitrados 5 mg Trycam 0.25 mg àÎ¡«ÒÅ àÍ¨Õ/ÍÂ. GPO DEXO/FDA Prefamone 75 mg 642 GPO/FDA 174 Í§¤ì¡ÒÃàÀÊÑª¡ÃÃÁ/ÍÂ. Codeine GPO 15 mg Codeine GPO 30 mg Ephedrine GPO 30 mg/mL x 1 mL 062 Methadone GPO 5 mg Methadone GPO 348 10 mg/mL x 1000 mL Fentanyl GPO Fentanyl GPO Fentanyl GPO 527 Fentanyl Hexal Fentanyl Hexal 528 Fentanyl Hexal 12 mcg/hr 25 mcg/hr 50 mcg/hr 12 mcg/hr 25 mcg/hr 50 mcg/hr 645 646 647 648 649 650 529 052 149 INPAC PHARMA 334 ÍÔ¹á¾¤¿ÒÃìÁÒ Inzolam 603 Inzolam Inzolam 531 Lorazin Lorazin Lorazin Tenmed Tenmed 0.25 mg 0.5 mg 1 mg 0.5 mg 1 mg 2 mg 5 mg 10 mg 104 251 294 324 044 227 440 269 004 018 INTERTHAI ÍÔ¹àµÍÃìä·Â 604 126 Tranxene 5 mg 438 596 JANSSEN-CILAG/FDA á¨¹à«è¹-«ÕáÅ¡/ÍÂ. EGIS ÍÕ¨ÕÊ GREATER PHARMA Grandaxin 50 mg 051 à¡Ãê·àµÍÃì¿ÒÃìÁèÒ Diapam 2 mg Diapam 5 mg GEDEON RICHTER/FDA ¡Õà´ÕÂ¹ ÃÔªàµÍÃì/ÍÂ. Calypsol 50 mg/mL x 10 mL 641 H K PHARM àÍª à¤ ¿ÒÃìÁÒ«ÙµÔ¤ÍÅ GENERAL DRUGS HOUSE àÂ¹à¹ÍÃìÃÒÅ´ÃÑê¡ÊìàÎéÒÊì Diazepam General Drugs House 2 mg Diazepam General Drugs House 5 mg Zora 0.5 mg Zora 2 mg 318 148 328 179 Allam 0.25 mg Allam 0.5 mg Allam 1 mg Deda 5 mg Deda 10 mg Diazepam H K Pharm 2 mg Diazepam H K Pharm 5 mg Diazepam H K Pharm 10 mg ÊÓ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp Wednesday, March 31, 2010 10:04:03 AM Durogesic 25 mcg/hr x 2.5 mg Durogesic 369 50 mcg/hr x 5 mg 329 Durogesic 100 mcg/hr x 10 mg Fentanyl Janssen-Cilag 0.05 mg/mL x 2 mL Fentanyl Janssen-Cilag 0.05 mg/mL x 10 mL 103 250 293 437 265 218 160 343 651 652 653 605 606 KENYAKU à¤¹ÂÒ¡Ø † Bronpect 10 mg Kenspa† 5 mg Prazol 0.5 mg 298 223 234 Frame Numbers in Bold Italics MANUFACTURER'S INDEX Zeda 0.5 mg Zeda 1 mg 67 HAMELN/FDA Color profile: Disabled Composite 150 lpi at 45 degrees 68 PN DEX 2010 MANUFACTURER'S INDEX LBS Marzolam 0.5 mg Marzolam 1 mg áÍÅ ºÕ àÍÊ áÅººÍàÃµÍÃÕè Hawkcopax 0.5 mg Pangon 30 mg/mL x 1 mL Ropam 10 mg/2 mL x 2 mL LERD SINGH Alpramed 0.25 mg Alpramed 0.5 mg Alpramed 1 mg Chlordixide 5 mg Chlordixide 10 mg Diazepam Lerd Singh 2 mg Diazepam Lerd Singh 5 mg 252 105 393 358 195 066 161 Rubifen 10 mg MANUFACTURER'S INDEX àÅÔÈÊÔ§Ëì M & H MANUFACTURING àÍçÁ áÍ¹´ì àÍçª áÁ¹Ùá¿¤à¨ÍÃÔè§ † Bluco 10 mg † Codicet Blue 15 mg Diano 2 mg Diano 5 mg † Mila-Tercon 8 mg † Parcono 8 mg ÁÒ«ÒáÅº † áÅçº ÃÙºÔâÍ/ÍÂ. ÁÔÅÒâ¹ 321 607 608 MASA LAB Cebarax 5 mg Dizepam 2 mg Dizepam 5 mg † Masapara With Codeine 038 15 mg † Neopect 10 mg Ora 0.5 mg Ora 1 mg LAB RUBIO/FDA 235 MILANO 283 MEDICINE PRODUCTS àÁ´Ô«Õ¹â»Ã´Ñ¡Êì 380 224 151 MILANO/FDA ÁÔÅÒâ¹/ÍÂ. 410 199 Pseudoephedrine 310 Milano 30 mg 030 Pseudoephedrine Milano 60 mg Pseudoephedrine Syrup Milano 30 mg/5 mL x 60 mL 313 019 MILLIMED 091 236 284 Anax 0.25 mg Anax 0.5 mg Co-Cof† 10 mg Nasa With Codeine† 15 mg MEDICINE PRODUCTS/FDA Poly-Cof Syrup† 355 9 mg/5 mL x 60 mL 352 Poly-Cof Syrup† Pseudoephedrine 9 mg/5 mL x 100 mL Medicine Products 60 mg 184 Vason 2 mg Lonza 0.5 mg Lonza 1 mg Xanacine 0.25 mg Xanacine 0.5 mg Xanacine 1 mg M & H MANUFACTURING/FDA Morphine Sulfate Inj Blue 10 mg/mL x 1 mL Morphine Sulfate Inj Purple 10 mg/mL x 1 mL Pethidine M & H Manufacturing 50 mg/mL x 1 mL Pethidine M & H Manufacturing 100 mg/2 mL x 2 mL 609 610 611 612 MACK/FDA áÁç¤/ÍÂ. Mirapront N 20 mg MARCH PHARMA áËÅÁ·Í§¡ÒÃá¾·Âì Chlordiazepoxide March Pharma 25 mg Manodiazo 2 mg Manodiazo 5 mg Manodiazo 10 mg Manolium 10 mg/2 mL x 2 mL Marzolam 0.25 mg † 504 136 045 547 ÁÔÅÅÔàÁ´ àÁ´Ô«Õ¹â»Ã´Ñ¡Êì/ÍÂ. àÍçÁ áÍ¹´ì àÍçª áÁ¹Ùá¿¤à¨ÍÃÔè§/ÍÂ. 015 140 167 079 085 230 165 080 548 549 396 MEDICPHARMA ÊËá¾·ÂìàÀÊÑª Codee-C† 10 mg † Codyl Cough 9 mg/5 mL x 60 mL † Codyl Cough 9 mg/5 mL x 100 mL Diamed 2 mg Diamed 5 mg Dirax† 5 mg Medazine 5 mg Medazine 10 mg Para-Co 15 mg Prenarpil 0.5 mg Prenarpil 1 mg Prenarpil 2 mg Tranmed 5 mg Zolam 0.25 mg Zolam 0.5 mg Zolam 1 mg 467 469 502 MEGA LIFESCIENCES 335 àÁ¡éÒ äÅ¿ìä«áÍç¹«ì 613 Codepect† 10 mg 090 Rolar† 10 mg Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp Wednesday, March 31, 2010 10:04:03 AM MODERN MANU 388 âÁà´ÍÃì¹áÁ¹Ù Cloraze 5 mg Moxinax 0.25 mg 541 Moxinax 0.5 mg 503 482 385 487 NOVARTIS/FDA 483 347 Ritalin 10 mg 407 337 054 428 OLAN-KEMED 093 237 285 Alpralan 0.25 mg Alpralan 0.5 mg Kemora 0.5 mg Kemora 1 mg Loramed 2 mg Tranolan 2 mg 202 Tranolan 5 mg 203 Tranolan 10 mg/2 mL x 2 mL 540 433 094 238 â¹ÇÒÃìµÕÊ/ÍÂ. 041 âÍÅÑ¹-à¤ÁàÁ´ ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ 042 214 411 024 210 130 177 615 Color profile: Disabled Composite 150 lpi at 45 degrees PN DEX 2010 MANUFACTURER'S INDEX PHARMASANT LAB âÍÅÔ¤ âÃª ¿ÒÃìÁÒÊÑ¹µì áÅçº Alprazolam Frx 0.5 mg † Codipront 30 mg Librax† 5 mg † Lomotil 2.5 mg † Phensedyl 9 mg/5 mL x 100 mL † Tylenol With Codeine 15 mg † Tylenol With Codeine 30 mg 256 494 381 006 553 075 076 OSMOPHARM/FDA ÍÍÊâÁ¿ÒÃìÁ/ÍÂ. D-Norpseudoephedrine SR Osmopharm 20 mg Panbesy 15 mg Panbesy 30 mg Phentermine Osmopharm 15 mg 505 425 461 Alcelam 0.25 mg Alcelam 0.5 mg Alcelam 1 mg Anta 0.5 mg Anta 1 mg Anta 2 mg † Centrodine CD 10 mg Cozep 10 mg Cozep 25 mg Pomadom 10 mg Povanil 0.5 mg Povanil 2 mg Pozapam 5 mg Pozapam 10 mg Zopam 2 mg Zopam 5 mg Zopam 10 mg 097 241 288 304 020 125 225 138 181 423 186 067 459 175 048 145 331 451 âÍÊ¶ÍÔ¹àµÍÃì Brown Mixture Osoth Interlab 0.6 mL/5 mL x 180 mL P P LAB ¾Õ ¾Õ áÅºÍÃÒµÍÃÕèÊì V Day Zepam 2 mg V Day Zepam 5 mg V Day Zepam 10 mg/2 mL x 2 mL V Day Zepam NL 10 mg/2 mL x 2 mL PARKE-DAVIS/FDA ¾ÒÃì¤à´ÇÔÊ/ÍÂ. Ketalar 50 mg/mL x 10 mL Domar 5 mg Mitranax 0.25 mg 554 Mitranax 0.5 mg Mitranax 1 mg Polizep 5 mg Tranavan 0.5 mg Tranavan 1 mg âÃª/ÍÂ. Dalmadorm 15 mg Dormicum 5 mg/mL x 1 mL Dormicum 15 mg Dormicum 15 mg/3 mL x 3 mL Mogadon 5 mg Rohypnol 1 mg 478 621 351 622 081 394 † 464 106 253 295 SALUTAS PHARMA/FDA 444 307 Methylphenidate Hexal 10 mg 034 617 Diazepam Pond’s Chemical 2 mg Diazepam Pond’s Chemical 5 mg † Pondnadyl 9 mg/5 mL x 60 mL 643 Pondnadyl† 9 mg/5 mL x 100 mL Pondnebium 5 mg á«¹´ÍÊ á¤¹Ò´Ò/ÍÂ. Fentanyl Sandoz 0.05 mg/mL x 2 mL 367 Fentanyl Sandoz 0.05 mg/mL x 10 mL 216 623 644 563 SANOFI-AVENTIS 564 371 «Òâ¹¿Õè-ÍàÇ¹µÕÊ Frisium 5 mg Gardenal 200 mg/4 mL ä¿à«ÍÃì 096 R P SCHERER/FDA 240 287 344 Euhypnos 20 20 mg 069 353 117 SANDOZ CANADA/FDA POND’S CHEMICAL ¾Í¹´ìà¤ÁÕ¤ÍÅ 566 «ÒÅÙ·ÑÊ ¿ÒÃìÁÒ/ÍÂ. PFIZER Xanax 0.25 mg Xanax 0.5 mg Xanax 1 mg Xanax XR 0.5 mg Xanax XR 1 mg Xanax XR 2 mg 070 228 408 055 ROCHE/FDA Nordyl Linctus 9 mg/5 mL x 100 mL 475 465 616 1.5 mg 3 mg 0.5 mg 2 mg âÃÊÁÍ¹·ì ¿ÒÃìÁ â»ÅÔ¿ÒÃìÁ † Lexotan Lexotan Rivotril Rivotril ROSEMONT PHARM POLIPHARM OSOTH INTERLAB 69 ROCHE ÍÒÃì ¾Õ àªÍàÃÍÃì/ÍÂ. 043 638 SANOFI-SYNTHELABO 398 «Òâ¹¿Õè-«Ô¹àµÅÒâº Sosegon 30 mg/mL x 1 mL 624 RECKITT BENCKISER/FDA àÃ¡¤Ô··ì àº¹¤Õà«ÍÃì/ÍÂ. PHARMACIA/FDA ¿ÒÃìÁÒà«ÕÂ/ÍÂ. Halcion 0.25 mg Temgesic 0.2 mg 350 Temgesic 0.3 mg/mL x 1 mL ÊÓ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp Wednesday, March 31, 2010 10:04:03 AM SANOFI-WINTHROP/FDA «Òâ¹¿Õè-ÇÔ¹·ÃÍ»/ÍÂ. 007 619 Stilnox 10 mg 110 Frame Numbers in Bold Italics MANUFACTURER'S INDEX OLIC Color profile: Disabled Composite 150 lpi at 45 degrees 70 Phenoco Elixir 20 mg/5 mL x 450 mL ÊÂÒÁàÀÊÑª Siampraxol 0.25 mg Siampraxol 0.5 mg Sipam 2 mg Sipam 5 mg Sipam 10 mg Sipam 10 mg/2 mL x 2 mL SIAM BHEASACH/FDA 098 243 056 T P DRUG 154 339 626 Diazepam T P Drug 10 mg/2 mL x 2 mL Trancap 5 mg Zepoxide 10 mg Buprine 0.2 mg 002 T P DRUG/FDA ·Õ ¾Õ ´ÃÑ¡/ÍÂ. SRIPRASIT PHARMA àÀÊÑª¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì † Decos 9 mg/5 mL x 100 mL † Neuramizone 20 mg † Seco 10 mg † Spasil 2.5 mg Tumax† 5 mg UDOMPHON (PHIHALAB) 584 572 403 389 009 400 Morphine T.P. Drug 10 mg/mL x 1 mL Morphine T.P. Drug 10 mg/mL x 1 mL Morphine T.P. Drug 10 mg/mL x 1 mL Pethidine T.P. Drug 50 mg/mL x 1 mL ÍØ´Á¾Ã (¿ÕÎÒáÅçº) Metaxide Zepaxid Zepaxid Zepaxid ·Õ ¾Õ ´ÃÑ¡ ÊÂÒÁàÀÊÑª/ÍÂ. MANUFACTURER'S INDEX PN DEX 2010 MANUFACTURER'S INDEX SIAM BHEASACH 10 mg 2 mg 5 mg 10 mg/2 mL x 2 mL 481 506 462 634 627 470 UTOPIAN 279 ÂÙâ·à»ÕéÂ¹ Anpress 0.5 mg Anxira 0.5 mg Anxira 1 mg Celium 5 mg Clonaril 1 mg † 628 Modurax 5 mg Trancon 5 mg 629 Vispam 10 mg Xiemed 0.25 mg 630 Xiemed 1 mg 248 300 022 397 342 377 456 323 108 296 631 V S PHARMA SUPHONG BHAESAJ ÊØ¾§ÉìàÀÊÑª Dizep 2 mg Dizep 5 mg Loravan 0.5 mg Loravan 1 mg Mixture Tussis† 0.45 mL/5 mL x 30 mL Mixture Tussis† 0.45 mL/5 mL x 60 mL Mixture Tussis† 0.45 mL/5 mL x 120 mL † Mixture Tussis 0.45 mL/5 mL x 240 mL † Mixture Tussis 0.45 mL/5 mL x 450 mL T MAN PHARMA ·Õ áÁ¹ ¿ÒÃìÁÒ Chlordiazepoxide T Man 10 mg Diazepam T Man 2 mg Diazepam T Man 5 mg Manex 0.25 mg Manex 0.5 mg Manex 1 mg Tranpate 5 mg T O CHEMICALS ·Õ âÍ à¤ÁÕ¤ÍÅÊì Cloraxene 5 5 mg † ÇÕ àÍÊ ¿ÒÃìÁèÒ TEMMLER/FDA à·ÁàÅÍÃì/ÍÂ. 575 ä·Â ¾Õ ´Õ à¤ÁÕ¤ÍÅÊì Pharnax 0.25 mg Pharnax 0.5 mg 115 Pharnax 1 mg 486 Phencodin† 9 mg/5 mL x 60 mL Tussidyl† 9 mg/5 mL x 60 mL Vorapam 2 mg Vorapam 5 mg 576 Monozide-10 10 mg/2 mL x 2 mL 632 171 Regenon Retard 75 mg 190 Regenon Retard 75 mg 302 027 574 THAI P D CHEMICALS 586 589 064 159 VESCO PHARM 577 578 101 247 292 THAIPHARMED 1942 ËéÒ§ÂÒä·Â 1942 Ditran 2 mg Ditran 5 mg 373 TORRENT 364 211 099 Alprax 0.25 mg 244 291 416 TRENKER/FDA ·ÍÃìàÃ¹·ì àÇÊâ¡¿ÒÃìÁÒ«ÙµÔ¤ÍÅ Diazepam Vesco 2 mg 325 Diazepam Vesco 5 mg 134 418 Vescopam 10 mg/2 mL x 2 mL 636 476 VIDHYASOM ÇÔ·ÂÒÈÃÁ † 156 Mist Tussis 0.6 mL/5 mL x 450 mL Squill and Ammonia Mixture† 1.3 mL/10 mL x 450 mL 590 591 à·Ã¹à¡ÍÃì/ÍÂ. Atractil 75 mg Dietil Retard 75 mg Phentermine Trenker 15 mg 436 Phentermine Trenker 30 mg Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp Wednesday, March 31, 2010 10:04:03 AM 497 WYETH-AYERST/FDA 084 466 424 Loramet 1 mg äÇàÍ·-àÍàÂÔÃìÊ·ì/ÍÂ. ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ 102 Color profile: Disabled Composite 150 lpi at 45 degrees GENERIC & BRAND NAME INDEX ´Ñª¹ÕÃÇÁª×èÍÊÒÁÑáÅÐª×èÍ·Ò§¡ÒÃ¤éÒ Registration No. Frame No. A Alcelam 0.25 mg Alcelam 0.5 mg Alcelam 1 mg Allam 0.25 mg Allam 0.5 mg Allam 1 mg Alnax 0.25 mg Alnax 0.5 mg Alnax 1 mg Alodorm 5 mg Alpazam 0.25 mg Alpazam 0.5 mg Alpazam 1 mg Alpralan 0.25 mg Alpralan 0.5 mg Alpramed 0.25 mg Alpramed 0.5 mg Alpramed 1 mg Alprax 0.25 mg Alprax 0.5 mg Alprax 1 mg Alprazolam: - Alcelam 0.25 mg - Alcelam 0.5 mg - Alcelam 1 mg - Allam 0.25 mg - Allam 0.5 mg - Allam 1 mg - Alnax 0.25 mg - Alnax 0.5 mg - Alnax 1 mg - Alpazam 0.25 mg - Alpazam 0.5 mg - Alpazam 1 mg - Alpralan 0.25 mg - Alpralan 0.5 mg - Alpramed 0.25 mg - Alpramed 0.5 mg - Alpramed 1 mg - Alprax 0.25 mg - Alprax 0.5 mg - Alprax 1 mg - Alprazolam Frx 0.25 mg P1A 1/52 P1A 23/49 P1A 24/49 P1A 1/48 P1A 2/48 P1A 3/48 P1A 51/50 P1A 52/50 P1A 47/50 P1A 48/50 P1A 7/48 P1C 1/46 - 097 241 288 103 250 293 087 232 281 078 100 245 246 042 214 252 105 393 156 409 057 P1A 1/52 P1A 23/49 P1A 24/49 P1A 1/48 P1A 2/48 P1A 3/48 P1A 51/50 P1A 52/50 P1A 47/50 P1A 48/50 P1A 7/48 P1C 1/46 - 097 241 288 103 250 293 087 232 281 100 245 246 042 214 252 105 393 156 409 057 - ÊÓ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:49 AM 109 Registration No. Frame No. - Alprazolam Frx 0.5 mg - Anax 0.25 mg - Anax 0.5 mg - Anpress 0.25 mg - Anpress 0.5 mg - Anpress 1 mg - Anzion 0.25 mg - Anzion 0.5 mg - Anzion 1 mg - Dizolam 0.25 mg - Dizolam 0.5 mg - Dizolam 1 mg - Farzolam 0.25 mg - Farzolam 0.5 mg - Farzolam 1 mg - Inzolam 0.25 mg - Inzolam 0.5 mg - Inzolam 1 mg - Manex 0.25 mg - Manex 0.5 mg - Manex 1 mg - Marzolam 0.25 mg - Marzolam 0.5 mg - Marzolam 1 mg - Mitranax 0.25 mg - Mitranax 0.5 mg - Mitranax 1 mg - Moxinax 0.25 mg - Moxinax 0.5 mg - Pharnax 0.25 mg - Pharnax 0.5 mg - Pharnax 1 mg - Prazol 0.5 mg - Siampraxol 0.25 mg - Siampraxol 0.5 mg - Siampraxol 1 mg - Sunax 0.25 mg - Sunax 0.5 mg - Xalam 0.25 mg - Xalam 0.5 mg - Xalam 1 mg - Xanacine 0.25 mg - Xanacine 0.5 mg - Xanacine 1 mg - Xanax 0.25 mg P1A 10/51 P1A 9/46 P1A 10/46 P1A 33/50 P1A 4/48 P1A 35/50 P1A 5/48 P1A 15/50 P1A 6/48 P1A 58/50 P1A 59/50 P1A 60/50 P1A 36/51 P1A 21/46 P1A 8/47 P1A 5/47 P1A 42/52 P1A 43/52 P1A 36/50 P1A 37/50 P1A 38/50 P1A 19/49 P1A 20/49 P1A 28/51 P1A 29/51 P1A 30/51 P1A 3/51 P1A 6/52 P1A 7/52 P1A 13/48 P1A 14/48 P1A 15/48 P1C 20/52 256 085 230 088 248 282 086 231 280 089 233 297 092 242 289 104 251 294 099 244 291 090 235 283 106 253 295 094 238 101 247 292 234 098 243 290 107 254 095 239 286 091 236 284 096 Frame Numbers in Bold Italics Color profile: Disabled Composite 150 lpi at 45 degrees 72 PN DEX 2010 GENERIC & BRAND NAME INDEX Registration No. Frame No. GENERIC & BRAND NAME INDEX - Xanax 0.5 mg - Xanax 1 mg - Xanax XR 0.5 mg - Xanax XR 1 mg - Xanax XR 2 mg - Xiemed 0.25 mg - Xiemed 0.5 mg - Xiemed 1 mg - Zolam 0.25 mg - Zolam 0.5 mg - Zolam 1 mg Alprazolam Frx 0.25 mg Alprazolam Frx 0.5 mg † Ama 50 mg Amobarbital: - Ama † 50 mg Amobarbital Na: - Amytal 0.5 g Amytal 0.5 g Anax 0.25 mg Anax 0.5 mg Anpress 0.25 mg Anpress 0.5 mg Anpress 1 mg Anta 0.5 mg Anta 1 mg Anta 2 mg Anxene 5 mg Anxene 10 mg Anxielax 5 mg Anxira 0.5 mg Anxira 1 mg Anzion 0.25 mg Anzion 0.5 mg Anzion 1 mg Ativan 0.5 mg Ativan 1 mg Ativan 2 mg Atractil 75 mg Azepam 2 mg Azepam 5 mg A-Zerax 2 mg A-Zerax 5 mg P1C 21/52 P1C 22/52 P1C 17/50 P1C 18/50 P1C 19/50 P1A 27/49 P1A 34/50 P1A 28/49 P1A 44/50 P1A 45/50 P1A 46/50 240 287 344 069 353 108 249 296 093 237 285 - 109 P1A 10/51 P2A 60/43 256 144 P2A 60/43 144 P1A 9/46 P1A 10/46 P1A 33/50 P1A 4/48 P1A 35/50 P1A 29/50 P1A 28/50 P1A 29/52 P1A 24/52 P1A 25/52 P1A 37/52 P1A 38/52 640 640 085 230 088 248 282 304 020 125 430 262 460 300 022 086 231 280 308 028 129 497 219 299 453 463 B Belladonna Alkaloids With Phenobarbital† 16.2 mg Bellergal† 20 mg Belloid† 30 mg Benadryl CD† 60 mL Benadryl CD† 1000 mL Benera† 20 mg † - 221 207 124 550 551 404 Registration No. Frame No. Benpine 5 mg Benpine 10 mg Benpine 25 mg † Benylin CD 60 mL † Bluco 10 mg † Blucon 10 mg † Bonadine CD 60 mL Bromazepam: - Lexotan 1.5 mg - Lexotan 3 mg † Bromtussia DC 60 mL † Bronpect 10 mg Brown Mixture GPO† 0.6 mL/5 mL x 180 mL † Brown Mixture GPO 0.6 mL/5 mL x 450 mL Brown Mixture Osoth Interlab† 0.6 mL/5 mL x 180 mL Buprenorphine HCl: - Buprine 0.2 mg - Temgesic 0.2 mg - Temgesic 0.3 mg/mL x 1 mL Buprine 0.2 mg 412 498 194 552 355 332 561 P1C 5/49 P1C 6/49 N2A 1/51 070 228 515 298 N2A 15/45 527 N2A 15/45 528 N2A 7/43 554 - 002 007 - 619 002 - 124 - 361 276 641 Butobarbital: - Belloid † 30 mg C Calmipam 2 mg Calmipam 5 mg Calypsol 50 mg/mL x 10 mL Camphorated Opium Tinct: - Brown Mixture GPO † 0.6 mL/5 mL x 180 mL N2A 15/45 - Brown Mixture GPO † 0.6 mL/5 mL x 450 mL N2A 15/45 - Brown Mixture Osoth Interlab † 0.6 mL/5 mL x 180 mL N2A 7/43 - Cough Syrup GPO † 0.6 mL/5 mL x 60 mL - Mist. Scill Ammon. GPO † 0.6 mL/5 mL x 180 mL N2A 13/46 - Mist Tussis † 0.6 mL/5 mL x 450 mL N2A 14/45 - Mixture Scillae Ammon † 2 mL/15 mL x 180 mL - Mixture Tussis † 0.45 mL/5 mL x 30 mL N2A 11/46 - Mixture Tussis † 0.45 mL/5 mL x 60 mL N2A 11/46 - Mixture Tussis † 0.45 mL/5 mL x 120 mL N2A 11/46 - Mixture Tussis † 0.45 mL/5 mL x 240 mL N2A 11/46 - Mixture Tussis † 0.45 mL/5 mL x 450 mL N2A 11/46 Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:49 AM P1A 8/49 P1A 3/49 P1A 1/49 N2A 12/47 - 527 528 554 530 531 590 557 574 575 576 577 578 ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ Color profile: Disabled Composite 150 lpi at 45 degrees GENERIC & BRAND NAME INDEX Registration No. Frame No. - Mixture Tussis 0.45 mL/5 mL x 1800 mL - Mixture Tussis † 0.45 mL/5 mL x 3600 mL - Squill and Ammonia Mixture † 1.33 mL/10 mL x 450 mL N2A 9/47 Camphorated Opium Tincture BP 1980† 5 mL/100 mL x 1000 mL N2A 9/45 † Cebarax 5 mg P2A 22/51 Celium 5 mg P1A 24/51 † Cemol Codeine 15 mg Centrodine CD† 10 mg N2A 11/47 Cexene 5 mg Cexene 10 mg Chlordiazepoxide Acdhon 10 mg Chlordiazepoxide Charoen Bhaesaj 10 mg Chlordiazepoxide HCl: - Benpine 5 mg P1A 8/49 - Benpine 10 mg P1A 3/49 - Benpine 25 mg P1A 1/49 - Cebarax † 5 mg P2A 22/51 - Chlordiazepoxide Acdhon 10 mg - Chlordiazepoxide Charoen Bhaesaj 10 mg - Chlordiazepoxide March Pharma 25 mg P1A 13/44 - Chlordiazepoxide T Man 10 mg P1A 4/51 - Chlordibrax † 5 mg - Chlordixide 5 mg P1A 9/51 - Chlordixide 10 mg P1A 26/51 - Chlorzep 5 mg - Comoben 5 mg P1A 30/49 - Comoben 10 mg P1A 31/49 - Cozep 10 mg P1A 3/50 - Cozep 25 mg P1A 4/50 - Dirax † 5 mg P2A 4/46 - Epoxide 10 mg - Epoxide 25 mg - Kenspa † 5 mg P2A 36/52 - Librax † 5 mg P2A 85/43 - Licon † 5 mg - Med-Zepoxide 5 mg - Med-Zepoxide 10 mg - Metaxide 10 mg P1A 7/51 - Minoxide 10 mg P1A 47/44 - Modurax † 5 mg P2A 46/44 - Pobrax † 5 mg - Pondnebium 5 mg P1A 13/49 - Pondnebium 10 mg - Radibrax † 5 mg - Tumax † 5 mg P2A 25/51 - Utorax † 5 mg - ÊÓ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:49 AM Registration No. Frame No. † † 579 580 591 529 380 397 072 225 450 273 501 500 412 498 194 380 501 500 467 373 382 358 195 359 362 491 138 181 385 187 193 223 381 379 468 053 481 477 377 376 371 192 392 400 383 73 - Zepobrax 5 mg - Zepoxide 5 mg - Zepoxide 10 mg - Zepoxin 5 mg - Zepoxin 10 mg Chlordiazepoxide March Pharma 25 mg Chlordiazepoxide T Man 10 mg † Chlordibrax 5 mg Chlordixide 5 mg Chlordixide 10 mg Chlorzep 5 mg † Clinepect 10 mg † Clinopect 10 mg † Clinopront 10 mg Clobazam: - Frisium 5 mg - Frisium 10 mg Clonaril 1 mg P1A 3/44 - 384 413 279 205 118 P1A 13/44 467 P1A 4/51 P1A 9/51 P1A 26/51 N2A 1/50 373 382 358 195 359 495 196 378 P1C 25/49, P1B 26/49 P1A 15/51 043 037 342 Clonazepam: - Clonaril 1 mg - Povanil 0.5 mg - Povanil 2 mg - Prenarpil 0.5 mg - Prenarpil 1 mg - Prenarpil 2 mg - Rivotril 0.5 mg - Rivotril 1 mg/mL x 1 mL - Rivotril 2 mg Cloramed 5 mg Cloramed 10 mg Cloraxene 5 5 mg Cloraze 5 mg Cloraze 10 mg P1A 15/51 P1A 33/52 P1A 34/52 P1A 30/52 P1A 31/52 P1A 32/52 P1C 7/49 342 186 067 407 337 054 408 P1C 17/48 P1A 4/49 P1A 32/51 - 637 055 429 264 436 433 266 Clorazepate Dipotassium: - Anxene 5 mg - Anxene 10 mg - Anxielax 5 mg - Cexene 5 mg - Cexene 10 mg - Cloramed 5 mg - Cloramed 10 mg - Cloraxene 5 5 mg - Cloraze 5 mg - Cloraze 10 mg - Clozene 5 mg - Clozene 10 mg - Clozepate 5 mg - Conzep 5 mg - Conzep 10 mg - Deda 5 mg - Deda 10 mg P1A 4/49 P1A 32/51 P1A 14/46 P1A 15/46 430 262 460 450 273 429 264 436 433 266 421 452 442 454 420 437 265 Frame Numbers in Bold Italics GENERIC & BRAND NAME INDEX PN DEX 2010 Color profile: Disabled Composite 150 lpi at 45 degrees 74 PN DEX 2010 GENERIC & BRAND NAME INDEX GENERIC & BRAND NAME INDEX Registration No. Frame No. - Diposef 5 mg - Diposef 10 mg - Dipot 5 mg - Dopam 5 mg - Exan 5 mg - Exan 10 mg - Flulium 5 mg - Flulium 10 mg - Frexene 5 mg - Frexene 10 mg - Gaxene 5 mg - Manotran 5 mg - Manotran 10 mg - Polizep 5 mg - Polizep 10 mg - Pomadom 5 mg - Pomadom 10 mg - Posene 5 mg - Posene 10 mg - Sanor 5 mg - Sanor 10 mg - Serene Masa Lab 10 mg - Serene V S Pharma 5 mg - Tamylab-S 5 mg - Tenmed 5 mg - Tenmed 10 mg - T-Five 5 mg - Tranadon-S 5 mg - Trancap 5 mg - Trancap 10 mg - Tranclor 5 mg - Tranclor 10 mg - Trancon 5 mg - Trancon 10 mg - Tranmed 5 mg - Tranmed 10 mg - Tranpate 5 mg - Tranpon 5 mg - Transpon Forte 10 mg - Tranxene 5 mg - Tranxene 10 mg - Tranzep 5 mg - Uptran 10 mg - Upzene 5 mg - Zetran 5 mg Clozene 5 mg Clozene 10 mg Clozepate 5 mg † Cocet 15 mg † Co-Cof 10 mg † Codee-C 10 mg Codeine GPO 15 mg † P1A 40/52 P1A 23/50 P1A 2/46 - 427 260 432 133 489 492 443 274 415 419 448 435 263 444 268 455 423 172 402 426 258 - 259 P1A 54/42 P1A 55/42 P1A 27/42 P1A 4/44 P1A 39/52 P1A 61/43 - 431 445 440 269 446 447 470 173 439 272 456 422 428 261 416 441 257 P1A 16/46 N2A 6/51 N2A 5/45 - 438 271 434 267 490 449 421 452 442 071 165 388 004 Registration No. Frame No. Codeine GPO 30 mg Codeine Phosphate (Analgesic): - Cemol Codeine † 15 mg - Cocet † 15 mg - Codeine GPO 15 mg - Codeine GPO 30 mg N1A 1/52 - Codicet † 15 mg N2A 10/51 - Codicet Blue † 15 mg - Codicet Pink † 15 mg N2A 3/50 - Codigesic † 15 mg - Cotenol † 15 mg - Masapara With Codeine † 15 mg N2A 5/50 - Nasa With Codeine † 15 mg N2A 4/51 - Pacogesic † 8 mg N2A 7/42 - Para-Co 15 mg N2A 2/50 - Paradeine † 15 mg - Paradyl 8 mg - Paragen Co † 15 mg - Paramed-Co † 15 mg - Parcod † 15 mg N2A 4/50 - Parcono † 8 mg - Tylenol With Codeine † 15 mg N2A 6/43 - Tylenol With Codeine † 30 mg N2A 11/43 Codeine Phosphate (Antitussive): - Benadryl CD † 60 mL - Benadryl CD † 1000 mL - Benylin CD † 60 mL N2A 12/47 - Bluco † 10 mg - Blucon † 10 mg - Bonadine CD † 60 mL - Bromtussia DC † 60 mL N2A 1/51 - Bronpect † 10 mg - Centrodine CD † 10 mg N2A 11/47 - Clinepect † 10 mg - Clinopect † 10 mg N2A 1/50 - Clinopront † 10 mg N2A 6/51 - Co-Cof † 10 mg N2A 5/45 - Codee-C † 10 mg N2A 4/52 - Codepect † 10 mg N2A 4/47 - Codesia † 10 mg - Codesia † 10 mg/5 mL x 60 mL N2A 3/47 - Codyl Cough † 9 mg/5 mL x 60 mL N2A 6/50 - Codyl Cough † 9 mg/5 mL x 100 mL N2A 6/50 - Codyl Cough † 9 mg/5 mL x 1000 mL - Codyl Cough † 9 mg/5 mL x 4500 mL - Cofcodyl Cough † 60 mL - Cofcodyl Cough † 100 mL Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:50 AM 018 072 071 004 018 414 352 255 112 073 410 080 189 347 074 083 113 395 077 079 075 076 550 551 552 355 332 561 515 298 225 495 196 378 165 388 202 391 516 540 541 542 543 521 522 ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ Color profile: Disabled Composite 150 lpi at 45 degrees GENERIC & BRAND NAME INDEX Registration No. Frame No. † - Comodine Cough 60 mL - Conadyl † 60 mL - Corynil † 10 mg - Cosedyl Cough Linctus † 60 mL - Decos † 9 mg/5 mL x 100 mL N2A 8/51 - Dimetane Expectorant DC † 2.5 L - Hisedyl † 60 mL - Hisedyl † 120 mL - Mantadyl Cough † 60 mL - Masadyl Cough † 60 mL - Masadyl Cough † 100 mL - Masadyl Cough † 240 mL - Mila-Cono † 60 mL N2A 7/47 - Mila-Tercon † 8 mg - Neo Cough † 60 mL - Neo Cough † 100 mL - Neo Cough † 240 mL - Neocod † 10 mg - Neo-Codein † 10 mg - Neocof † 10 mg - Neo-Cophen 10 mg N2A 10/46 - Neopect † 10 mg - Nordyl Linctus † 9 mg/5 mL x 100 mL N2C 3/51 - Nordyl Linctus † 9 mg/5 mL x 500 mL - Nortuss Linctus † 100 mL - Nortuss Linctus † 500 mL - P-Codyl † 9 mg/5 mL x 60 mL - P-Codyl † 9 mg/5 mL x 120 mL - Percidyl Cough † 100 mL - Phencodin † 9 mg/5 mL x 60 mL N2A 10/43 - Phencodin † 9 mg/5 mL x 500 mL - Phencodin † 9 mg/5 mL x 1000 mL - Phensedyl † 9 mg/5 mL x 100 mL N2A 8/43 - Phensodi † 60 mL - Phensodi † 120 mL - Phensodi † 1000 mL - Poly-Cof Syrup † 9 mg/5 mL x 60 mL N2A 5/51 - Poly-Cof Syrup † 9 mg/5 mL x 100 mL N2A 5/51 - Polydine CD † 10 mg - Pondnadyl † 9 mg/5 mL x 60 mL N2A 3/48 - Pondnadyl † 9 mg/5 mL x 100 mL N2A 3/48 ÊÓ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:50 AM 507 583 200 582 572 592 555 556 581 534 535 536 546 167 537 538 539 345 346 188 198 199 566 567 568 569 558 559 562 586 587 588 553 524 525 526 548 549 270 563 564 75 Registration No. Frame No. † - Pondnadyl 9 mg/5 mL x 1000 mL - Rolar † 10 mg - Ropect † 10 mg - Rotuss † 10 mg - Seco † 10 mg - Tenadrin-C † 60 mL - Teradene † 60 mL - Teradyl Syrup † 60 mL - Teradyl Syrup † 1000 mL - Terco-C † 10 mg - Tocodyl † 10 mg - Tussidyl † 9 mg/5 mL x 60 mL - Zorituss 10 mg Codeine Resinate: - Codipront † 30 mg - Codipront † 30 mg - Codipront † 60 mL Codepect† 10 mg Codesia† 10 mg Codesia† 10 mg/5 mL x 60 mL Codicet† 15 mg Codicet Blue† 15 mg Codicet Pink† 15 mg Codigesic† 15 mg Codipront† 30 mg Codipront† 30 mg Codipront† 60 mL Codyl Cough † 9 mg/5 mL x 60 mL Codyl Cough † 9 mg/5 mL x 100 mL † Codyl Cough 9 mg/5 mL x 1000 mL Codyl Cough † 9 mg/5 mL x 4500 mL Cofcodyl Cough† 60 mL † Cofcodyl Cough 100 mL Comoben 5 mg Comoben 10 mg Comodine Cough† 60 mL Conadyl† 60 mL Concerta 18 mg Concerta 36 mg Conzep 5 mg Conzep 10 mg Corynil† 10 mg Cosedyl Cough Linctus† 60 mL Cotenol† 15 mg Cough Syrup GPO† 0.6 mL/5 mL x 60 mL Cozep 10 mg Cozep 25 mg N2A 3/52 N2C 12/46 N2C 9/46 N2A 2/47 N2A 1/49 - 565 203 201 204 389 519 520 532 533 387 390 N2A 6/45 - 589 197 N2A 9/51 N2A 4/52 N2A 4/47 493 494 593 202 391 N2A 3/47 N1A 1/52 N2A 10/51 N2A 3/50 N2A 9/51 - 516 414 352 255 112 493 494 593 N2A 6/50 540 N2A 6/50 541 - 542 P1A 30/49 P1A 31/49 - 543 521 522 362 491 507 583 169 114 454 420 200 582 P1A 3/50 P1A 4/50 073 530 138 181 Frame Numbers in Bold Italics GENERIC & BRAND NAME INDEX PN DEX 2010 Color profile: Disabled Composite 150 lpi at 45 degrees 76 Registration No. Frame No. D Dalmadorm 15 mg Davol† 32.5 mg † Decos 9 mg/5 mL x 100 mL Deda 5 mg Deda 10 mg N2A 8/51 P1A 14/46 P1A 15/46 GENERIC & BRAND NAME INDEX Dextropropoxyphene HCl: - Davol † 32.5 mg Dextropropoxyphene Napsylate: - Pardex 32.5 mg Diadon 5 mg Diamed 2 mg P1A 9/49 Diamed 5 mg P1A 10/49 Diano 2 mg P1A 9/48 Diano 5 mg P1A 10/48 Diapam 2 mg P1A 5/51 Diapam 5 mg P1A 6/51 Diapine 2 mg P1A 13/50 Diapine 2 mg P1A 12/50 Diapine 5 mg P1A 11/51 Diapine 5 mg P1A 14/50 Diapine 5 mg/mL x 1 mL P1A 21/51 Diapine 10 mg P1A 18/49 Diapine 10 mg/2 mL x 2 mL P1A 21/51 Diaz 2 mg Diaz 5 mg Diaz 10 mg Diaza 2 mg Diaza 5 mg Diaza 10 mg/2 mL x 2 mL Diazepam: - Azepam 2 mg - Azepam 5 mg - A-Zerax 2 mg - A-Zerax 5 mg - Calmipam 2 mg - Calmipam 5 mg - Diadon 5 mg - Diamed 2 mg - Diamed 5 mg - Diano 2 mg - Diano 5 mg - Diapam 2 mg - Diapam 5 mg - Diapine 2 mg - Diapine 2 mg - Diapine 5 mg - Diapine 5 mg - Diapine 5 mg/mL x 1 mL † PN DEX 2010 GENERIC & BRAND NAME INDEX 478 275 572 437 265 275 116 349 503 482 015 140 369 329 010 473 166 484 600 386 601 061 157 341 338 153 625 P1A 37/52 P1A 38/52 P1A 9/49 P1A 10/49 P1A 9/48 P1A 10/48 P1A 5/51 P1A 6/51 P1A 13/50 P1A 12/50 P1A 11/51 P1A 14/50 219 299 453 463 361 276 349 503 482 015 140 369 329 010 473 166 484 P1A 21/51 600 Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:50 AM Registration No. Frame No. - Diapine 10 mg - Diapine 10 mg/2 mL x 2 mL - Diaz 2 mg - Diaz 5 mg - Diaz 10 mg - Diaza 2 mg - Diaza 5 mg - Diaza 10 mg/2 mL x 2 mL - Diazepam Acdhon 2 mg - Diazepam BJ Benjaosoth 2 mg - Diazepam BJ Benjaosoth 5 mg - Diazepam BJ Benjaosoth 10 mg - Diazepam Charoen Bhaesaj 2 mg - Diazepam General Drugs House 2 mg - Diazepam General Drugs House 5 mg - Diazepam GPO 2 mg - Diazepam GPO 5 mg - Diazepam GPO 10 mg - Diazepam GPO 10 mg/2 mL x 2 mL - Diazepam H K Pharm 2 mg - Diazepam H K Pharm 5 mg - Diazepam H K Pharm 10 mg - Diazepam Lerd Singh 2 mg - Diazepam Lerd Singh 5 mg - Diazepam Pond’s Chemical 2 mg - Diazepam Pond’s Chemical 5 mg - Diazepam Pond’s Chemical 5 mg - Diazepam Samakeephaesaj 2 mg - Diazepam Samakeephaesaj 5 mg - Diazepam Sommai Bhaesaj 5 mg - Diazepam T Man 2 mg - Diazepam T Man 5 mg - Diazepam T Man 5 mg - Diazepam T Man 10 mg - Diazepam T P Drug 2 mg - Diazepam T P Drug 5 mg P1A 18/49 386 P1A 21/51 - 601 061 157 341 338 153 - 625 472 P1A 13/52 050 P1A 14/52 374 P1A 15/52 222 - 333 P1A 14/49 318 P1A 24/50 - 148 052 149 334 - 603 P1A 32/49 218 P1A 33/49 160 P1A 34/49 343 P1A 49/50 066 P1A 50/50 161 P1A 32/45 367 P1A 33/45 162 216 - 363 - 142 P1A 12/52 P1A 62/44 - 320 364 163 211 327 - 017 - 155 ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ Color profile: Disabled Composite 150 lpi at 45 degrees GENERIC & BRAND NAME INDEX Registration No. Frame No. - Diazepam T P Drug 10 mg - Diazepam T P Drug 10 mg/2 mL x 2 mL - Diazepam Vesco 2 mg - Diazepam Vesco 5 mg - Diazepion 2 mg - Diazepion 5 mg - Diazepion 10 mg - Dilium 2 mg - Dilium 5 mg - Dimed 2 mg - Dimed 5 mg - Dipam 2 mg - Dipam 5 mg - Dipam 10 mg - Ditran 2 mg - Ditran 5 mg - Divopan 2 mg - Divopan 5 mg - Dizan 2 mg - Dizan 5 mg - Dizep 2 mg - Dizep 5 mg - Dizepam 2 mg - Dizepam 5 mg - DZP2 2 mg - Laylium-10 10 mg/2 mL x 2 mL - Manodiazo 2 mg - Manodiazo 5 mg - Manodiazo 10 mg - Manolium 10 mg/2 mL x 2 mL - Med-Zepam 2 mg - Med-Zepam 5 mg - Monozide 2 mg - Monozide-10 10 mg/2 mL x 2 mL - Pam-5 5 mg - Popam 2 mg - Popam 5 mg - Ropam 5 mg - Ropam 10 mg/2 mL x 2 mL - S.Co Zepam 5 mg - Sipam 2 mg - Sipam 5 mg - Sipam 10 mg - Sipam 10 mg/2 mL x 2 mL - Stesolid 2 mg - Stesolid 5 mg - Stesolid 10 mg - Tranolan 2 mg - Tranolan 5 mg - 340 P1A 27/51 P1A 53/50 P1A 54/50 P1A 8/50 P1A 61/50 P1A 11/48 P1A 12/48 P1A 5/50 P1A 6/50 P1A 21/49 P1A 22/49 - 627 325 134 480 474 191 178 326 068 164 040 137 330 418 476 049 146 457 417 171 190 224 151 471 P1A 83/43 P1A 84/43 P1A 23/51 635 469 502 335 P1A 12/49 - 613 039 336 496 P1A 37/49 - 632 206 111 170 158 P1A 13/45 P1A 15/49 P1A 16/49 P1A 17/49 608 220 056 154 339 P1A 39/50 P1A 42/50 P1A 43/50 626 401 485 479 130 177 ÊÓ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:50 AM 77 Registration No. Frame No. - Tranolan 10 mg/2 mL x 2 mL - V Day Zepam 2 mg - V Day Zepam 5 mg - V Day Zepam 10 mg/2 mL x 2 mL - V Day Zepam NL 10 mg/2 mL x 2 mL - Valax 2 mg - Valax 5 mg - Valax 10 mg - Valenium 2 mg - Valenium 5 mg - Valium 5 mg - Valium 10 mg/2 mL x 2 mL - Vason 2 mg - Vescopam 10 mg/2 mL x 2 mL - Vispam 2 mg - Vispam 5 mg - Vispam 10 mg - Vomed 2 mg - Vomed 5 mg - Vorapam 2 mg - Vorapam 5 mg - Winopam 2 mg - Winopam 5 mg - Zepam 2 mg - Zepam 5 mg - Zepam 10 mg/2 mL x 2 mL - Zepaxid 2 mg - Zepaxid 5 mg - Zepaxid 10 mg/2 mL x 2 mL - Zopam 2 mg - Zopam 5 mg - Zopam 10 mg Diazepam Acdhon 2 mg Diazepam BJ Benjaosoth 2 mg Diazepam BJ Benjaosoth 5 mg Diazepam BJ Benjaosoth 10 mg Diazepam Charoen Bhaesaj 2 mg Diazepam General Drugs House 2 mg Diazepam General Drugs House 5 mg Diazepam GPO 2 mg Diazepam GPO 5 mg Diazepam GPO 10 mg P1A 41/52 P1A 88/42 P1A 89/42 615 475 465 P2A 82/43 616 P1A 11/46 - 617 031 132 322 065 150 152 P1A 16/48 620 396 P1A 7/50 P1A 16/50 P1A 40/50 P1A 41/50 - 636 366 213 323 059 147 064 159 063 375 399 354 P1A 20/50 P1A 21/50 614 506 462 P1A 32/50 P1A 35/49 P1A 36/49 P1A 3/46 - 634 048 145 331 472 P1A 13/52 050 P1A 14/52 374 P1A 15/52 222 - 333 P1A 14/49 318 P1A 24/50 - 148 052 149 334 Frame Numbers in Bold Italics GENERIC & BRAND NAME INDEX PN DEX 2010 Color profile: Disabled Composite 150 lpi at 45 degrees 78 PN DEX 2010 GENERIC & BRAND NAME INDEX Registration No. Frame No. Diazepam GPO 10 mg/2 mL x 2 mL Diazepam H K Pharm 2 mg Diazepam H K Pharm 5 mg Diazepam H K Pharm 10 mg Diazepam Lerd Singh 2 mg Diazepam Lerd Singh 5 mg Diazepam Pond’s Chemical 2 mg Diazepam Pond’s Chemical 5 mg Diazepam Pond’s Chemical 5 mg Diazepam Samakeephaesaj 2 mg Diazepam Samakeephaesaj 5 mg Diazepam Sommai Bhaesaj 5 mg Diazepam T Man 2 mg Diazepam T Man 5 mg Diazepam T Man 5 mg Diazepam T Man 10 mg Diazepam T P Drug 2 mg Diazepam T P Drug 5 mg Diazepam T P Drug 10 mg Diazepam T P Drug 10 mg/2 mL x 2 mL Diazepam Vesco 2 mg Diazepam Vesco 5 mg Diazepion 2 mg Diazepion 5 mg Diazepion 10 mg GENERIC & BRAND NAME INDEX Diethylpropion HCl: - Dietil Retard 75 mg - Prefamone 75 mg - Regenon Retard 75 mg - Regenon Retard 75 mg Diethylpropion Resinate: - Atractil 75 mg Dietil Retard 75 mg Dilium 2 mg Dilium 5 mg Dilomil† 2.5 mg Dimed 2 mg Dimed 5 mg † Dimetane Expectorant DC 2.5 L Dipam 2 mg Dipam 5 mg Dipam 10 mg † - 603 P1A 32/49 218 P1A 33/49 160 P1A 34/49 343 P1A 49/50 066 P1A 50/50 161 P1A 32/45 367 - 162 P1A 33/45 216 - 363 - 142 P1A 12/52 P1A 62/44 - 320 364 163 211 327 017 155 340 P1A 27/51 P1A 53/50 P1A 54/50 - 627 325 134 480 474 191 - - 084 174 115 486 - 497 084 178 326 001 068 164 - 592 040 137 330 - Registration No. Frame No. Diphenoxylate HCl: - Dilomil † 2.5 mg - Ditropine † 2.5 mg - Lomotil † 2.5 mg - Spasil † 2.5 mg Diposef 5 mg Diposef 10 mg Dipot 5 mg † Dirax 5 mg Ditran 2 mg Ditran 5 mg Ditropine† 2.5 mg Divopan 2 mg Divopan 5 mg Dizan 2 mg Dizan 5 mg Dizep 2 mg Dizep 5 mg Dizepam 2 mg Dizepam 5 mg Dizolam 0.25 mg Dizolam 0.5 mg Dizolam 1 mg D-Norpseudoephedrine HCl: - Mirapront N 20 mg D-Norpseudoephedrine Resinate: D-Norpseudoephedrine SR Osmopharm 20 mg D-Norpseudoephedrine SR Osmopharm 20 mg Domar 5 mg P1A 5/52 † Donnatal 16.2 mg Dopam 5 mg Dormicum 5 mg/mL x 1 mL Dormicum 15 mg Dormicum 15 mg/3 mL x 3 mL Durogesic 25 mcg/hr x 2.5 mg Durogesic 50 mcg/hr x 5 mg Durogesic 100 mcg/hr x 10 mg Duromine 15 mg Duromine 30 mg DZP2 2 mg - 001 008 006 009 427 260 432 385 418 476 008 049 146 457 417 171 190 224 151 089 233 297 504 505 505 464 060 133 621 351 622 651 652 653 499 488 471 E Elixir Phenobarb 60 mL Ephedrine GPO 30 mg/mL x 1 mL Ephedrine HCl: - Ephedrine GPO 30 mg/mL x 1 mL Epoxide 10 mg Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:50 AM N2A 4/48 N2A 2/51 P1A 40/52 P2A 4/46 P1A 8/50 P1A 61/50 P1A 11/48 P1A 12/48 P1A 5/50 P1A 6/50 P1A 21/49 P1A 22/49 P1A 5/48 P1A 15/50 P1A 6/48 - 573 - 604 - 604 187 ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ Color profile: Disabled Composite 150 lpi at 45 degrees PN DEX 2010 GENERIC & BRAND NAME INDEX Registration No. Frame No. Epoxide 25 mg - 193 Ethyl Loflazepate: - Meilax 1 mg - Meilax 2 mg - Victan 2 mg Euhypnos 20 20 mg Exan 5 mg Exan 10 mg - 021 176 182 398 489 492 - 092 242 289 - 651 - 652 - 653 645 646 647 648 649 650 - 598 - 599 - 598 - 599 - 605 - 606 - 623 - 644 645 646 647 648 649 650 - 605 - 606 - 623 F Fentanyl: - Durogesic 25 mcg/hr x 2.5 mg - Durogesic 50 mcg/hr x 5 mg - Durogesic 100 mcg/hr x 10 mg - Fentanyl GPO 12 mcg/hr - Fentanyl GPO 25 mcg/hr - Fentanyl GPO 50 mcg/hr - Fentanyl Hexal 12 mcg/hr - Fentanyl Hexal 25 mcg/hr - Fentanyl Hexal 50 mcg/hr Fentanyl Antigen 0.05 mg/mL x 2 mL Fentanyl Antigen 0.05 mg/mL x 10 mL Fentanyl Citrate: - Fentanyl Antigen 0.05 mg/mL x 2 mL - Fentanyl Antigen 0.05 mg/mL x 10 mL - Fentanyl Janssen-Cilag 0.05 mg/mL x 2 mL - Fentanyl Janssen-Cilag 0.05 mg/mL x 10 mL - Fentanyl Sandoz 0.05 mg/mL x 2 mL - Fentanyl Sandoz 0.05 mg/mL x 10 mL Fentanyl GPO 12 mcg/hr Fentanyl GPO 25 mcg/hr Fentanyl GPO 50 mcg/hr Fentanyl Hexal 12 mcg/hr Fentanyl Hexal 25 mcg/hr Fentanyl Hexal 50 mcg/hr Fentanyl Janssen-Cilag 0.05 mg/mL x 2 mL Fentanyl Janssen-Cilag 0.05 mg/mL x 10 mL Fentanyl Sandoz 0.05 mg/mL x 2 mL Registration No. Frame No. Fentanyl Sandoz 0.05 mg/mL x 10 mL Flulium 5 mg Flulium 10 mg - 644 443 274 Flunitrazepam: - Rohypnol 1 mg - 394 Flurazepam: - Dalmadorm 15 mg Fortwin 30 mg/mL x 1 mL Frexene 5 mg Frexene 10 mg Frisium 5 mg P1C 25/49, P1B 26/49 - Frisium 10 mg 478 618 415 419 043 037 G Gardenal 200 mg/4 mL Gaxene 5 mg Grandaxin 50 mg P1C 1/50 P1C 27/50 638 448 051 H Halcion 0.25 mg Hawkcopax 0.5 mg Hawkcopax 1 mg Hisedyl† 60 mL Hisedyl† 120 mL P1A 8/51 - 350 321 365 555 556 P1A 58/50 P1A 59/50 P1A 60/50 104 251 294 I ÊÓ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:50 AM Inzolam 0.25 mg Inzolam 0.5 mg Inzolam 1 mg K Kapanol 20 mg Kapanol 50 mg Kapanol 100 mg Kemora 0.5 mg P1A 18/47 Kemora 1 mg P1A 21/47 † Kenspa 5 mg P2A 36/52 Keta-Hameln 50 mg/mL x 10 mL Ketalar 50 mg/mL x 10 mL Ketamine HCl: - Calypsol 50 mg/mL x 10 mL - Keta-Hameln 50 mg/mL x 10 mL - Ketalar 50 mg/mL x 10 mL 119 120 121 411 024 223 642 643 - 641 - 642 643 - Frame Numbers in Bold Italics GENERIC & BRAND NAME INDEX Farzolam 0.25 mg Farzolam 0.5 mg Farzolam 1 mg 79 Color profile: Disabled Composite 150 lpi at 45 degrees 80 PN DEX 2010 GENERIC & BRAND NAME INDEX Registration No. Frame No. GENERIC & BRAND NAME INDEX L Laylium-10 10 mg/2 mL x 2 mL Lexotan 1.5 mg Lexotan 3 mg † Librax 5 mg † Licon 5 mg Lizavan 0.5 mg Lizavan 1 mg Lomotil† 2.5 mg Lonza 0.5 mg Lonza 1 mg Lora 0.5 mg Lora 1 mg Lora 2 mg Lora-P 0.5 mg Lora-P 1 mg Lora-P 2 mg Loramed 0.5 mg Loramed 1 mg Loramed 2 mg Loramet 1 mg Lorapam 0.5 mg Lorapam 1 mg Lorapam 2 mg Lorapine 0.5 mg Lorapine 1 mg Loravan 0.5 mg Loravan 1 mg Lorazene 0.5 mg Lorazene 1 mg Lorazene 2 mg Lorazep 0.5 mg Lorazep 1 mg Lorazep 2 mg P1C 5/49 P1C 6/49 P2A 85/43 N2A 4/48 P1A 11/49 P1A 18/48 P1A 17/51 P1A 18/51 P1A 19/51 P1A 23/47 P1A 22/50 P1A 2/49 P1A 17/47 P1A 20/47 P1A 22/47 635 070 228 381 379 305 023 006 313 019 368 036 217 319 016 123 306 025 210 102 311 026 128 314 035 302 027 301 013 127 309 003 357 Lorazepam: - Anta 0.5 mg - Anta 1 mg - Anta 2 mg - Anxira 0.5 mg - Anxira 1 mg - Ativan 0.5 mg - Ativan 1 mg - Ativan 2 mg - Hawkcopax 0.5 mg - Hawkcopax 1 mg - Kemora 0.5 mg - Kemora 1 mg - Lizavan 0.5 mg - Lizavan 1 mg - Lonza 0.5 mg - Lonza 1 mg - Lora 0.5 mg P1A 29/50 P1A 28/50 P1A 29/52 P1A 24/52 P1A 25/52 P1A 8/51 P1A 18/47 P1A 21/47 P1A 11/49 P1A 18/48 P1A 17/51 304 020 125 300 022 308 028 129 321 365 411 024 305 023 313 019 368 † Registration No. Frame No. - Lora 1 mg - Lora 2 mg - Lora-P 0.5 mg - Lora-P 1 mg - Lora-P 2 mg - Loramed 0.5 mg - Loramed 1 mg - Loramed 2 mg - Lorapam 0.5 mg - Lorapam 1 mg - Lorapam 2 mg - Lorapine 0.5 mg - Lorapine 1 mg - Loravan 0.5 mg - Loravan 1 mg - Lorazene 0.5 mg - Lorazene 1 mg - Lorazene 2 mg - Lorazep 0.5 mg - Lorazep 1 mg - Lorazep 2 mg - Lorazepam Acdhon 0.5 mg - Lorazepam Acdhon 1 mg - Lorazepam Macrophar 1 mg - Lorazin 0.5 mg - Lorazin 1 mg - Lorazin 2 mg - Lozepam 0.5 mg - Lozepam 1 mg - Ora 0.5 mg - Ora 1 mg - Ora 2 mg - Pora 0.5 mg - Pora 1 mg - Pora 2 mg - Razepam 0.5 mg - Razepam 1 mg - Razepam 2 mg - Tranavan 0.5 mg - Tranavan 1 mg - Vemed 0.5 mg - Zeda 0.5 mg - Zeda 1 mg - Zora 0.5 mg - Zora 2 mg Lorazepam Acdhon 0.5 mg Lorazepam Acdhon 1 mg Lorazepam Macrophar 1 mg Lorazin 0.5 mg Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:50 AM P1A 18/51 P1A 19/51 P1A 23/47 P1A 22/50 P1A 2/49 P1A 17/47 P1A 20/47 P1A 22/47 036 217 319 016 123 306 025 210 311 026 128 314 035 302 027 301 013 127 309 003 357 - 317 - 033 P1A 28/45 P1A 29/45 P1A 30/45 P1A 12/51 P1A 13/51 P1A 3/52 P1A 4/52 P1A 8/52 P1A 9/52 P1A 25/50 P1A 26/50 372 324 044 227 303 405 310 030 212 370 139 215 315 032 131 307 034 316 014 360 328 179 - 317 - 033 P1A 28/45 372 324 ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ Color profile: Disabled Composite 150 lpi at 45 degrees GENERIC & BRAND NAME INDEX Registration No. Frame No. Lorazin 1 mg Lorazin 2 mg P1A 29/45 P1A 30/45 044 227 - 102 303 405 Lormetazepam: - Loramet 1 mg Lozepam 0.5 mg Lozepam 1 mg M Manex 0.25 mg Manex 0.5 mg Manex 1 mg Manodiazo 2 mg Manodiazo 5 mg Manodiazo 10 mg Manolium 10 mg/2 mL x 2 mL Manotran 5 mg Manotran 10 mg Mantadyl Cough† 60 mL Marzolam 0.25 mg Marzolam 0.5 mg Marzolam 1 mg Masadyl Cough† 60 mL Masadyl Cough† 100 mL Masadyl Cough† 240 mL Masapara With Codeine† 15 mg Medazepam: - Celium 5 mg - Medazine 5 mg - Medazine 10 mg Medazine 5 mg Medazine 10 mg Med-Zepam 2 mg Med-Zepam 5 mg Med-Zepoxide 5 mg Med-Zepoxide 10 mg Meilax 1 mg Meilax 2 mg Menobarb 60 mg Menobarb Elixir 15 mg/5 mL x 60 mL Menobarb-20 Elixir 20 mg/5 mL x 60 mL Meprobamate: - Reinbamate 400 mg Metaxide 10 mg Methadone GPO 5 mg Methadone GPO 10 mg/mL x 1000 mL Methadone HCl: - Methadone GPO 5 mg - Methadone GPO 10 mg/mL x 1000 mL P1A 36/51 P1A 21/46 P1A 8/47 P1A 83/43 P1A 84/43 P1A 23/51 099 244 291 469 502 335 P1A 12/49 P1A 5/47 P1A 42/52 P1A 43/52 - 613 435 263 581 090 235 283 534 535 536 N2A 5/50 410 P1A 24/51 P1A 30/50 P1A 31/50 P1A 30/50 P1A 31/50 - 397 487 483 487 483 039 336 468 053 021 176 185 - 544 - 545 P1A 7/51 - 082 481 126 - 596 - 126 - 596 ÊÓ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:50 AM 81 Registration No. Frame No. Methylphenidate HCl: - Concerta 18 mg - Concerta 36 mg - Methylphenidate Hexal 10 mg - Ritalin 10 mg - Rubifen 10 mg Methylphenidate Hexal 10 mg Midazolam: - Dormicum 5 mg/mL x 1 mL - Dormicum 15 mg - Dormicum 15 mg/3 mL x 3 mL † Mila-Cono 60 mL Mila-Tercon† 8 mg Minoxide 10 mg Mirapront N 20 mg Mist Tussis† 0.6 mL/5 mL x 450 mL Mist. Scill Ammon. GPO† 0.6 mL/5 mL x 180 mL Mitranax 0.25 mg Mitranax 0.5 mg Mitranax 1 mg † Mixture Scillae Ammon 2 mL/15 mL x 180 mL Mixture Tussis† 0.45 mL/5 mL x 30 mL Mixture Tussis† 0.45 mL/5 mL x 60 mL Mixture Tussis† 0.45 mL/5 mL x 120 mL † Mixture Tussis 0.45 mL/5 mL x 240 mL Mixture Tussis† 0.45 mL/5 mL x 450 mL Mixture Tussis† 0.45 mL/5 mL x 1800 mL Mixture Tussis† 0.45 mL/5 mL x 3600 mL † Modurax 5 mg Mogadon 5 mg Monozide 2 mg Monozide-10 10 mg/2 mL x 2 mL - 169 114 - 117 041 038 - 117 - 621 351 N2A 7/47 P1A 47/44 - 622 546 167 477 504 N2A 14/45 590 N2A 13/46 P1A 36/50 P1A 37/50 P1A 38/50 531 106 253 295 - 557 N2A 11/46 574 N2A 11/46 575 N2A 11/46 576 N2A 11/46 577 N2A 11/46 578 - 579 P2A 46/44 - 580 377 081 496 P1A 37/49 632 Morphine Sulfate: - Kapanol 20 mg - Kapanol 50 mg - Kapanol 100 mg - Morphine Sulfate Inj Blue 10 mg/mL x 1 mL - Morphine Sulfate Inj Purple 10 mg/mL x 1 mL - Morphine T.P. Drug 10 mg/mL x 1 mL - Morphine T.P. Drug 10 mg/mL x 1 mL - 119 120 121 - 609 - 610 - 628 - 629 Frame Numbers in Bold Italics GENERIC & BRAND NAME INDEX PN DEX 2010 Color profile: Disabled Composite 150 lpi at 45 degrees 82 PN DEX 2010 GENERIC & BRAND NAME INDEX Registration No. Frame No. - Morphine T.P. Drug 10 mg/mL x 1 mL - MST Continus 10 mg - MST Continus 30 mg - MST Continus 60 mg - Oramorph 10 mg/5 mL x 250 mL - Oramorph 20 mg/mL x 30 mL Morphine Sulfate Inj Blue 10 mg/mL x 1 mL Morphine Sulfate Inj Purple 10 mg/mL x 1 mL Morphine T.P. Drug 10 mg/mL x 1 mL Morphine T.P. Drug 10 mg/mL x 1 mL Morphine T.P. Drug 10 mg/mL x 1 mL Moxinax 0.25 mg Moxinax 0.5 mg MST Continus 10 mg MST Continus 30 mg MST Continus 60 mg - 630 406 278 183 - 594 - 595 - 609 - 610 - 628 - 629 P1A 19/49 P1A 20/49 - 630 094 238 406 278 183 N GENERIC & BRAND NAME INDEX † Nasa With Codeine 15 mg Nembutal 50 mg/mL x 20 mL Neo Cough† 60 mL Neo Cough† 100 mL Neo Cough† 240 mL Neocod† 10 mg Neo-Codein† 10 mg Neocof† 10 mg Neo-Cophen 10 mg Neopect† 10 mg Neuramizone† 20 mg Nitrados 5 mg Nitrazepam: - Alodorm 5 mg - Mogadon 5 mg - Nitrados 5 mg Nordyl Linctus† 9 mg/5 mL x 100 mL † Nordyl Linctus 9 mg/5 mL x 500 mL Nortuss Linctus† 100 mL Nortuss Linctus† 500 mL N2A 4/51 080 P1F 2/50 N2A 10/46 P2A 5/45 - 639 537 538 539 345 346 188 198 199 403 062 - 078 081 062 N2C 3/51 566 - 567 568 569 O Opium Tinct: - Camphorated Opium Tincture BP 1980 † 5 mL/100 mL x 1000 mL N2A 9/45 † 529 Registration No. Frame No. Ora 0.5 mg Ora 1 mg Ora 2 mg Oramorph 10 mg/5 mL x 250 mL Oramorph 20 mg/mL x 30 mL 310 030 212 - 594 - 595 - 189 206 425 461 P1A 20/51 N2A 7/42 N2A 2/50 N2A 4/50 - 607 347 074 083 113 395 077 079 116 - 558 - 559 - 618 P † Pacogesic 8 mg Pam-5 5 mg Panbesy 15 mg Panbesy 30 mg Pangon 30 mg/mL x 1 mL Para-Co 15 mg Paradeine† 15 mg Paradyl 8 mg † Paragen Co 15 mg Paramed-Co† 15 mg † Parcod 15 mg Parcono† 8 mg Pardex 32.5 mg P-Codyl† 9 mg/5 mL x 60 mL † P-Codyl 9 mg/5 mL x 120 mL Pentazocine: - Fortwin 30 mg/mL x 1 mL - Pangon 30 mg/mL x 1 mL - Pentazocine All Plants 30 mg/mL x 1 mL - Sosegon 30 mg/mL x 1 mL - Tazcine 30 mg/mL x 1 mL Pentazocine All Plants 30 mg/mL x 1 mL Pentazocine HCl: - Tazcine 25 mg - Tazcine 50 mg Pentobarbital Na: - Nembutal 50 mg/mL x 20 mL Percidyl Cough† 100 mL Pethidine Biolab 100 mg/2 mL x 2 mL Pethidine HCl: - Pethidine Biolab 100 mg/2 mL x 2 mL - Pethidine M & H Manufacturing 50 mg/mL x 1 mL - Pethidine M & H Manufacturing 100 mg/2 mL x 2 mL Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:50 AM P1A 12/51 P1A 13/51 - P1A 20/51 P1C 29/49 607 597 624 - 633 - 597 - 058 226 P1F 2/50 - 639 562 - 602 - 602 - 611 - 612 ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ Color profile: Disabled Composite 150 lpi at 45 degrees GENERIC & BRAND NAME INDEX Registration No. Frame No. - Pethidine T.P. Drug 50 mg/mL x 1 mL Pethidine M & H Manufacturing 50 mg/mL x 1 mL Pethidine M & H Manufacturing 100 mg/2 mL x 2 mL Pethidine T.P. Drug 50 mg/mL x 1 mL Pharnax 0.25 mg P1A 28/51 Pharnax 0.5 mg P1A 29/51 Pharnax 1 mg P1A 30/51 † Phencodin 9 mg/5 mL x 60 mL N2A 10/43 † Phencodin 9 mg/5 mL x 500 mL Phencodin† 9 mg/5 mL x 1000 mL Phenobarb 30 mg Phenobarb 60 mg Phenobarb Elixir 20 mg/5 mL x 60 mL Phenobarbital Acdhon 15 mg Phenobarbital Acdhon 30 mg Phenobarbital Acdhon 60 mg Phenobarbital Atlantic 16.25 mg Phenobarbital Atlantic 32.5 mg P1A 33/51 Phenobarbital Atlantic 65 mg P1A 34/51 Phenobarbital Atlantic 100 mg P1A 35/51 Phenobarbital Chew Brothers 30 mg Phenobarbital Elixir Acdhon 20 mg/5 mL x 30 mL Phenobarbital Elixir Acdhon 20 mg/5 mL x 60 mL Phenobarbital Elixir Acdhon 20 mg/5 mL x 120 mL Phenobarbital Elixir Acdhon 20 mg/5 mL x 240 mL Phenobarbital Elixir Acdhon 20 mg/5 mL x 450 mL Phenobarbital Elixir Acdhon 20 mg/5 mL x 500 mL Phenobarbital Elixir Acdhon 20 mg/5 mL x 1000 mL Phenobarbital Na: - Belladonna Alkaloids With Phenobarbital † 16.2 mg 631 611 612 631 101 247 292 586 587 588 209 046 560 356 122 029 208 011 012 277 312 508 509 510 511 512 513 514 - 221 - Bellergal † 20 mg - 207 - Benera † 20 mg - 404 - Donnatal † 16.2 mg - 060 - Elixir Phenobarb 60 mL - 573 - Gardenal 200 mg/4 mL P1C 1/50 638 - 185 - Menobarb 60 mg ÊÓ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:50 AM 83 Registration No. Frame No. - Menobarb Elixir 15 mg/5 mL x 60 mL - Menobarb-20 Elixir 20 mg/5 mL x 60 mL P2A 5/45 - Neuramizone † 20 mg - Phenobarb 30 mg - Phenobarb 60 mg - Phenobarb Elixir 20 mg/5 mL x 60 mL - Phenobarbital Acdhon 15 mg - Phenobarbital Acdhon 30 mg - Phenobarbital Acdhon 60 mg - Phenobarbital Atlantic 16.25 mg - Phenobarbital P1A 33/51 Atlantic 32.5 mg - Phenobarbital P1A 34/51 Atlantic 65 mg - Phenobarbital Atlantic 100 mg P1A 35/51 - Phenobarbital Chew Brothers 30 mg - Phenobarbital Elixir Acdhon 20 mg/5 mL x 30 mL - Phenobarbital Elixir Acdhon 20 mg/5 mL x 60 mL - Phenobarbital Elixir Acdhon 20 mg/5 mL x 120 mL - Phenobarbital Elixir Acdhon 20 mg/5 mL x 240 mL - Phenobarbital Elixir Acdhon 20 mg/5 mL x 450 mL - Phenobarbital Elixir Acdhon 20 mg/5 mL x 500 mL - Phenobarbital Elixir Acdhon 20 mg/5 mL x 1000 mL - Phenobarbitone New Life Pharma 30 mg - Phenobarbitone New Life Pharma 60 mg - Phenoco Elixir 20 mg/5 mL x 450 mL P1A 26/47 - Phenoco Elixir 20 mg/5 mL x 3800 mL - Phenocon 60 mg - Phenosil Elixir 20 mg/5 mL x 60 mL - Phenosil Elixir 20 mg/5 mL x 450 mL - Phenotal Elixir P1A 16/52 20 mg/5 mL x 60 mL Phenobarbitone New Life Pharma 30 mg Phenobarbitone New Life Pharma 60 mg - 544 545 403 209 046 560 356 122 029 208 011 012 277 312 508 509 510 511 512 513 514 005 180 584 585 229 570 571 517 005 180 Frame Numbers in Bold Italics GENERIC & BRAND NAME INDEX PN DEX 2010 Color profile: Disabled Composite 150 lpi at 45 degrees 84 PN DEX 2010 GENERIC & BRAND NAME INDEX Registration No. Frame No. Phenoco Elixir 20 mg/5 mL x 450 mL Phenoco Elixir 20 mg/5 mL x 3800 mL Phenocon 60 mg Phenosil Elixir 20 mg/5 mL x 60 mL Phenosil Elixir 20 mg/5 mL x 450 mL Phenotal Elixir 20 mg/5 mL x 60 mL Phensedyl† 9 mg/5 mL x 100 mL † Phensodi 60 mL † Phensodi 120 mL Phensodi† 1000 mL Phentermine HCl: - Panbesy 15 mg - Panbesy 30 mg - Phentermine Osmopharm 15 mg Phentermine Osmopharm 15 mg Phentermine Resinate: - Duromine 15 mg - Duromine 30 mg - Phentermine Trenker 15 mg - Phentermine Trenker 30 mg Phentermine Trenker 15 mg Phentermine Trenker 30 mg GENERIC & BRAND NAME INDEX Phenylpropanolamine HCl: - Phenylpropanolamine Pharmasant 25 mg Phenylpropanolamine Pharmasant 25 mg Pinazepam: - Domar 5 mg † Pobrax 5 mg Polizep 5 mg Polizep 10 mg † Poly-Cof Syrup 9 mg/5 mL x 60 mL Poly-Cof Syrup† 9 mg/5 mL x 100 mL † Polydine CD 10 mg Pomadom 5 mg Pomadom 10 mg † Pondnadyl 9 mg/5 mL x 60 mL Pondnadyl† 9 mg/5 mL x 100 mL † Pondnadyl 9 mg/5 mL x 1000 mL Pondnebium 5 mg † P1A 26/47 584 - 585 229 - 570 - 571 P1A 16/52 517 N2A 8/43 - 553 524 525 526 - 425 461 - 451 - 451 - 499 488 - 466 - 424 466 424 - - 141 - 141 P1A 5/52 P1A 23/50 - Registration No. Frame No. Pondnebium 10 mg Popam 2 mg Popam 5 mg Pora 0.5 mg Pora 1 mg Pora 2 mg Posene 5 mg Posene 10 mg Povanil 0.5 mg Povanil 2 mg Pozapam 5 mg Pozapam 10 mg Prasepine 5 mg P1A 33/52 P1A 34/52 P1A 23/52 P1A 39/51 - 192 111 170 370 139 215 172 402 186 067 459 175 458 Prazepam: - Pozapam 5 mg P1A 23/52 459 P1A 39/51 175 P1A 3/51 P1A 30/52 P1A 31/52 P1A 32/52 458 234 174 407 337 054 - 143 - 047 - Pozapam 10 mg - Prasepine 5 mg Prazol 0.5 mg Prefamone 75 mg Prenarpil 0.5 mg Prenarpil 1 mg Prenarpil 2 mg Pseudoephedrine Asian Pharm 30 mg Pseudoephedrine Asian Pharm 60 mg Pseudoephedrine BJ Benjaosoth 60 mg - 135 Pseudoephedrine HCl: - Pseudoephedrine Asian Pharm 30 mg - 143 - Pseudoephedrine Asian Pharm 60 mg - 047 - Pseudoephedrine BJ Benjaosoth 60 mg - 135 - Pseudoephedrine Medicine Products 60 mg - 184 - Pseudoephedrine Milano 30 mg - 136 - Pseudoephedrine Milano 60 mg - 045 - Pseudoephedrine Syrup Asian Pharm 30 mg/5 mL x 60 mL - 518 - Pseudoephedrine Syrup BJ Benjaosoth 30 mg/5 mL x 60 mL - 523 - 547 - 184 - 136 - 045 464 376 444 268 N2A 5/51 548 N2A 5/51 P1A 2/46 549 270 455 423 N2A 3/48 563 N2A 3/48 564 P1A 13/49 565 371 - Pseudoephedrine Syrup Milano 30 mg/5 mL x 60 mL Pseudoephedrine Medicine Products 60 mg Pseudoephedrine Milano 30 mg Pseudoephedrine Milano 60 mg Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:50 AM ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ Color profile: Disabled Composite 150 lpi at 45 degrees GENERIC & BRAND NAME INDEX Registration No. Frame No. Pseudoephedrine Syrup Asian Pharm 30 mg/5 mL x 60 mL Pseudoephedrine Syrup BJ Benjaosoth 30 mg/5 mL x 60 mL Pseudoephedrine Syrup Milano 30 mg/5 mL x 60 mL - 518 - 523 - 547 R † Radibrax 5 mg Razepam 0.5 mg Razepam 1 mg Razepam 2 mg Regenon Retard 75 mg Regenon Retard 75 mg Reinbamate 400 mg Ritalin 10 mg Rivotril 0.5 mg Rivotril 1 mg/mL x 1 mL Rivotril 2 mg Rohypnol 1 mg Rolar† 10 mg Ropam 5 mg Ropam 10 mg/2 mL x 2 mL Ropect† 10 mg Rotuss† 10 mg Rubifen 10 mg P1C 7/49 392 315 032 131 115 486 082 041 408 P1C 17/48 N2A 3/52 - 637 055 394 203 158 P1A 13/45 N2C 12/46 N2C 9/46 - 608 201 204 038 S S.Co Zepam 5 mg Sanor 5 mg Sanor 10 mg † Seco 10 mg N2A 2/47 Serene Masa Lab 10 mg Serene V S Pharma 5 mg Siampraxol 0.25 mg P1A 6/52 Siampraxol 0.5 mg P1A 7/52 Siampraxol 1 mg Sipam 2 mg P1A 15/49 Sipam 5 mg P1A 16/49 Sipam 10 mg P1A 17/49 Sipam 10 mg/2 mL x 2 mL P1A 39/50 Sosegon 30 mg/mL x 1 mL P1C 29/49 Spasil† 2.5 mg N2A 2/51 Squill And Ammonia Mixture† 1.3 mL/10 mL x 450 mL N2A 9/47 Stesolid 2 mg - ÊÓ¹Ñ¡§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:51 AM 220 426 258 389 259 431 098 243 290 056 154 339 626 624 009 591 401 85 Registration No. Frame No. Stesolid 5 mg Stesolid 10 mg Stilnox 10 mg Sunax 0.25 mg Sunax 0.5 mg - 485 479 110 107 254 - 445 058 633 226 T Tamylab-S 5 mg Tazcine 25 mg Tazcine 30 mg/mL x 1 mL Tazcine 50 mg Temazepam: - Euhypnos 20 20 mg Temgesic 0.2 mg Temgesic 0.3 mg/mL x 1 mL Tenadrin-C† 60 mL Tenmed 5 mg P1A 54/42 Tenmed 10 mg P1A 55/42 Teradene† 60 mL Teradyl Syrup† 60 mL † Teradyl Syrup 1000 mL Terco-C† 10 mg N2A 1/49 T-Five 5 mg Tocodyl† 10 mg Tofisopam: - Grandaxin 50 mg Tranadon-S 5 mg Tranavan 0.5 mg Tranavan 1 mg Trancap 5 mg Trancap 10 mg Tranclor 5 mg Tranclor 10 mg Trancon 5 mg Trancon 10 mg Tranmed 5 mg Tranmed 10 mg Tranolan 2 mg Tranolan 5 mg Tranolan 10 mg/2 mL x 2 mL Tranpate 5 mg Tranpon 5 mg Transpon Forte 10 mg Tranxene 5 mg Tranxene 10 mg Tranzep 5 mg Trialam 0.25 mg Triazolam: - Halcion 0.25 mg - Trialam 0.25 mg - Trycam 0.25 mg Trycam 0.25 mg 398 007 619 519 440 269 520 532 533 387 446 390 P1C 27/50 P1A 3/52 P1A 4/52 P1A 27/42 P1A 4/44 P1A 39/52 P1A 42/50 P1A 43/50 051 447 307 034 470 173 439 272 456 422 428 261 130 177 P1A 41/52 P1A 61/43 P1A 16/46 - 615 416 441 257 438 271 434 168 - 350 168 348 348 Frame Numbers in Bold Italics GENERIC & BRAND NAME INDEX PN DEX 2010 Color profile: Disabled Composite 150 lpi at 45 degrees 86 PN DEX 2010 GENERIC & BRAND NAME INDEX Registration No. Frame No. † Tumax 5 mg † Tussidyl 9 mg/5 mL x 60 mL † Tylenol With Codeine 15 mg † Tylenol With Codeine 30 mg P2A 25/51 400 N2A 6/45 589 N2A 6/43 075 N2A 11/43 076 U Uptran 10 mg Upzene 5 mg † Utorax 5 mg 267 490 383 - GENERIC & BRAND NAME INDEX V V Day Zepam 2 mg V Day Zepam 5 mg V Day Zepam 10 mg/2 mL x 2 mL V Day Zepam NL 10 mg/2 mL x 2 mL Valax 2 mg Valax 5 mg Valax 10 mg Valenium 2 mg Valenium 5 mg Valium 5 mg Valium 10 mg/2 mL x 2 mL Vason 2 mg Vemed 0.5 mg Vescopam 10 mg/2 mL x 2 mL Victan 2 mg Vispam 2 mg Vispam 5 mg Vispam 10 mg Vomed 2 mg Vomed 5 mg Vorapam 2 mg Vorapam 5 mg P1A 88/42 P1A 89/42 475 465 P2A 82/43 616 P1A 11/46 - 617 031 132 322 065 150 152 P1A 16/48 - 620 396 316 P1A 7/50 P1A 16/50 P1A 40/50 P1A 41/50 636 182 366 213 323 059 147 064 159 Registration No. Frame No. Xanax 0.25 mg Xanax 0.5 mg Xanax 1 mg Xanax XR 0.5 mg Xanax XR 1 mg Xanax XR 2 mg Xiemed 0.25 mg Xiemed 0.5 mg Xiemed 1 mg P1C 20/52 P1C 21/52 P1C 22/52 P1C 17/50 P1C 18/50 P1C 19/50 P1A 27/49 P1A 34/50 P1A 28/49 096 240 287 344 069 353 108 249 296 Z Zeda 0.5 mg Zeda 1 mg Zepam 2 mg Zepam 5 mg Zepam 10 mg/2 mL x 2 mL Zepaxid 2 mg Zepaxid 5 mg Zepaxid 10 mg/2 mL x 2 mL † Zepobrax 5 mg Zepoxide 5 mg Zepoxide 10 mg Zepoxin 5 mg Zepoxin 10 mg Zetran 5 mg Zolam 0.25 mg Zolam 0.5 mg Zolam 1 mg Zolpidem Tartrate: - Stilnox 10 mg Zopam 2 mg Zopam 5 mg Zopam 10 mg Zora 0.5 mg Zora 2 mg Zorituss 10 mg P1A 8/52 P1A 9/52 - 014 360 399 354 P1A 20/50 P1A 21/50 614 506 462 P1A 32/50 P1A 3/44 P1A 44/50 P1A 45/50 P1A 46/50 634 384 413 279 205 118 449 093 237 285 P1A 35/49 P1A 36/49 P1A 3/46 P1A 25/50 P1A 26/50 - 110 048 145 331 328 179 197 W - 063 375 P1A 13/48 P1A 14/48 P1A 15/48 095 239 286 091 236 284 Winopam 2 mg Winopam 5 mg X Xalam 0.25 mg Xalam 0.5 mg Xalam 1 mg Xanacine 0.25 mg Xanacine 0.5 mg Xanacine 1 mg † Indicates brands that contain more than 1 ingredient C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp Wednesday, March 31, 2010 10:04:51 AM ¡Í§¤Çº¤ØÁÇÑµ¶ØàÊ¾µÔ´ แบบสำ�รวจและแจ้งความต้องการหนังสือและ/หรือแผ่นซีดี หน่วยงานต้นสังกัด กระทรวงสาธารณสุข สำ�นักงานคณะกรรมการป้องกันและปราบปรามยาเสพติด สำ�นักงานตำ�รวจแห่งชาติ อื่น ๆ……………………………………………………………… 1. ความเห็นของท่านต่อ PNdex ในการพิสูจน์เอกลักษณ์ เพื่อค้นหาชื่อยา มากที่สุด มาก ปานกลาง ความสำ�คัญของการพิสูจน์เอกลักษณ์ เม็ดยาต่องานของท่าน ประโยชน์ของ PNdex ที่ช่วยท่าน ในการพิสูจน์หรือค้นหาชื่อยา รูปแบบของหนังสือ ช่วยให้ท่านพิสูจน์ หรือค้นหาได้อย่างรวดเร็ว รูปแบบของซีดีรอม ช่วยท่านให้พิสูจน์ หรือค้นหาได้อย่างรวดเร็ว น้อย ไม่แน่ใจ 2. ข้อผิดพลาดของหนังสือ หรือ /ซีดี-รอม ที่ควรแก้ไข 3. ข้อเสนอแนะในการพัฒนาการจัดทำ�หนังสือเล่มต่อๆ ไป 4. หน่วยงานของท่านมีความต้องการหนังสือเล่มปัจจุบัน (PNdex 2010) เพิ่ม จำ�นวน และ/หรือแผ่นซีดี-รอม จำ�นวน แผ่น เหตุผลความจำ�เป็น 5. ผู้ให้ข้อมูลเพศ 6. ผูใ้ ห้ข้อมูลอายุ ชาย 21-30 ปี หญิง 31-40 ปี 41-50 ปี เล่ม 51-60 ปี 7. ชื่อหน่วยงาน 8. ทีอ่ ยู่หน่วยงาน เพื่อส่งของทางไปรษณีย์ และเบอร์โทรเพื่อติดต่อกลับ กรุณาส่งแบบสำ�รวจนี้กลับมายังที่อยู่ด้านหลัง และขอขอบคุณท่านในการให้ข้อมูลที่เป็นประโยชน์ข้างต้นมา ณ ที่นี้ P87-88 Feed back.indd 1 5/4/2553 13:21:29 ส่ง แสตมป์ P87-88 Feed back.indd 2 กองควบคุมวัตถุเสพติด สำ�นักงานคณะกรรมการอาหารและยา กระทรวงสาธารณสุข ถ.ติวานนท์ อ.เมือง จ.นนทบุรี 11000 2/4/2553 12:34:42

Top subcategories

Top subcategories

Top subcategories

Top subcategories

Top subcategories

Top subcategories

Top subcategories

Top subcategories

Download PNdex - กองควบคุมวัตถุเสพติด